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DISSERTATION ABSTRACT 
Dylan Charles Sieck 
Doctor of Philosophy 
Department of Human Physiology 
September 2020 
Title: Histamine and Cardiovascular Adaptation to Endurance Exercise 
Adaptations associated with repeated aerobic exercise come in many forms and 
act synergistically to increase the amount of oxygen an individual can consume during 
exercise. Moderate intensity aerobic exercise causes increased histamine concentrations 
within the active skeletal muscle that is released from mast cell degranulation or de novo 
formation through the enzyme histidine decarboxylase (Steven A. Romero et al., 2016). 
Histamine activates H1 and H2 receptors on vascular endothelial cells and vascular 
smooth muscle cells of the working skeletal muscle to acutely cause vasodilation and 
promote increased blood flow. Exercise induced histamine release not only affects post-
exercise hemodynamics, but also influences glucose delivery to skeletal muscle, mediates 
the normal inflammatory response to aerobic exercise, as well as mRNA expression 
following a single bout of exercise (S A Romero et al., 2016). Outside of the exercise-
induced mRNA response, histamine release also mediates other signaling mechanisms 
that are indirectly involved with adaptation to exercise training such as angiogenesis and 
red blood cell maturation (Byron, 1877; Qin et al., 2013). Taken together, there is ample 
evidence that by repeatedly activating or antagonizing histamine receptors during 
exercise, physiological adaptations to repeated exercise stress could be modulated. The 
overall purpose of this dissertation was to determine the role of histamine receptor 
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activation in adaptations to aerobic exercise training. We hypothesized histamine receptor 
antagonists would blunt positive physiologic adaptation, or gains in aerobic capacity, by 
effecting the ability to deliver and utilize oxygen during subsequent exercise. The results 
indicate that the ability to deliver oxygen through increased blood volume via 
hematopoiesis did not contribute to increased aerobic capacity and was not affected by 
histamine receptor blockade. However, the ability to deliver oxygen through increased 
angiogenesis (assessed via capillary density and corroborated by peak vasodilatory 
capacity) and utilize oxygen through increased SDH activity (corroborated by VO2peak) 
contribute to increased exercise capacity but that these adaptations occur either 
independent of the effects of histamine receptor activation or that adaptation is generated 
by redundant mechanisms in a highly resilient manner. 
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CHAPTER I 
INTRODUCTION 
Statement of the Problem  
The measurement of maximal oxygen consumption (VO2Max) is used not only to 
assess exercise performance, but also as a marker of population-based cardiorespiratory 
fitness, cardiovascular disease, and mortality, which all show positive adaptation with 
continued exercise training (Lamonte et al., 2006; Lee, Hsieh, & Paffenbarger, 1995; 
Pedersen & Saltin, 2015). Physical inactivity is a known, but modifiable, risk factor that 
can contribute to lifestyle-related diseases, including many causes of preventable death 
(F. Booth, Roberts, & Laye, 2012). However, only 50% of the American population 
exercise regularly with only 33% of the exercising population that perform the 
recommended amount of physical activity each week (Benjamin et al., 2017). Since 
exercise is medicine that the general population does not want to consume, all efforts 
should be made to ensure the beneficial adaptations associated with repeated exercise are 
realized. Therefore, the need to maximize the positive effects of exercise training is of the 
upmost importance and strategies to enhance post-exercise recovery such as altered 
nutrition, temperature, or supplements are commonly employed (Dalleck, 2017). The 
efficacy of post-exercise recovery strategies remains questionable and generally cannot 
be applied across a population to promote positive responses, therefore factors that 
modulate training induced adaptation need further exploration (Meredith J. Luttrell & 
Halliwill, 2015; Padilla & Mickleborough, 2007). 
 Adaptations associated with repeated aerobic exercise come in many forms and 
act synergistically to increase the amount of oxygen an individual can consume during 
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exercise. The concept that there is a limit to the transport of oxygen from the environment 
to be used for energy production, termed maximal oxygen consumption, started nearly a 
century ago and is still being utilized today (Hill, Long, & Lupton, 1924). Maximum 
oxygen consumption is now a commonly used tool in exercise physiology to assess 
fitness levels, and can also be used in the general population to assess clinical risk of 
multiple preventable diseases (F. Booth et al., 2012). The ability to adapt to exercise 
training is highly variable across individuals and that variability is not well understood 
(Green, Spence, Rowley, Thijssen, & Naylor, 2012; Moreau & Ozemek, 2017; Peake et 
al., 2015). Exploiting physiological responses to acute exercise can provide insight into 
the process of physiological adaptation and help further understand how to promote 
positive physiologic adaptations across the population. 
 Many of the signaling mechanisms thought to be responsible for the beneficial 
physiological adaptations to exercise training remain elevated during the period of 
recovery from exercise and could be exploited to modulate adaptation (Meredith J. 
Luttrell & Halliwill, 2015; Steven A. Romero, Minson, & Halliwill, 2017). Histamine 
receptor activation is known to be the primary driver of post-exercise hypotension 
(Barrett-O’Keefe, Kaplon, & Halliwill, 2013); thus, modulation of histamine receptor 
activation during exercise, and subsequent reduction in post-exercise hypotension, could 
influence adaptation to repeated exercise stress (Meredith J. Luttrell & Halliwill, 2015). 
Exercise induced histamine release not only affects post-exercise hemodynamics, but also 
influences glucose delivery to skeletal muscle, mediates the normal inflammatory 
response to aerobic exercise, as well as mRNA expression following a single bout of 
exercise (S A Romero et al., 2016). Outside of the exercise-induced mRNA response, 
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histamine release also mediates other signaling mechanisms that are indirectly involved 
with adaptation to exercise training such as angiogenesis and red blood cell maturation 
(Byron, 1877; Qin et al., 2013). Taken together, there is ample evidence that by 
repeatedly activating or antagonizing histamine receptors during exercise, physiological 
adaptations to repeated exercise stress could be modulated.  
Purpose and Hypothesis 
The overall purpose of this dissertation was to determine the role of histamine 
receptor activation in adaptations to aerobic exercise training. Specifically, following six 
weeks of aerobic cycling exercise training in young healthy inactive volunteers, we 
determined the effect of histamine receptor antagonists on improvements in:1) aerobic 
capacity, 2) angiogenesis and blood volume, and 3) skeletal muscle SDH activity. The 
overall hypothesis of this dissertation is that histamine receptor antagonists will blunt 
positive physiologic adaptation, or gains in aerobic capacity, by affecting the ability to 
deliver and utilize oxygen during exercise. Specifically, following six weeks of aerobic 
cycling exercise training in young healthy inactive volunteers, we hypothesized that 
histamine receptor antagonists will blunt exercise induced gains in: 1) aerobic capacity 
and maximal work, 2) capillarization and blood volume, and 3) skeletal muscle 
mitochondrial succinate dehydrogenase activity.  
Significance 
The research objectives outlined in this dissertation represent an advance in the 
basic scientific and mechanistic literature of adaptation to aerobic exercise training 
through a pathway responsible for robust post-exercise hemodynamic responses and gene 
expression responses to acute aerobic exercise. The mechanisms by which repeated 
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exercise stress are translated into beneficial physiological adaptation are not fully 
understood. However, histamine receptor activation during exercise has been clearly 
implicated. By blocking histamine receptor activation, we have gained novel insight into 
what role this signaling pathway has in the physiologic mechanisms that drive adaptation 
to aerobic exercise training. This dissertation also advances our knowledge concerning 
the role of histamine receptor activation in recovery from exercise and how this distinct 
physiological state can be used as a tool to maximize the benefits of aerobic exercise. 
Additionally, this study furthers the knowledge of disease states like hypertension and the 
use of exercise as a non-pharmacological approach to chronically reduce blood pressure.  
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CHAPTER II 
REVIEW OF LITERATURE 
Introduction. 
The maximum amount of oxygen an individual can consume during exercise, 
termed VO2Max, is calculated as cardiac output multiplied by arterio-venous oxygen 
difference. The equation for VO2Max can be broken down into two parts: oxygen delivery 
and oxygen utilization. VO2Max is determined by the combined capacities of the nervous 
system to recruit muscle (motor units), the cardiovascular and pulmonary system to 
extract and deliver oxygen from the environment to the contracting skeletal muscle, and 
the increase in skeletal muscle metabolism to consume oxygen. Simply, oxygen is 
extracted from the environment, transported by blood, and utilized by working muscle 
cells. Repeated exercise stress causes physiologic adaptations of multiple body systems 
that lead to the ability to consume more oxygen and perform more work during 
subsequent exercise (F. W. Booth, Ruegsegger, Toedebusch, & Yan, 2015). The exact 
chemical and physical signals derived from exercise that drive adaption are still unknown 
and require further exploration. Isolating and manipulating these signals provides insight 
into unknown mechanisms underlying adaption to chronic exercise training.  
It is known that histamine is released during exercise and histamine receptor 
activation is an obligatory step in the normal response to an acute bout of aerobic 
exercise (Halliwill, Buck, Lacewell, & Romero, 2013; Steven A. Romero et al., 2017). 
When histamine receptor activation is antagonized, normal molecular responses to 
exercise are modulated and post-exercise reductions in blood pressure are attenuated (S A 
Romero et al., 2016). These physiological responses to histamine receptor antagonism 
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play a major role in how the body responds to exercise and allude to the lack of 
understanding regarding the role of histamine receptors in adaption to exercise training. 
(M J Luttrell & Halliwill, 2017; S A Romero et al., 2016). This chapter will address 
exercise-induced histamine release, the physiologic responses to normal adaptation to 
chronic exercise, and highlight the importance of histamine receptor activation in these 
processes with an emphasis on how manipulating the histamine signaling pathway can 
augment the adaptive response to exercise training.  
 
Acute Exercise and Histamine. 
Evidence that histamine is released during exercise comes from a line of research 
in Dr. Halliwill’s laboratory exploring post-exercise hypotension. This research found 
that histamine is created, stored, and released within skeletal muscle. Histamine activates 
H1 and H2 receptors on vascular endothelial cells and vascular smooth muscle cells to 
cause vasodilation and promote increased blood flow. Previously active skeletal muscle 
vasculature will remain dilated for hours following exercise and result in reduced arterial 
pressure during that time. The increased blood flow and reduced arterial pressure 
following exercise is attenuated by blocking histamine H1 and H2 receptors (Mccord & 
Halliwill, 2006; J.L. McCord, Beasley, & Halliwill, 2006; Steven A. Romero et al., 
2016). Additionally, blocking histamine H1 and H2 receptors during exercise modulates 
the normal change in skeletal muscle mRNA expression related to endothelial and 
vascular function, metabolism, angiogenesis, cell maintenance, and inflammation (S A 
Romero et al., 2016). Due to the wide range of exercise related factors affected by 
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histamine receptor activation, chronic blockade of histamine receptors during exercise 
will likely affect normal exercise adaptation. 
Histamine concentrations are difficult to measure in blood because of its short 
half-life in vivo of approximately 100 s and its rapid degradation via enzymatic processes 
of di-amine oxidase or histamine-N-methyltransferase (M J Luttrell & Halliwill, 2017). 
Studies that have shown attenuation of sustained post-exercise vasodilation and post-
exercise hypotension with histamine receptor antagonism have failed to demonstrate that 
whole blood or plasma histamine concentrations increase during or following whole body 
exercise (Lockwood, Wilkins, & Halliwill, 2005; J.L. McCord & Halliwill, 2006; 
Jennifer L McCord, Beasley, & Halliwill, 2006). Additionally, studies that utilize small 
muscle mass exercise, like unilateral knee kicking, show no vasodilation in the 
unexercised leg (Barrett-O’Keefe et al., 2013; S A Romero et al., 2016). Histamine is 
released locally in the active skeletal muscle and does not spillover into the systemic 
circulation, which was confirmed by use of muscle microdialysis during exercise (S A 
Romero et al., 2016). This evidence suggests that histamine exerts its influence locally 
and that blocking its actions will have little to no effect on systemic exercise adaptations, 
but greater effects on the local exercised skeletal muscle. 
  
Mechanisms of Histamine Release.  
The mechanisms of local production and release of histamine in exercising 
skeletal muscle include mast cell degranulation and de novo formation through the 
enzyme histidine decarboxylase (Steven A. Romero et al., 2016). Both mechanisms act 
through the enzyme histidine decarboxylase (HDC) to contribute to the local production 
8 
and release of histamine in exercising skeletal muscle. The histamine molecule is a 
biogenic amine and synthesized by the pyridoxal phosphate (activated vitamin B6) 
containing L-histidine decarboxylase from the amino acid L-histidine (Criado, Criado, 
Maruta, & Filho, 2010; M J Luttrell & Halliwill, 2017). Once histamine has been 
released, it acts as either an autocrine or paracrine signal and binds to one of its 4 known 
(H1-H4) receptor subtypes. All 4 histamine receptor subtypes are G protein-coupled 
receptors but signal through different second messengers (Parsons & Ganellin, 2006). 
Activation of H1 receptors acts through a G-protein coupled (Gq) receptor that activates 
phospholipase-C and culminates in the formation of inositol triphosphate (IP3) and 
diacylglycerol (DAG), leading to increased intracellular calcium (Criado et al., 2010). 
Activation of H2 receptors acts through a G-protein coupled (Gs) receptor that causes 
increased cyclic adenosine monophosphate (cAMP) and leads to smooth muscle 
relaxation.  
The exercise-related factors that trigger histamine release are still unclear, but it 
has been thought that factors such as increased heat production, oxidative stress, 
vibration, pH changes, shear stress, and cytokines cause mast cell degranulation leading 
to histamine release (Halliwill et al., 2013). Research within the Halliwill lab has ruled 
out oxidative stress as a potential trigger of histamine release with exercise, as a potent 
antioxidant did not attenuate post-exercise hypotension (S A Romero et al., 2015). 
Vibration from muscular movement does not seem to be a likely trigger of histamine 
release, because no sustained vasodilation is observed following passive movement 
(unpublished results). Increased muscle temperature as a byproduct of muscular 
contraction is a promising candidate for histamine release as local heat therapy causes 
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increased interstitial histamine concentration, which is similar to that observed during 
exercise (Romero et al., 2016, unpublished results). Other causes of exercise-induced 
histamine release could occur, and more research is needed to understand the signal for 
histamine production during exercise. 
 
Actions of Histamine. 
Histamine H1 and H2 receptors are located on vascular smooth muscle cells and 
cause differing responses depending on the type and location of the receptor (Marshal, 
1984). When histamine is directly introduced into the circulation, it causes increased 
blood flow through small resistance coronary arteries regardless of metabolic needs 
(Kern, 1991). Intravenous injection of histamine causes hypotension, which is acutely 
mediated through H1 receptors and sustained by slower activation of H2 receptors, which 
causes vasoaction for longer periods of time (Marshal, 1984). In endothelial or smooth 
muscle cells surrounding the vasculature, activation of histamine H1 and H2 receptors 
ultimately causes vasodilation through reduced smooth muscle cytosolic calcium 
concentration. 
Histamine is synthesized and released by different cell types (mast, basophils, 
platelets) in humans and is a potent mediator of numerous physiological reactions (Criado 
et al., 2010). Depending on the location and type of receptor, histamine causes 
vasodilation, increased gut motility, bronchoconstriction, increased cardiac contractility, 
and induces shock-like symptoms (Parsons & Ganellin, 2006). Histamine induced 
vasodilation is reduced when H1 receptors are antagonized but no effect was observed 
with H2 receptor blockade, suggesting H1 receptors drive this tissue specific vasodilatory 
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response in coronary resistance arteries (Vigorito et al., 1987). In humans, activation of 
H1 and H2 receptors causes constriction of large conduit arteries when exposed to 
histamine, primarily through H1 receptors (Daneshmand, Keller, Canver, Canver, & 
Canver, 2004). In humans and other animal models, histamine H1 receptors found on the 
smooth muscle of epicardial coronary arteries cause vasodilation when exposed to 
histamine, however, activation of histamine H1 receptors in large conduit coronary 
arteries causes vasoconstriction (Miller & Bove, 1988; Toda, 1983; Vigorito, Poto, 
Picotti, Triggiani, & Marone, 1986). In animal models, activation of histamine H2 
receptors found on the smooth muscle of epicardial coronary resistance arteries causes 
vasoconstriction, but their actions are reversed in larger conduit arteries (Miller & Bove, 
1988). Together, these results demonstrate there are differing responses of activation of 
histamine receptors based on their anatomical location within species, tissues, and cell 
types. 
  
Adaptation to Repeated Exercise Stress. 
The term adaptation refers to the idea that repeated low levels of stress upregulate 
cellular pathways that improve the capacity of an organism to resist greater stress 
(Calabrese et al., 2007). On a molecular level, gene expression is increased in response to 
acute exercise stress, which causes increased synthesis of respective proteins, and 
facilitate gradual structural remodeling that leads to long-term functional improvements 
(Perry et al., 2010). On a systemic level, repeated exercise stress will improve oxygen 
delivery and utilization, enhancing one’s ability to maintain homeostasis in the face of 
increasing metabolic challenges. Adaptations to exercise that are oxygen delivery centric 
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include blood volume expansion, improved vascular function, and angiogenesis. 
Adaptation to exercise that are oxygen utilization centric include increased mitochondrial 
volume density and oxidative function. Additionally, adaptations to exercise will 
eventually cause improved overall health status via decreased blood pressure, improved 
body composition, reduced risk of cardiovascular disease, and reduced all-cause mortality 
(Lamonte et al., 2006; Lee et al., 1995; Pedersen & Saltin, 2015). 
 
Angiogenesis. With chronic dynamic exercise, there is remodeling of the vascular system 
in skeletal muscles subjected to training in order to increase oxygen delivery. This 
remodeling includes an increase in the diameter of feed arteries and also the quantity of 
arterioles and capillaries within the exercised skeletal muscle. (Green et al., 2012). 
Simply, exercise promotes growth and expansion of the capillary network, known as 
angiogenesis, within skeletal muscle (Green, Hopman, Padilla, Laughlin, & Thijssen, 
2017; Green & Smith, 2017; Prior, Yang, & Terjung, 2004). Angiogenesis causes 
increased oxygen delivery by increasing the surface area for diffusion of oxygen from red 
blood cells, which allows more oxygen to be consumed and higher levels of exercise to 
be accomplished (Green & Smith, 2017; D. H J Thijssen, De Groot, Smits, & Hopman, 
2007). The growth or decline of the skeletal muscle capillary network is dependent upon 
pro- and anti-angiogenic growth factors that are stimulated in various ways, one being 
activity level (Olfert & Birot, 2011). The upstream mechanisms of exercise induced 
angiogenesis are unclear, however shear stress and hypoxia are both thought to drive the 
formation of new capillaries in skeletal muscle with chronic exercise (Egginton, 2009, 
2011). 
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New capillaries are formed via sprouting or intussusceptive (splitting) 
angiogenesis, with much more information available on sprouting (Haas, Lloyd, Yang, & 
Terjung, 2012). Sprouting angiogenesis has 5 major steps that include: increased 
capillary permeability, endothelial cell proliferation, degradation of the vessel basement 
membrane, extension of endothelial cells, and vessel perfusion (Haas et al., 2012). 
Splitting angiogenesis is thought to occur by growth of new capillaries within the existing 
vasculature, which creates two separate vessels in parallel with each other that eventually 
become independent vessels (Olfert & Birot, 2011). Both sprouting and splitting 
angiogenesis have been shown to occur in response to increased blood flow which occurs 
during exercise (Egginton, Zhou, Brown, & Hudlická, 2001). Blood flow in the 
previously active skeletal muscle normally remains elevated following exercise and could 
be a continued stimulus for angiogenesis. However, blood flow in the previously active 
skeletal muscle following exercise is reduced with antihistamine consumption, which 
could limit the angiogenic stimulus (Barrett-O’Keefe et al., 2013; J.L. McCord & 
Halliwill, 2006).  
Capillary remodeling and angiogenesis in skeletal muscle is complex and 
dependent on the balance of pro- and anti-angiogenic factors. When the balance is in 
favor of pro-angiogenic factors, the capillary network will grow and conversely when the 
balance tips to anti-angiogenic factors the capillary network will decline (Olfert & Birot, 
2011). Acute aerobic exercise upregulates both pro- and anti-angiogenic growth factors 
within the previously active skeletal muscle such as vascular endothelial growth factor 
(VEGF), nitric oxide synthase, thrombospondin 1 and endostatin (Richardson et al., 
1999; S A Romero et al., 2016). Importantly, histamine receptor blockade modulates the 
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balance of pro- and anti-angiogenic factors following acute exercise by blunting both 
nitric oxide synthase and thrombospondin 1 mRNA (S A Romero et al., 2016). The 
blunting of both a pro- and anti-angiogenic factor with histamine receptor blockade may 
influence vascular adaptations, like angiogenesis, with exercise training. 
Activation of histamine receptors during aerobic exercise upregulates the pro-
angiogenic growth factor vascular endothelial growth factor (Ghosh, Hirasawa, & 
Ohuchi, 2001), which is attenuated with histamine receptor blockade (S A Romero et al., 
2016). The synergistic effect of histamine on vascular endothelial growth factor acts 
through H1 receptors as it is attenuated with histamine H1 receptor blockade (Lu et al., 
2013). Additionally, histamine has been shown to directly stimulate angiogenesis through 
activation of histamine receptors and is independent from growth factors like vascular 
endothelial growth factor (Qin et al., 2013). Taken together, histamine receptor activation 
and histamine itself could be a signal for angiogenesis associated with aerobic exercise 
training. Since antagonism of histamine receptors attenuates the upregulation of vascular 
endothelial growth factor, it could blunt the angiogenic potential of exercise training. 
 
Blood Volume Expansion. Chronic dynamic exercise causes an expansion of red blood 
cell and plasma volume to enhance the ability to deliver oxygen and increase aerobic 
exercise capacity (David Montero et al., 2017). Exercise training-induced blood volume 
expansion is evident by increased red blood cell and plasma volumes found in endurance 
trained individuals when compared to sedentary counterparts, regardless of sex 
differences (Michael N. Sawka, Convertino, Eichner, Schnieder, & Young, 2000). The 
primary role of red blood cells is the transport of respiratory gasses that diffuse across 
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alveolar or capillary barriers and bind to hemoglobin to be transported as bulk blood flow 
and used in oxidative phosphorylation or removed from the body. Red blood cells also 
participate in supporting exercise by buffering blood pH, clearing metabolic waste 
products, and releasing molecules like ATP or nitric oxide to modulate vascular 
conductance (Mairbäurl, 2013). Expansion of red blood cell and plasma volume with 
exercise training is a fundamental adaptation and primary driver of the enhanced ability 
to consume oxygen via increased oxygen delivery through increased cardiac preload and 
maximal cardiac output (David Montero et al., 2015). Improvements in oxygen 
consumption following exercise training are not solely due to passive increases in blood 
volume and rely on the combined adaptations of vascular oxygen delivery mechanisms 
and blood volume expansion (Warburton et al., 2004). 
Exercise training-derived increases in blood volume cause increased VO2Max that 
is reversed when red blood cell volume is experimentally manipulated to pre-exercise 
training levels through phlebotomy (Bonne et al., 2014). Additionally, sedentary 
individuals, who have no history of exercise training but higher than average VO2Max, 
have enhanced red blood cell volume, demonstrating the importance of red blood cell 
volume and oxygen delivery in determining maximal oxygen consumption during 
exercise (Martino, Gledhill, & Jamnik, 2002). Red blood cell volume expansion usually 
occurs slowly over weeks to months of exercise training, while plasma volume expansion 
occurs rapidly and can change within hours (Michael N. Sawka et al., 2000). Within the 
first 2 weeks of exercise training, all blood volume expansion can be accounted for by 
plasma volume expansion, however it takes up to 3 weeks of exercise training before red 
blood cell volume expansion is observed. Red blood cell volume expansion continues 
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with additional exercise training and has maximal values around a 10% increase from 
pre-training (Michael N. Sawka et al., 2000).  
Studies that utilize exercise training have reported inconsistent expansion of red 
blood cell volume ranging from no change following months of training (Shoemaker, 
Green, Coates, Ali, & Grant, 1996), to a 10% increase in red cell volume following 6-
weeks of exercise training (Bonne et al., 2014). It is likely that inconsistencies in training 
intensity, duration, and population are driving these differences in response (David 
Montero et al., 2017; Michael N. Sawka et al., 2000). Current meta-analyses demonstrate 
that young sedentary individuals will show moderate (4%) red blood cell volume 
expansion in response to endurance exercise training averaging 15 weeks, with duration 
and intensity of exercise training playing a major role in the scale of response (D. 
Montero & Lundby, 2017). When exercise intensity is controlled, continuous exercise 
training and high intensity interval training have similar effects on blood volume 
expansion across similar time periods (Warburton et al., 2004). Additionally, exercise 
training related factors like initial training status of the population, exercise intensity, 
exercise modality, and posture during exercise can all factor into the scale of blood 
volume expansion observed (Michael N. Sawka et al., 2000). 
Red blood cell production is a heavily regulated process that starts with 
hematopoietic stem cells located within bone marrow that have the unique ability to 
produce any mature blood cell type in a process termed hematopoiesis. The hormone 
erythropoietin is required for common myeloid progenitor cells to mature into red blood 
cells (M.N. Sawka, 1999). The principle factor regulating red cell volume expansion is 
the hormone erythropoietin, which is stimulated by factors like hypoxia and reduced 
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central venous pressure that occur during exercise (M.N. Sawka, 1999). Erythropoietin is 
a glycoprotein hormone produced in the kidney and stimulates proliferation and 
maturation of erythroid progenitor cells found in bone marrow, which ultimately leads to 
increased release of red blood cells into the circulation (Jelkmann, 2011). Plasma 
erythropoietin levels will increase around 30% in untrained individuals following 60 min 
of cycle exercise at 50-70% VO2Max. However acute plasma erythropoietin responses to 
exercise will decrease with continued exercise training (David Montero et al., 2017). 
These findings suggest that sedentary individuals will have a robust erythropoietin 
response to exercise that will decrease with further exercise exposure at the same 
intensity and could shine light on the inconsistent red blood cell volume expansion found 
across the literature. 
Mature red blood cells and mast cells are derived specifically from common 
myeloid progenitors and as the stem cell matures it undergoes changes in gene expression 
that move it closer to a specific cell type (Szade et al., 2018). The level of the enzyme 
histidine decarboxylase is very high in bone marrow compared to other tissue types and 
histamine release in bone marrow initiates additional histamine induction through 
enzymatic activity (Hirata, 1975). Additionally, hematopoietic stem cells express 
histamine H2 receptors that initiate changes in the cell cycle when activated (Byron, 
1877). This indicates that antihistamine use could inhibit hematopoiesis that would 
normally be associated with exercise training. 
 
Mitochondrial Biogenesis. There is a well-established expansion of the oxidative capacity 
of trained skeletal muscles to enhance the ability to utilize oxygen with chronic aerobic 
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exercise (F. W. Booth et al., 2015; Howald, 1985). It has been known since the 1960s that 
exercise training results in increased mitochondrial protein levels involved with ATP 
production when compared with sedentary controls (Holloszy, 1967). Mitochondrial 
biogenesis is defined as an increase in skeletal muscle mitochondrial number and volume, 
with increased organelle protein content (Egan & Zierath, 2013). Mitochondria found in 
skeletal muscle form two distinct populations, subsarcolemmal and intermyofibrillar, 
based on their location within the myocyte. Intermyofibrillar mitochondrial populations 
are in close proximity to the contractile apparatus, while subsarcolemmal mitochondria 
are responsible for energy demands of maintaining the cell membrane (F. W. Booth et al., 
2015). The stimulus for mitochondrial biogenesis is muscle contraction; thus, 
mitochondrial biogenesis is fiber type specific such that muscle fibers not recruited 
during exercise training will display limited or no mitochondrial adaptations (Hood, 
2001).  
Mitochondrial biogenesis is a complicated process that involves the coordinated 
transcription of two genomes and assembly of large protein and enzyme complexes into a 
functional electron transport chain (Hood, Irrcher, Ljubicic, & Joseph, 2006). Muscular 
contraction is the primary signal for mitochondrial biogenesis and can cause altered rate 
of gene transcription, mRNA degradation, mitochondrial protein import, or protein 
folding, all of which can influence protein level and functional oxygen consumption 
capacities (F. W. Booth et al., 2015; Hood, 2001). A single bout of endurance exercise 
has been shown to upregulate the expression of the inducible coactivator protein 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha, which regulates 
the coordinated expression of mitochondrial proteins and has been positively correlated 
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with increased skeletal muscle mitochondria quantity (F. W. Booth et al., 2015; Lin, 
Handschin, & Spiegelman, 2005). Continuous exercise stimulus is needed to maintain 
elevated mitochondrial volume density as mitochondrial protein and enzyme levels will 
start to decline following 7 days of disuse (Henriksson & Reitman, 1977). Mitochondrial 
content will increase up to 100% and remain at that elevated steady state following 6-
weeks of exercise training depending on intensity and duration of exercise (Hoppeler, 
1986). Moderate improvements in VO2Max (around 5-20%) with 6-weeks of endurance 
exercise training can be explained by the large increases (50-100%) in mitochondrial 
content and the ability to utilize oxygen. Interestingly, moderate improvements in VO2Max 
fail to explain large enhancements in exercise performance within the same time frame 
(Levine, 2008; Vollaard et al., 2009).  
Increases in mitochondrial biogenesis can be assessed using multiple methods 
including direct assessment of organelle volume in relation to total cellular volume 
(mitochondrial volume density), total count of mitochondrial DNA copy number, or 
expression of inducible coactivators like peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha that regulate the expression of mitochondrial proteins (Hood, 
2001). Additionally, mitochondrial content can be assessed by the maximal velocity of 
reactions of marker enzymes like citrate synthase or succinate dehydrogenase under 
supraphysiological substrate concentration conditions in vitro (Henriksson & Reitman, 
1977; Proctor, Sinning, Walro, Sieck, & Lemon, 1995). Changes in mitochondrial 
volumes estimated morphometrically are highly correlated with changes in enzyme 
maximum velocity values, which allows functional measurements of potential oxygen 
utilization (Reichmann, Hoppeler, Mathieu-Costello, von Bergen, & Pette, 1985). 
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Influences on Adaptation to Exercise Training. 
Hormesis refers to a process in which low doses of stress, which are damaging at 
high doses, induces a beneficial effect on an organism (Mattson, 2008; Peake et al., 
2015). Hormesis embodies the basic concept of adaptation and can be a useful tool when 
thinking about adaptation to chronic exercise stress (Radak, Chung, & Goto, 2005). The 
concept of hormesis is likely why moderate levels of physical activity cause reduced 
illness and mortality, while high doses of exercise increase those risks (Lee et al., 1995; 
Peake et al., 2015). The exact chemical or physical signals from exercise that drive 
adaptation are still unknown but thought to occur during exercise, which drive an 
adaptive response within hours following exercise. The recovery from exercise could 
therefore be a window of opportunity to modulate the exercise derived signals that drive 
adaptation (Meredith J. Luttrell & Halliwill, 2015). 
The gold standard measurement of cardiorespiratory fitness is the measurement of 
maximal oxygen consumption during exercise, or VO2Max, and can be applied across the 
population. There is a robust response in VO2Max to aerobic physical fitness programs that 
allow for increased ability to consume oxygen, along with multifaceted health benefits. 
However, there is high variation (up to 50%) in individual responses to exercise training 
with some individuals exhibiting reduced ability to increase cardiorespiratory fitness 
measured as VO2Max (Bouchard et al., 2011). In young healthy sedentary individuals, 
VO2Max is thought to be limited by cardiac output, or the ability to deliver oxygen to 
working skeletal muscle in the face of basal metabolic demand and maintaining 
homeostasis (González-Alonso & Calbet, 2003; Lundby, Montero, & Joyner, 2016; Saltin 
& Strange, 1992). However, the ability to utilize oxygen in skeletal muscle through 
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oxidative metabolism can also be a limiting factor in some populations and must be 
explored to understand the full picture of adaptation to exercise training (Joyner & Coyle, 
2008; David Montero & Díaz-Cañestro, 2015). To overcome variation associated with 
responses to exercise training, the combination of continuous and high intensity interval 
exercise will demonstrate more robust increases in VO2Max across a population (Bacon, 
Carter, Ogle, & Joyner, 2013). Therefore, studies aiming to understand the basic biology 
of exercise-induced training adaptations need to utilize methods designed for the most 
robust responses in cardiovascular fitness. 
Antioxidant supplementation is a common strategy employed to promote 
enhanced health effects associated with aerobic exercise training. Antioxidants like 
vitamin C and E are supplemented to help counteract the production of reactive oxygen 
species from mitochondrial oxidative phosphorylation (Ristow et al., 2009). However, 
antioxidant supplementation may interfere with exercise induced cell signaling is skeletal 
muscle and blunt or block adaptations to exercise training (Padilla & Mickleborough, 
2007). Direct evidence shows that daily antioxidant supplementation with vitamin C and 
E diminish increases in markers of mitochondrial biogenesis following exercise training, 
however no clear interactions were detected for improvements of VO2Max (Paulsen et al., 
2014). These results imply that normally functioning cell signaling pathways are essential 
in maximizing exercise induced adaptations to training and anything that modulates 
normal cell signaling may blunt positive adaptations. 
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Adaptation and Histamine Receptor Activation. 
Histamine is an important signaling molecule that is released during exercise, and 
activation of its receptors drive multiple post-exercise responses. Histamine receptors are 
located in multiple cell types, found throughout the body, and cause a multitude of 
physiological responses. Histamine receptor antagonism causes decrements in exercise 
performance in competitive cyclists, suggesting histamine has an inherent role in 
endurance exercise capacity (Ely et al., 2019). Additionally, histamine receptor 
antagonism during muscle damaging exercise results in increased markers of muscle 
damage, while minimizing strength loss normally associated with this exercise modality, 
suggesting histamine may play a protective role in exercise induced muscle damage (Ely 
et al., 2017). Blocking histamines actions could influence physiological adaptation to 
exercise training in multiple ways including reduced expression of nitric oxide synthase, 
post-exercise blood flow, angiogenesis, and red blood cell formation. Normally 
functioning cell signaling pathways are essential in maximizing exercise induced 
adaptations to training and anything that modulates normal cell signaling may blunt 
positive adaptations (Padilla & Mickleborough, 2007). 
Histamine is an established endothelial-dependent vasodilator that acutely 
modulates smooth muscle tone by activation of endothelial nitric oxide synthase and 
formation of nitric oxide. Histamine H1 and H2 receptor blockade has been shown to 
decrease expression of endothelial nitric oxide synthase following acute exercise (S A 
Romero et al., 2016). A histamine-induced upregulation of endothelial nitric oxide 
synthase gene expression could result in a sustained enhancement of nitric oxide 
production, which would help increase oxygen delivery during exercise. This represents a 
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clear pathway of histamine receptor activation and positive adaptations to endurance 
exercise training that could be blunted with chronic use of histamine receptor antagonists.  
Histamine receptor activation is essential for normally observed post exercise 
increased blood flow of the previously active skeletal muscle. Specifically, histamine H2 
receptor activation on vascular smooth muscle causes sustained vasodilation in the 
previously active skeletal muscle (J.L. McCord & Halliwill, 2006; Jennifer L McCord et 
al., 2006; Pellinger, Simmons, Maclean, & Halliwill, 2010). Antagonism of histamine H1 
and H2 receptors consistently reduces post-exercise vasodilation by ~80% and post-
exercise hypotension by ~65% following 60 min cycling exercise at 60% VO2Peak 
(Lockwood et al., 2005; J.L. McCord & Halliwill, 2006; Jennifer L McCord et al., 2006). 
Histamine receptor activation induced blood flow patterns and blood pressure reductions 
following exercise could be a stimulus for positive adaptations to endurance exercise 
training that could be blunted with chronic use of histamine receptor antagonists 
Both sprouting and splitting angiogenesis have been shown to occur in response 
to increased blood flow (Egginton et al., 2001), which occurs during exercise. Blood flow 
is also elevated following exercise due to activation of histamine receptors (Barrett-
O’Keefe et al., 2013; J.L. McCord & Halliwill, 2006). Histamine has been shown to 
directly stimulate angiogenesis through activation of histamine receptors and is 
independent from growth factors like vascular endothelial growth factor (Qin et al., 
2013). Histamine receptor blockade modulates the balance of pro- and anti-angiogenic 
factors following acute exercise by blunting both nitric oxide synthase and 
thrombospondin 1 gene expression (S A Romero et al., 2016). The blunting of both a pro- 
and anti-angiogenic factor with histamine receptor blockade may influence vascular 
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adaptations, like angiogenesis, with exercise training. Activation of histamine receptors 
during aerobic exercise upregulated the pro-angiogenic growth factor vascular 
endothelial growth factor (Ghosh et al., 2001) and is attenuated with histamine receptor 
blockade (S A Romero et al., 2016). The synergistic effect of histamine on vascular 
endothelial growth factor could be attenuated with histamine H1 receptor blockade (Lu et 
al., 2013). Taken together, histamine receptor activation and histamine itself could be 
signals for angiogenesis that occurs with aerobic exercise training. Since antagonism of 
histamine receptors attenuates post-exercise vasodilation following acute exercise, it 
could also blunt the angiogenic potential of exercise training. 
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CHAPTER III 
EXPLANATION OF THE METHODOLOGY 
Overview of Project.  
Studies conducted in this dissertation were approved by the Institutional Review 
Board at the University of Oregon (Protocol #10272017.031) and conducted in 
accordance with guidelines set forth by the Office for Protection of Human Subjects at 
the University of Oregon. Written informed consent was obtained from all subjects 
subsequent to a verbal briefing of experimental design, total time commitments, and 
testing procedures. The double-blind placebo controlled research protocol included 
young, recreationally active men and women undergoing a 6-week exercise training 
intervention (exercising 3-4 times per week, totaling 21 sessions) with the experimental 
group consuming over-the-counter antihistamine drugs and a control group consuming a 
placebo 1h prior to each exercise session. There were 6 data collection study days that 
included 2 separate study days for pre- and post-training measurements (4 total) and 1 
study day after every 7 exercise sessions, or 2 weeks, depending on subject schedules. All 
study days were conducted on the University of Oregon Campus in Esslinger Hall apart 
from muscle biopsy procedures, which were completed in Pacific Hall. Figure 3.1 shows 
an overview of the research timeline.  
 
Subject Characterization. 
Seventeen (11 women) healthy subjects participated in this study (age 25 ± 4 yrs, 
height 171.8 ± 9.3 cm, weight 73.8 ± 11.8 kg, body mass index 25 ± 3.2 m
2
, mean ± SD), 
Table 3.1. Sixteen (10 women) subjects completed the study as 1 subject withdrew from 
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the study after the second study day due to scheduling conflicts, thus those data were not 
included in any analysis. 
Figure 3.1. Overview of the research timeline. 
 
 
Subjects were deemed healthy following a standard health screening. Once 
written informed consent was obtained, subjects completed a self-reported questionnaire 
(Baecke sport index) to determine their average activity level for the 12 months prior to 
participating in the study in order to classify subjects as sedentary to recreationally active 
(Baecke, Burema, & Frijters, 1982). All subjects were required to abstain from 
supplements, caffeine, and alcohol for at least 12 h, and exercise for at least 24 h prior to 
all study days. Additionally, food logs were kept 24 h prior to starting the study and 
replicated before all subsequent data collection days.  
Subjects reported to the laboratory after an overnight fast for muscle biopsies and 
following a 4-h fast for all other data collection study days. All data collection study days 
took place in a thermoneutral (18-22
o
C) lab environment and were completed 24-48 h 
after the most recent exercise session. Data collection start time varied across subjects 
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due to scheduling conflicts; however, experimental start-time was held constant within a 
subject to minimize circadian influence on physiologic variables. None of the subjects 
were using any over the counter or prescription medications at the time of the study, 
except for oral contraceptives. Women completed a pregnancy test prior to all data 
collection study days, and due to the design of the exercise training program, were 
studied irrespective of menstrual cycle phase. Each vascular function testing day (study 
day 2, 16, 30, 46) started with measurements of body mass and height before the subject 
lay quietly in the supine position on a padded exam table for 20 min before vascular 
measurements started. During this time, subjects were briefed on experimental 
procedures and instrumented with a 3-lead ECG and brachial blood pressure cuff.  
Table 3.1. Subject Characteristics  
 Control Blockade 
n 9 8 
Age (yrs) 25 ± 5 24 ± 4 
Height (cm) 175.2 ± 8.4 169.8 ± 9.4 
Weight (kg) 73.2 ± 13.6 74.2 ± 10.8 
Body Mass Index (kg m-2) 23.7 ± 3.0 26.0 ± 3.2 
Baecke sport index (arbitrary units) 2.5 ± 0.6 2.5 ± 0.8 
Physical activity index (MET hr-1 week-1) 22.2 ± 13.9 35.9 ± 10.5 
60% power output (W) 124 ± 37 123 ± 36 
 Values are mean ± SD, MET, metabolic equivalents. 
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Histamine Receptor Blockade and Placebo.  
Common over-the-counter oral antihistamine drugs were used in the experimental 
arm of this study. Histamine H1 and H2 receptors were blocked using a dose of 540 mg 
fexofenadine and 300 mg ranitidine. Oral fexofenadine has been shown to selectively 
block H1 receptors (time to peak plasma concentration 1.15 h and half-life 12 h), while 
oral ranitidine has been shown to selectively block H2 receptors (time to peak plasma 
concentration 2 h and 2.5 h half-life) (Garg, 1985; Russell, 1998). Fexofenadine and 
ranitidine do not appear to cross the blood-brain barrier into the central nervous system or 
possess sedative actions (Brunton, Chabner, & Knollman, 2011). Furthermore, these 
drugs do not have any direct cardiovascular effects in the absence of histamine receptor 
stimulation (J.L. McCord & Halliwill, 2006). The combination of fexofenadine and 
ranitidine reduces sustained post-exercise vasodilation by ~80% following moderate 
intensity aerobic exercise on a cycle ergometer (Lockwood et al., 2005; Mccord & 
Halliwill, 2006; J.L. McCord et al., 2006). 
Placebo pills were manufactured by a compounding pharmacy (Creative 
Compounds, Wilsonville, OR) and contained the inactive ingredients of the fexofenadine 
and ranitidine tablets. Subjects consumed the antihistamine medication, or placebo, with 
water 1 h prior to every exercise session, but not before data collection study days. 
 
Exercise Testing and Training Protocol. 
Peak oxygen consumption. Subjects performed an incremental cycle exercise test 
(Lode Excalibur, Groningen, The Netherlands) to exhaustion, four times (following 
muscle biopsies, and/or once every data collection day (study day 1, 16, 30, 45)) 
28 
throughout the study. The exercise test consisted of 1-min workload increments until 
exhaustion to determine maximal oxygen uptake (VO2peak). Specifically, subjects expired 
breath was collected through a one-way valve connected to a pneumotach and breathed 
normally during a 2-min resting period sitting quietly on the bike. After the rest period, 
subjects began pedaling at a self-selected cadence for a 4-min warm-up period of low 
intensity cycling (40-130 W) determined as 1.5 times body weight (kg). Following the 4-
min warm-up, subjects started the maximal exercised test and continued cycling while 
workloads increased at 20 or 30 W every min until volitional fatigue. Selection of the 
workload increment was subjective based on sex and training status, with the goal of 
producing exhaustion within 9-12 min. Whole body oxygen consumption (VO2) was 
measured with a mixing chamber (Parvomedics, Sandy, UT, USA). The peak test was 
stopped and a cool-down period (40-60 W) of 3-5 min was initiated once subject reached 
exhaustion. Criteria for ending the peak test include; respiratory exchange ratio of 1.10 or 
greater, age-predicted heart rate max (220-age) was reached, pedaling cadence dropped 
below ~60 rpm, and perceived subjective exhaustion (rating of perceived exertion) on the 
Borg scale of 19-20 (Borg, 1970; Poole & Jones, 2017). The peak test was ended once 3 
of 4 criteria were met or the subject could not continue pedaling. Additionally, subjects 
completed a supramaximal exercise test (110% work rate, 90-120 s) to verify peak O2 
consumption following the cool down (Poole & Jones, 2017). Subjects continued to pedal 
and cool down for 3-5 min following the supramaximal exertion. 
Exercise Training Intervention. This study utilized a combination of exercise 
approaches including continuous exercise (CE) of moderate intensity aerobic cycling for 
1 h and high intensity interval training (HIIT) for 30 min. There were 21 exercise 
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sessions (18 CE, 3 HIIT) through the 6-week exercise program with intensity prescription 
assessed every 7 exercise sessions. Continuous exercise has been shown to elicit a robust 
vasodilatory response during recovery from exercise that is reduced by ~80% via H1 and 
H2 histamine receptor blockade (Lockwood et al., 2005; Mccord & Halliwill, 2006; J.L. 
McCord et al., 2006). High intensity interval training was included to ensure increases in 
VO2peak with training as some individuals will not show, or have blunted, adaptation to 
continuous exercise alone (Bacon et al., 2013). 
Moderate Exercise Intensity. Continuous exercise consisted of a 5 min warm-up 
and cool-down at 30% VO2peak separated by a workload that produced 60% VO2peak and 
was estimated from the following equation: 
 
[Target VO2 (ml/min)/12] – 25 = estimated workload (watts) 
Equation 3.1 Estimated Workload 
 
Steady state continuous exercise VO2 was confirmed to be 60% of peak within the first 2 
exercise session after each assessment of VO2peak. The workload was adjusted, if needed, 
to achieve a workload that produced steady-state 60% VO2peak. This workload was used 
on each of the continuous exercise sessions until VO2peak was re-assessed.  
 High Intensity Interval Training Intensity. High intensity interval training 
consisted of 5-min warm-up and cool-down periods at 30% VO2peak separated by a 20-
min period of 3:1 interval training at 90% and 30% VO2peak for a total of five 3-min 
intervals at 90% VO2peak. Equation 3.1 was used to determine all cycle intensities during 
exercise sessions. 
30 
Hemodynamic Measurements.  
Heart Rate. Heart rate was monitored on all study visits (data collection days and 
exercise sessions) using a combination of instruments. On all vascular study days, heart 
rate was monitored continuously while the subject was supine, using a three-lead 
electrocardiograph (Datex-Ohmeda Cardiocap/5, GE Healthcare, Tewksbury, MA, USA) 
and recorded using data acquisition software (Windaq; Dataq Instruments, Akron, OH, 
USA). During all exercise testing and training sessions, heart rate was also measured with 
commercially available Polar chest straps (Polar Electro, New York, NY, USA) 
connected to a Polar watch sensor and recorded manually every minute during exercise 
testing or every 5-10 min during exercise sessions.  
Arterial Blood Pressure. Arterial blood pressure was measured in the right arm at 
heart level while the subject was supine using an automated sphygmomanometer 
(Tango+, SunTech Medical, Raleigh, N.C., USA). Arterial blood pressure was measured 
in triplicate after 20 min of supine rest to begin each vascular study day and in 
accordance with guidelines set forth by the American Heart Association (Muntner et al., 
2019). Additionally, arterial blood pressure was taken following each dynamic arterial 
compliance measurement to be used in that calculation. Mean arterial pressure was 
calculated as: 
𝑀𝐴𝑃 = 𝐷𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐 𝐵𝑃 + [(𝑆𝑦𝑠𝑡𝑜𝑙𝑖𝑐 𝐵𝑃 −  𝐷𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐 𝐵𝑃) ÷ 3] 
Equation 3.2 Mean Arterial Pressure 
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Arterial Stiffness.  
Arterial stiffness was assessed via measures of dynamic arterial compliance and 
pulse wave velocity. Dynamic arterial compliance was assessed in the common carotid 
and common femoral arteries while pulse wave velocity was assessed between the 
common carotid and femoral arteries and the brachial and pedal arteries. All vascular 
function measurements were measured using either Doppler ultrasonography, applanation 
tonometry, or both. 
Doppler ultrasound applies the principles of sound wave reflection and Doppler 
shift to make measurements of arterial diameter and blood velocity simultaneously to 
estimate blood flow. This study utilized the Doppler ultrasound to make measurements of 
arterial diameter. A Phillips iE33 ultrasound was used with a 9 MHz linear array probe to 
image arterial diameter. The ultrasound probe contains a piezoelectric element that 
converts electric signals into mechanical vibrations and emits ultrasonic sound waves. 
The ultrasound probe also detects the reflected ultrasonic sound waves and converts them 
back into electrical signals (Franklin, Schlegel, & Rushmer, 2020). Video recordings of 
arterial diameter were transferred to an external hard drive for offline analysis using 
commercial wall-tracking software (Brachial Analyzer for Research v6.11.9, Medical 
Imaging Applications LLC, Coralville, IA, USA) to make vessel diameter measurements.  
Applanation tonometry measures changes in pressure using pencil-like pressure 
transducers (PCU-2000; Millar, Inc., Houston, Tx, USA) and can be applied over any 
artery of interest. Tracings were recorded using Windaq (Dataq, Inc.) and the foot 
(diastolic to systolic transition, fig 3.1) of the pressure tracing was marked to determine 
the time difference between sites. Velocity was calculated as distance over time, where 
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distance was measured between the carotid and femoral probes, or the sum of the brachial 
probe to the sternal notch, to anterior superior iliac spine, to ankle probe minus the 
distance between the brachial probe to sternal notch. Measures of dynamic arterial 
compliance and pulse wave velocity were assessed across multiple sites on the body to 
estimate stiffness of one or both conduit and peripheral segments of the arterial tree.  
 
Figure 3.2. Example carotid-brachial pulse wave velocity measurement. Distance 
measurement with time differential (left) and sample of pulse tracings from which time 
differential is measured (right) used for pulse wave velocity. Adapted from (Zanoli, 
Rastelli, Inserra, & Castellino, 2015). 
 
Common carotid and femoral dynamic arterial compliance were measured using 
high-resolution Doppler ultrasound (Phillips iE33) with a 9 MHz linear array probe and 
concurrent applanation tonometry on the contralateral side of the body. Sampling was 
initiated through DUC2 software and sampled in 40-s simultaneous recording from both 
instruments. All ultrasound recordings were performed on the right side of the body. 
Changes in arterial diameter were assessed through ultrasound images, which were 
recorded at 46 Hz and saved to the ultrasound system before being transferred to a 
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computer with custom software (Brachial Analyzer) for analysis. Changes in pressure 
were measured using applanation tonometry and recorded via Windaq data acquisition 
(Dataq, Inc.) at 100 Hz and analyzed using the valley to peak pressure differential, fig 
3.2. The change in pressure was assessed relative to changes in diameter in order to 
calculate cross-sectional compliance and β-stiffness using the following equations: 
 
DAC= [(ΔD/D)/2ΔP] * πD2 
Equation: 3.3 Dynamic arterial compliance 
 
β-index = Ln (SBP/DBP) * D/ΔD 
Equation: 3.4 β-stiffness index 
 
Pulse Wave Velocity. Pulse wave velocity is the most robust and reproducible 
measurement of arterial stiffness (Laurent et al., 2006; Rourke, Staessen, Vlachopoulos, 
Duprez, & Plante, 2002). Decreases in pulse wave velocity represent a less stiff artery, or 
better cardiovascular health (Rourke et al., 2002). Arterial pulse wave velocity has been 
shown to decrease (less stiff) with exercise training (Sugawara et al., 2005). Carotid-
femoral pulse wave velocity is a measurement of conduit artery stiffness and is predictive 
of cardiovascular outcomes in various disease conditions (Ben-Shlomo et al., 2014; 
Vlachopoulos, Aznaouridis, & Stefanadis, 2014). Brachial-ankle pulse wave velocity 
provides information about peripheral artery stiffness (Sugawara et al., 2005) as well as 
some information about conduit artery stiffness. 
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Figure 3.3. Example of femoral dynamic arterial compliance measurement. Sample 
ultrasound measurement of the common femoral artery (top) and sample pressure 
tracings with peak and valley marked for analysis (bottom) used for measurement of 
dynamic arterial compliance.  
 
Peak Reactive Hyperemia. A measurement of vascular function termed flow 
mediated dilation was collected 4 times throughout this study according to established 
methodology (Dick H.J. Thijssen et al., 2011) in order to examine well established 
increases in vascular function associated with aerobic exercise training and its role in 
oxygen delivery during exercise and improved exercise performance. However, technical 
issues associated with ultrasound video file size impacted the ability to observe peak 
dilation following arterial occlusion, which usually occurs about 30 s following release of 
the occlusion cuff. Due to these technical difficulties flow mediated dilation 
measurements had to be excluded, however peak reactive hyperemia at the onset of 
occlusion cuff release was still obtained. The measurement of peak reactive hyperemia 
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can give some insight into microvascular adaptation with exercise training as increased 
reactive hyperemia could be indicative of more complex capillary networks allowing for 
increased bulk blood flow through the conduit artery. Peak reactive hyperemia was 
measured using high-resolution Doppler ultrasound (Phillips iE33) with a 9 MHz linear 
array probe to detect blood velocity and image arterial diameter. The Phillips iE33 
ultrasound was interfaced with a computer running custom software (DUC2) to measure 
velocity through audio recordings. Ultrasound recordings were performed on the right 
side of the body. Arterial diameter was assessed through ultrasound images, which were 
recorded at 46 Hz and saved to the ultrasound system before being transferred to a 
computer with custom software (Brachial Analyzer) for analysis.  
Artery Lumen Diameter. Resting carotid, and femoral artery lumen diameter were 
measured via duplex ultrasonography. A linear-array vascular ultrasound probe (9MHz, 
Phillips iE33, Andover, MA., USA) was used for this study. An insonation angle of 60
o
 
was used to accesses artery lumen diameter across multiple locations. Video recordings 
of arterial diameter were transferred to an external hard drive for offline analysis using 
commercial wall-tracking software (Brachial Analyzer for Research v6.11.9, Medical 
Imaging Applications LLC, Coralville, IA, USA) to make vessel diameter measurements. 
Measurements of lumen diameter were taken from at least 10 cardiac cycles at end-
diastole and the mean values are reported. 
Other Acceptable Methods. In addition to measures of arterial stiffness, measures 
of vascular function to assess the ability of the artery to vasodilate and increase blood 
flow that positively correlate with increase oxygen consumption during exercise could 
have been explored. One such measurement is flow mediated dilation, which is a non-
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invasive means to assess endothelium-dependent vasodilation (Celermajer, Sorensen, 
Bull, Robinson, & Deanfield, 1994). Flow-mediated dilation uses Doppler ultrasound to 
image changes in arterial diameter in response to 5 min of arterial occlusion. Hyperemia 
follows the occlusion release, which increases shear stress on the blood vessel walls and 
translates to larger arterial diameter. Larger changes in arterial diameter indicate greater 
endothelial function and is also a well-established predictor of cardiovascular risk and 
future cardiovascular events (Shechter, Shechter, Koren-Morag, Feinberg, & Hiersch, 
2014).  
 
Blood Volume. 
Hemoglobin, hematocrit, and carbon monoxide bound to hemoglobin 
(carboxyhemoglobin (COHb)), were measured for the purpose of estimating blood and 
plasma volume. Blood and plasma volume were assessed with a carbon monoxide (CO) 
uptake method as previously described (Burge & Skinner, 1995). The CO uptake method 
was used for pre and post exercise training measurements (Day 2 and 46), while blood 
samples were collected to measure hematocrit and hemoglobin across all 4 data collection 
study days (2, 16, 30, and 46). The CO uptake blood volume technique is based on the 
dilution of a tracer, inhaled CO, which binds to hemoglobin. Once CO is bound to 
hemoglobin (HbCO) its color changes (Burge & Skinner, 1995; David Montero et al., 
2017; Siebenmann, Keiser, Robach, & Lundby, 2017) and can be detected 
spectrophotometrically with the diode-array spectrophotometer OSM3 hexoximeter 
(OSM3 hexoximeter, Radiometer, Copenhagen, Denmark). Hematocrit was measured 
with the microcapillary (75 mm) centrifuge method (Autocrit Ultra 3, Becton Dickson, 
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USA) and spun for 10 min at 11,700 rpm. Hemoglobin was measured with the OSM3 
hexoximeter (day 2 and 46) and hemocue (day 2, 16, 30, 46) (Wilburn Medical, 
Kernersville, NC, USA). All blood samples were collected in heparinized syringes or 
vacutainers and transferred to capillary tubes or microcuvettes when necessary. Subjects 
sat in a phlebotomy chair for at least 20 min in the same body position before every blood 
draw for the volume measurements. 
Carbon Monoxide Uptake Method. The CO uptake method used a dosage of 1mL 
CO per kg body weight. This dosage is predicted to raise HbCO by ~6.5% to levels 
around 8% (Burge & Skinner, 1995). A closed rebreathing circuit was utilized for this 
measurement and consisted of a glass structure connected to 2 1 L non-diffusible 
anesthesia bags and mouthpiece. The rebreathing circuit was pre-filled with 100% O2 and 
equipped with a soda-lime CO2 scrubber to prevent buildup of CO2 in the circuit. 
Subjects were instructed to exhale most of their breath to the environment before going 
onto the rebreathing circuit mouthpiece, that was still open to the environment, and 
exhaling to residual volume. Once the subject had expired to residual volume, a glass 
syringe filled with a calibrated volume of pure CO was connected to an open port. Within 
1 s of breathing down to residual volume, the subject inhaled maximally, and the CO was 
injected into the system. After reaching inspiratory capacity, the subject held their breath 
for 10 s before breathing normally for the remainder of the 2 min period, after which the 
subject breathed back down to residual volume and came off the mouthpiece. Blood 
samples were obtained before and 7 min after the CO was added to the rebreathing circuit 
in order to measure the change in HbCO% in accordance with previously described 
methods (Burge & Skinner, 1995).  
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𝑛𝐶𝑂 = 1000 𝑋 [
(
𝑃𝐵
760) 𝑋 𝑉𝑐𝑜
(0.08206)𝑋 (273 + 𝑇)
] 
Equation: 3.5 Molar Amount of Carbon Monoxide 
 
𝑛𝐻𝐵 =
𝑛𝐶𝑂 𝑋 25
∆𝐻𝑏𝐶𝑂
 
Equation: 3.6 Hemoglobin Mass 
 
𝑉𝑟𝑏𝑐 = [
644 𝑋 𝐻𝑐𝑡
𝐻𝑏
] 𝑋 𝑛𝐻𝑏 
Equation: 3.7 Hemoglobin Mass Bound to Carbon Monoxide in Milliliters 
 
𝐵𝑉 =
𝑉𝑟𝑏𝑐 𝑋 100
𝐻𝑐𝑡 𝑋 𝐹𝑐𝑒𝑙𝑙 𝑟𝑎𝑡𝑖𝑜
 
Equation: 3.8 Blood Volume 
 
𝑃𝑉 = 𝐵𝑉 − 𝑉𝑟𝑏𝑐 
Equation: 3.9 Plasma Volume 
 
These series of equations are used to calculate blood volume, plasma volume, and 
hemoglobin mass where nCO is the molar amount of carbon monoxide added to the 
rebreathing system (mmol), PB is the barometric pressure (mmHg), VCO is the volume of 
carbon monoxide (ambient temperature and pressure, dry) added to the rebreathing 
system (Liters), T is the room temperature (
o
C), nHb is the hemoglobin mass (mmol), 
ΔHbCO is the difference in carbon monoxide bound to hemoglobin levels measured 
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before and after rebreathing (percentage), VRBC is the volume of red blood cells 
(milliliters), Hct is hematocrit (percentage), Hb is hemoglobin in grams per liter, BV is 
blood volume in milliliters, PV is plasma volume in milliliters, and Fcell ratio is the 
venous to body hematocrit correction factor. 
Venous Blood Sampling. During each study day, either a butterfly needle (day 16 
and 30) or venous catheter (day 2 and 46) was used to draw venous blood samples. A 
catheter was utilized for each CO uptake experiment to sample blood at specific times 
before and after CO administration. After disinfecting the antecubital region of the arm, 
an intravenous catheter was placed by inserting a 20- or 22-gauge needle into the vein. 
Once the catheter was in place, the needle was removed, the catheter was connected to a 
saline locked extension set and held in place with a clear adhesive cover (Tagaderm, 3M, 
Maplewood, MN, USA). After each blood draw, the sampling line and catheter were 
cleared with non-lactated, non-dextrose saline solution (0.9%) and closed to both the 
sampling line and the environment. Blood samples were obtained from the sampling line 
into a sterile heparinized syringe and immediately analyzed. 
Other Acceptable Methods. Several techniques based on tracers and dyes (Evans 
blue dye, chromium, carbon monoxide) can be used to measure vascular volumes. These 
methods are based on the Fick principle with a known volume introduced into the system 
and measurements made at certain time points following, depending on the tracer or dye. 
Different tracers or dyes are useful in measuring specific components of the blood and 
are most useful depending on what question is being asked. The carbon monoxide 
technique was chosen for this study because the tracer (carbon monoxide) binds to 
hemoglobin, which is then measured by the change in color caused by this reaction. Since 
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hemoglobin carries most of the oxygen in the blood, this method was the best choice as 
this dissertation was based around increases in oxygen consumption during exercise. 
Changes in blood and plasma volume can be estimated from changes in 
hematocrit and hemoglobin using the method of Dill and Costill (Dill & Costill, 1974). 
Changes in PV are generally calculated indirectly from values of hemoglobin and 
hematocrit. The underlying assumption when using the Dill and Costill method to 
calculate relative changes is that peripheral circulating erythrocyte volume does not 
change and is comparable to total erythrocyte volume (Stewart, Warburton, Hodges, 
Lyster, & McKenzie, 2003). However, circulating erythrocyte volume was assumed to 
change through the course of exercise training so this technique was not used (Warburton 
et al., 2004).  
 
Body Composition. 
Body composition was measured on every two weeks (day 2, 16, 30, 46) by 7-site 
skinfold analysis in accordance with best practices (Reilly, Wilson, & Durnin, 1995). 
Skinfolds are measured using large calipers to determine skin and adipose tissue 
thickness around certain anatomical landmarks. The seven sites used were triceps, 
pectoralis, midaxillary, subscapular, abdomen, suprailliac, and quadriceps. Skinfold 
measurements are all made on the right side of the body and measured in duplicate with 
third measurements made if a difference of over 2 mm was observed. Additionally, body 
weight was measured at the beginning of every data collection day. Subjects were asked 
to remove their shoes and step onto a scale (Sartorius EB6CE-I, Precision Weighing 
Balances, Bradford, MA, USA). 
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Other Acceptable Measurements. Measurements of body composition can be 
made with several techniques including hydrostatic weighing, dual-energy x-ray 
absorptiometry, or air displacement plethysmography. Hydrostatic weighing is the gold 
standard for determining body composition followed closely by dual-energy x-ray 
absorptiometry. Both methods require expensive equipment and put the subject at a 
higher risk when compared to skinfold analysis. Since body composition was included in 
this dissertation as good practice with the exercise training intervention and was not a 
main variable of interest, we were able to use the less accurate but least invasive 
technique to determine body composition. 
 
Skeletal Muscle Biopsy.  
All skeletal muscle biopsies were performed on the University of Oregon campus 
in Pacific Hall by an expert muscle physiologist, Dr. Hans C. Dreyer. Prior to the 
procedure, subjects refrained from exercise for 24 h and arrived in lab fasted overnight. 
Biopsies were taken from the left vastus lateralis muscle under sterile technique. To start, 
the skin and underlying fascia were anesthetized using 1% lidocaine hydrochloride 
(Hospira Worldwide, Lake Forest, IL, USA) and subject perception of pain was verbally 
acquired to ensure the biopsy area was effectively anesthetized. Once verbal confirmation 
of local anesthetic was obtained, a small incision made in the skin and underlying fascia 
before introduction of a 5 mm Bergstrom biopsy needle to the vastus lateralis muscle. A 
20-cc syringe and tubing were attached to the aspiration port on the Bergstrom needle in 
order to apply negative pressure to assist the biopsy. After the vastus lateralis muscle 
sample was collected, a series of Steri-Strips (3M, Maplewood, MN, USA) were placed 
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over the incision and covered with a sterile transparent dressing (Tagaderm). The tissue 
sample was blotted with gauze, and any visible adipose tissue was removed before being 
mounted on cork, covered in medium (Optimal Cutting Temperature Compound (OCT)) 
and immediately fresh-frozen in melting isopentane cooled with liquid nitrogen and 
stored at -80
o
C until analysis. The muscle sample mounted on cork and fresh frozen was 
used to access either the maximum velocity of the succinate dehydrogenase reaction in 
single type-identified muscle fibers (SDHmax) or capillary density.  
Succinate Dehydrogenase Activity: Vastus lateralis muscle biopsy samples were 
cut in transverse serial sections at 6 µm thickness using a cryostat (Reichert Jung 
Frigocut 2800 Cryostat, Reichert Microscope Services, Depew, NY, USA), maintained at 
a temperature of -30
o
C. Sections were used for a quantitative assessment of the maximum 
velocity of succinate dehydrogenase reaction using a previously described quantitative 
histochemical procedure (Blanco, Sieck, & Edgerton, 1988; Enad, Fournier, & Sieck, 
1989; Fogarty, Mathieu, Mantilla, & Sieck, 2020; Proctor et al., 1995). Sections were cut 
and placed on a cover slip where they were immediately visualized to determine cross-
section orientation of cells, maintained at 5
o
C with a control solution covering the section 
on the slide. Once the orientation of the section was confirmed, serial sections were cut 
from the sample at 6 m for SDHmax measurements and at 10 µm thickness to identify 
capillaries (haematoxylin and eosin, H&E stain) and fiber type (immunoreactivity to 
myosin heavy chain, MyHC, antibodies), as described below in detail. 
For SDHmax determinations, a baseline image was acquired (Olympus IX71, 
Olympus America, Melville, NY) with a camera and image capture system running 
software (Elements C-ER, Nikon, Tokyo, Japan) for image processing. Images were 
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acquired using a 20x objective (1.0 NA) and captured in a 1200 x 1200-pixel array, with 
similar acquisition parameters across samples. An interference filter (570 nm) was used 
to limit the spectral range of the light source to the optimal absorbance wavelength for 
nitroblue tetrazolium diformazan (the SDH reaction indication). Once the baseline image 
was acquired, the control solution was removed via suction and a solution containing 80 
M succinate (to maximize substrate availability for the SDH reaction) was added. 
Thereafter, images were acquired every 15s for a 10-min period with no changes to the 
environmental conditions or image processing system throughout the experiment, fig 3.3. 
Both control (no succinate) and succinate (80 nM) solutions contained 1.5 mM 
nitro blue tetrazolium (NTB – reaction indicator), 5 mM EDTA, 0.2 mM PMS, and 0.1 
mM azide in 0.1 M phosphate buffer (pH = 7.6). The maximum concentration of 
succinate for the succinate dehydrogenase activity reaction was previously determined 
(Blanco et al., 1988; Enad et al., 1989) and validated for human muscle fibers (Proctor et 
al., 1995). In the quantitative histochemical procedure, the progressive precipitation of 
diformazan from the reduction of nitro blue tetrazolium is used as the reaction indicator 
(Blanco et al., 1988; Proctor et al., 1995). The linearity of the accumulation of NBT 
diformazan in individual vastus lateralis muscle fibers was confirmed across a 20-min 
period. Based on the linearity of the SDH reaction, a final end-point time of 10 min was 
selected to avoid any saturation of the imaging system. The SDHmax was calculated using 
the Beer-Lambert-Bouguer law: 
NTB reduction = OD/kL 
Equation: 3.10 Beer-Lambert-Bouguer Law 
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 Where OD is the average optical density within a region of interest (in this case the 
boundary of a muscle fiber), k is the molar extinction coefficient of nitro blue tetrazolium 
diformazan (26, 478 mol/cm) and L is the path length of light absorbance (6 µm) at 570 
nm (peak absorbance wavelength for nitro blue tetrazolium diformazan).  
Figure 3.4. Baseline succinate dehydrogenase activity (left) and following 10min of 
reaction (right) used to quantify the change in optical density. Scale bar indicates 150 
µm. 
 
Based on calculations using the Beer-Lambert-Bouguer law, the maximum velocity of the 
succinate dehydrogenase reaction within individual type-identified muscle fibers was 
expressed as millimoles of fumarate L tissue
-1 
min
-1
.  
Capillary Density: The assessment of capillary density was assessed using a 
Hematoxylin and Eosin staining procedure as previously described (“Guidelines for 
Hematoxylin & Eosin Staining,” 2001). Alternate 10 µm serial sections adjacent to those 
used for the succinate dehydrogenase activity SDHmax and fiber type analysis, were 
placed on a cover slip and allowed to dry for 15 min to prevent lifting of the section.  
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Figure 3.5. Example of Hematoxylin and Eosin stained transverse section of vastus 
lateralis muscle used to identify capillaries (left) zoomed in on same sample to visualize 
capillaries (right) used to quantify the number of capillaries in contact with each muscle 
fiber.  
 
Samples were fixed in 10% buffered formalin solution for 20 s before being 
stained in hematoxylin (Gill’s III, Millipore Sigma GHD332-1L, St. Louis, MO, USA) 
for 2 min. Staining was stopped by detaining slides in 1% acid alcohol (1ml HCL/100ml 
70% EtOH) for 10 s then rinsed in tap water for 5 min. A bluing reagent (0.3% ammonia 
water) was applied for 1 min before the slides were rinsed in distilled water to color the 
hematoxylin stain. The Eosin stain was applied by serial washes in 70% then 95% 
ethanol for 60 s each before staining slides in eosin-Y (Polysciences Cat309859, 
Warrington, PA, USA) for 60s. The slides were then dehydrated by serial washes in 
150 µm 400 µm 
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duplicate of 95% and 100% ethanol for 60s before the slides were cleared in xylene for 5 
min. Slides were imaged using a Motic slide scanner (Motic, Richmond, British 
Columbia, Canada) with a 20x aperture according to manufacturer specifications, fig 3.4. 
Muscle Fiber Types: Alternate 10 µm serial sections adjacent to those used for 
determination of SDHmax and H&E staining of capillaries, were placed on a cover slip 
and allowed to dry for 15 min to prevent lifting of the section. A total of 5 sections were 
cut from each sample and mounted onto a single slide to assess all fiber types. Samples 
were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for 5 min prior to starting 
immunofluorescence staining protocols. Slides were washed thoroughly in 0.1 M 
phosphate buffer before being incubated overnight at 4
o
C with each section covered in a 
unique primary antibody.  
A total of 4 primary antibodies were used to determine immunoreactivity of 
myosin heavy chain (MyHC) isoforms expressed by different muscle fiber types: (1) A 
specific skeletal muscle MyHCSlow antibody (Novus, NBP2-50299 Mouse IgG, 
Centennial, CO, USA) was used at a 1:10 dilution to identify slow type I muscle fibers. 
(2) A specific fast skeletal muscle MyHC 2A antibody (SC-71 Developmental Studies 
Hybridoma Bank, Mouse IgG, Iowa City, IA, USA) was used at a 1:1 dilution to identify 
fast type IIa muscle fibers. (3) A specific skeletal muscle MyHC2X antibody (Novus, 
NBP1-22811 Mouse IgG, Centennial, CO, USA) was used at a 1:10 dilution to identify 
fast type IIx muscle fibers. (4) A non-specific skeletal muscle MyHCFast antibody (Vector 
VP-M665, Mouse IgG, Burlingame, CA, USA) was used at a 1:10 dilution to identify all 
fast type II muscle fibers and by exclusion any fibers expressing MyHC2B (type IIb 
muscle fibers for which there is no specific antibody). After the primary antibodies 
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incubated overnight, the slides were washed thoroughly in 0.1 M phosphate buffer and 
then all sections were incubated for 2 h in secondary antibody at a 1:200 dilution (Cy3 
donkey anti-mouse IgG, ThermoFisher Scientific, Waltham, MA, USA) to assist in 
detection during imaging. Finally, the samples were washed in 0.1M phosphate buffer 
and allowed to dry before confocal microscopy. 
Transverse vastus lateralis muscle sections were imaged using a 20x oil-
immersion objective (NA 1.0) on an Olympus FV2000 laser confocal microscope capable 
of simultaneous multilabel florescence imaging. Images were captured in a 1200 x 1200-
pixel array, with similar acquisition parameters across preparations. Type-identified 
fibers were paired with the sections used to determine SDHmax and capillary density.  
 
Statistics. 
The statistical analysis for this research was performed using Prism software 
(GraphPad Prism 8, CA, USA). All subject characteristics are reported as mean ± SD and 
all additional data are reported as mean ± SEM. A Two-way ANOVA and Tukey post 
hoc test were used to compare groups and factor. There were repeated measurements over 
time with subject, drug, and time analyzed. Significance was set at P<0.05 for all 
analyses. 
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Figure 3.6. Example of slow fiber type stain (top left), fast fiber type stain (top right), all 
but 2x fiber type stain (bottom left), fast 2a fiber type stain (bottom right) used to identify 
fiber type for succinate dehydrogenase and capillary quantification.  
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CHAPTER IV 
Aerobic Exercise, Training Effects, and Vascular Health 
 
This study was made possible through the contributions of Brendan W. Kaiser, Joshua E. 
Mangum, Emily A. Larson, Michael A. Francisco, Sydney Kobak, Christopher T. 
Minson, and John R. Halliwill. Brendan, Josh, Emily, and Sydney provided much needed 
assistance with data collection throughout the study. John Halliwill and Chris Minson 
assisted in the intellectual development of the project. I was involved with all aspects of 
this project including the development of the protocol, funding through fellowship 
applications, completed all data collection, compiled the data, analysis of the data, and 
developed the manuscript.  
 
INTRODUCTION 
Aerobic exercise capacity increases with repeated exercise stress and can be 
quantified by measuring oxygen consumption during graded exercise tests (VO2Max). 
Increases in oxygen consumption with exercise training are typically associated with an 
increase in exercise performance, reflected by the amount of work accomplished at peak 
exercise. Exercise training not only promotes increased ability to preform greater work 
during subsequent exercise, but also promotes beneficial adaptation associated with 
vascular health such as increased vascular function and decreased arterial stiffness 
(Green, 2009; David Montero & Lundby, 2016). The observation that aerobic exercise 
training protects against premature cardiovascular disease and mortality is robust 
(Keteyian et al., 2008). The beneficial vascular health adaptations associated with aerobic 
exercise training cause reduced cardiovascular risk and lower rates of all-cause mortality 
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that are more protective than predicted based on traditional risk factors like hypertension 
or blood lipid levels (Green, 2009; Joyner & Green, 2009). Additionally, variables like 
arterial diameter and compliance are independent risk factors for the development of 
cardiovascular disease, which will show improvements with continuous aerobic exercise 
training (Tanaka et al., 2000). Moderate intensity aerobic exercise training results in 
improvements in aerobic capacity for the duration of training (Bacon et al., 2013), while 
also improving measures of vascular health and decreasing risk of future cardiovascular 
disease. 
Moderate intensity aerobic exercise causes increased histamine concentrations 
within the active skeletal muscle that is released from mast cell degranulation or through 
de novo formation through the enzyme histidine decarboxylase (Steven A. Romero et al., 
2016). Histamine activates H1 and H2 receptors on vascular endothelial cells and vascular 
smooth muscle cells to acutely cause vasodilation and promote increased blood flow. 
Previously active skeletal muscle vasculature will remain dilated for hours following 
exercise and result in reduced arterial pressure during that time. The increased blood flow 
and reduced arterial pressure following exercise is attenuated by blocking histamine H1 
and H2 receptors (Mccord & Halliwill, 2006; J.L. McCord et al., 2006; Steven A. Romero 
et al., 2016). Additionally, blocking histamine H1 and H2 receptors during exercise 
modulates the normal change in skeletal muscle mRNA expression related to endothelial 
and vascular function, metabolism, angiogenesis, cell maintenance, and inflammation (S 
A Romero et al., 2016).  
Blocking histamine’s actions during exercise has potential to blunt enhancements 
in markers of vascular health, like pulse wave velocity or dynamic arterial compliance, 
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normally associated with aerobic exercise training. Histamine is an established 
endothelial-dependent vasodilator that acutely modulates smooth muscle tone by 
activation of endothelial nitric oxide synthase and formation of nitric oxide. Blockade of 
histamine H1 and H2 receptors has been shown to decrease expression of endothelial nitric 
oxide synthase following acute exercise (S A Romero et al., 2016), which could 
potentially lead to reduced levels of nitric oxide and a blunted vasodilator tone 
manifested as reduced arterial compliance or increased arterial pulse wave velocity 
(Fitch, Vergona, Sullivan, & Wang, 2001). A histamine-induced upregulation of 
endothelial nitric oxide synthase gene expression could result in a sustained enhancement 
of nitric oxide production, which would benefit the previously mentioned measures of 
vascular health.  
It is unknown if chronically consuming antihistamines prior to exercise cause 
differences in the rate or scope to exercise-induced cardiovascular adaptations. The 
purpose of this study was to determine the role of histamine receptor activation in 
adaptations to aerobic exercise training. Specifically, following six weeks of aerobic 
cycling exercise training in young healthy inactive volunteers, we determined the effect 
of histamine receptor antagonists on improvements in aerobic capacity and measures of 
vascular health. The hypothesis of this study is that in young healthy inactive volunteers, 
histamine receptor antagonists will blunt aerobic exercise-induced gains in VO2Peak and 
maximal work, as well as beneficial changes in vascular health associated with aerobic 
exercise training.  
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METHODS 
Subjects 
This study was approved by the Institutional Review Board at the University of 
Oregon. Written informed consent was obtained from all subjects prior to participation 
and the study conformed to the principles of the Declaration of Helsinki. Seventeen (6 
men, 11 women) healthy, non-smoking individuals participated in this study and were 
considered recreationally active based on exercise habits over the previous 12 months 
(Baecke, Burema, & Frijters, 1982). Subjects were deemed healthy following a standard 
health screening. Sixteen (10 women) subjects completed the study while one subject 
withdrew from the study after the second study day due to scheduling conflicts. The data 
from this subject was not included in any analysis. All subjects were required to abstain 
from supplements, caffeine, and alcohol for at least 12 h, and exercise for at least 24 h 
prior to all study days. None of the subjects were using any over the counter or 
prescription medications at the time of the study, with the exception of oral 
contraceptives. Women were studied irrespective of menstrual cycle phase and had a 
negative pregnancy test prior to all study days. Subjects reported to the laboratory 
following a 4 h fast and all study days took place in a thermoneutral lab environment. 
Data collection start-time varied across subjects due to scheduling conflicts; however, 
experimental start-time was held constant within a subject to minimize circadian 
influence on physiologic variables. With the exception of the first study day, all data 
collection occurred between 24-48 h after the most recent exercise session.  
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Experimental Design 
The research protocol consisted of a double-blind placebo-controlled exercise 
training study. Subjects underwent a 6-week exercise training intervention (exercising 3-
4 times per week, totaling 21 sessions) with an experimental group receiving 
antihistamines (BLK) and a control group receiving a placebo (CTL) prior to each 
exercise session. There were 6 study days that included 2 separate study days for pre- and 
post-training measurements and 1 study day after every 7 exercise sessions, or 2 weeks, 
depending on subject schedules. Study days are referred to as “vascular testing days” or 
“exercise testing days” based on the measurements that were made. Subjects started and 
ended the study with exercise testing days and both mid-point study days (following 2-
weeks of training) consisted of both vascular and exercise testing. All study days were 
conducted on the University of Oregon Campus in Esslinger Hall. Prior to starting the 
first study day, subjects were block-randomly assigned to the control or blockade group. 
Each exercise testing study day started with measurement of height and weight. 
The subject was then instrumented with a Polar chest-strap heart rate monitor and Hans-
Rudolph two-way non-rebreathing valve with headgear and nose clip. Subjects sat quietly 
on the bike for 2 min before warming up for 5 min and starting the incremental exercise 
test. Once peak oxygen consumption was reached, subjects cooled down for 3-4 min 
before completing a supra-maximal exercise effort to verify that VO2Peak had been 
attained.  
Each vascular function testing day started with measurements of body mass and 
height before the subject lay quietly in the supine position on a padded exam table for 20 
min prior to initiating vascular measurements. During this time, subjects were 
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instrumented with a 3-lead electrocardiogram and brachial blood pressure cuff. Following 
the 20-min supine resting period, heart rate and blood pressure were measured in 
triplicate. Vascular measurements started with dynamic arterial compliance 
measurements of the carotid and femoral arties, followed by pulse wave velocity 
measurements of the carotid-femoral segments and the brachial-ankle segments 
 
Histamine Receptor Blockade and Placebo.  
Common over-the-counter oral antihistamine drugs were used in the experimental 
arm of this study. Histamine H1 and H2 receptors were blocked using a dose of 540 mg 
fexofenadine and 300 mg ranitidine. Placebo pills were manufactured by a compounding 
pharmacy (Creative Compounds, Wilsonville, OR) and contained the inactive ingredients 
of the fexofenadine and ranitidine tablets. Subjects consumed the antihistamine 
medication, or placebo, with water 1 h prior to every exercise session, but not before data 
collection study days. 
 
Exercise Testing and Training Protocol. 
Peak oxygen consumption. Subjects performed an incremental cycle exercise test 
(Lode Excalibur, Groningen, The Netherlands) to exhaustion, four times (study day 1, 16, 
30, 45) throughout the study. The exercise test consisted of 1-min workload increments 
until exhaustion to determine maximal oxygen uptake (VO2peak). Specifically, subjects 
expired breath was collected through a one-way valve connected to a pneumotach and 
mixing chamber and breathed normally during a 2-min resting period sitting quietly on 
the bike. After the rest period, subjects began pedaling at a self-selected cadence for a 4-
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min warm-up period of low intensity cycling (40-130 W) determined as 1.5 times body 
weight (kg). Following the 4-min warm-up, subjects started the maximal exercised test 
and continued cycling while workloads increased at 20 or 30 W every min until volitional 
fatigue. Selection of the workload increment was subjective based on sex and training 
status, with the goal of producing exhaustion within 9-12 min. Whole body oxygen 
consumption (VO2) was measured with a mixing chamber (Parvomedics, Sandy, UT, 
USA). The peak test was stopped and a cool-down period (40-60 W) of 3-5 min was 
initiated once subject reached exhaustion. Criteria for ending the peak test include; 
respiratory exchange ratio of 1.10 or greater, age-predicted heart rate max (220 - age) was 
reached, pedaling cadence dropped below ~60 rpm, and perceived subjective exhaustion 
(rating of perceived exertion) on the Borg scale of 19-20 (Borg, 1970; Poole & Jones, 
2017). The peak test was ended once 3 of 4 criteria were met or the subject could not 
continue pedaling. Additionally, subjects completed a supramaximal exercise test (110% 
work rate, 90-120 s) to verify peak O2 consumption following the cool down (Poole & 
Jones, 2017). Subjects continued to pedal and cool down for 3-5 min following the 
supramaximal exertion. 
Exercise Training Intervention. This study utilized a combination of exercise 
approaches including continuous exercise (CE) of moderate intensity aerobic cycling for 
1 h and high intensity interval training (HIIT) for 30 min. There were 21 exercise 
sessions (18 CE, 3 HIIT) through the 6-week exercise program with intensity prescription 
assessed every 7th exercise session. Continuous exercise has been shown to elicit a robust 
vasodilatory response during recovery from exercise that is reduced by ~80% via H1 and 
H2 histamine receptor blockade (Lockwood et al., 2005; Mccord & Halliwill, 2006; J.L. 
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McCord et al., 2006). High intensity interval training was included to ensure increases in 
VO2peak with training as some individuals will not show, or have blunted, adaptation to 
continuous exercise alone (Bacon et al., 2013). 
Moderate Exercise Intensity. Continuous exercise consisted of a 5 min warm-up 
and cool-down at 30% VO2peak separated by a workload that produced 60% VO2peak for 
50 min. Steady state continuous exercise VO2 was confirmed to be 60% of peak within 
the first 2 exercise session after each assessment of VO2peak. The workload was adjusted, 
if needed, to achieve a workload that produced steady-state 60% VO2peak. This workload 
was used on each of the continuous exercise sessions until VO2peak was re-assessed.  
 High Intensity Interval Training Intensity. High intensity interval training 
consisted of 5-min warm-up and cool-down periods at 30% VO2peak separated by a 20-
min period of 3:1 interval training at 90% and 30% VO2peak for a total of five 3-min 
intervals at 90% VO2peak.  
 
Hemodynamic Measurements.  
Heart Rate. Heart rate was monitored on all study visits (data collection days and 
exercise sessions) using a combination of instruments. On all vascular study days, heart 
rate was monitored continuously while the subject was supine, using a three-lead 
electrocardiograph (Datex-Ohmeda Cardiocap/5, GE Healthcare, Tewksbury, MA, USA) 
and recorded using data acquisition software (Windaq; Dataq Instruments, Akron, OH, 
USA). During all exercise testing and training sessions, heart rate was measured with 
commercially available Polar chest straps (Polar Electro, New York, NY, USA) 
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connected to a Polar watch sensor and recorded manually every minute during exercise 
testing or every 5-10 min during exercise sessions.  
Arterial Blood Pressure. Arterial blood pressure was measured in the right arm at 
heart level while the subject was supine using an automated sphygmomanometer 
(Tango+, SunTech Medical, Raleigh, N.C., USA). Arterial blood pressure was measured 
in triplicate after 20 min of supine rest to begin each vascular study day and in 
accordance with guidelines set forth by the American Heart Association (Muntner et al., 
2019). Additionally, arterial blood pressure was taken following each dynamic arterial 
compliance measurement to be used in that calculation 
 
Body Composition. 
Body composition was measured every two weeks (day 2, 16, 30, 46) by 7-site 
skinfold analysis in accordance with best practices (Reilly et al., 1995). Skinfolds are 
measured using large calipers to determine skin and adipose tissue thickness around 
certain anatomical landmarks. The seven sites used were triceps, pectoralis, midaxillary, 
subscapular, abdomen, suprailliac, and quadriceps. Skinfold measurements were all made 
on the right side of the body and measured in duplicate with third measurements made if 
a difference of over 2 mm was observed. Additionally, body weight was measured at the 
beginning of every data collection day. Subjects were asked to remove their shoes and 
step onto a scale (Sartorius EB6CE-I, Precision Weighing Balances, Bradford, MA, 
USA). 
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Artery Lumen Diameter 
Carotid, and femoral artery lumen diameter were measured via duplex 
ultrasonography. A linear-array vascular ultrasound probe (9MHz, Phillips iE33, 
Andover, MA., USA) was used for this study. An insonation angle of 60
o
 was used to 
accesses artery lumen diameter across multiple locations. Video recordings of arterial 
diameter were transferred to an external hard drive for offline analysis using commercial 
wall-tracking software (Brachial Analyzer for Research v6.11.9, Medical Imaging 
Applications LLC, Coralville, IA, USA) to make vessel diameter measurements. 
Measurements of lumen diameter were taken from at least 10 cardiac cycles at end-
diastole and the mean values are reported. 
 
Arterial Stiffness. 
Arterial stiffness was assessed via measures of dynamic arterial compliance and 
pulse wave velocity. Dynamic arterial compliance was assessed in the common carotid 
and common femoral arteries while pulse wave velocity was assessed between the 
common carotid and femoral arteries and the brachial and pedal arteries. All vascular 
function measurements were measured using either doppler ultrasonography, applanation 
tonometry, or both. 
Doppler ultrasound applies the principles of sound wave reflection and doppler 
shift to make measurements of arterial diameter and blood velocity simultaneously to 
estimate blood flow. This study utilized the Doppler ultrasound to make measurements of 
arterial diameter. A Phillips iE33 ultrasound was used with a 9 MHz linear array probe to 
image arterial diameter. The ultrasound probe contains a piezoelectric element that 
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converts electric signals into mechanical vibrations and emits ultrasonic sound waves. 
The ultrasound probe also detects the reflected ultrasonic sound waves and converts them 
back into electrical signals (Franklin et al., 2020). Video recordings of arterial diameter 
were transferred to an external hard drive for offline analysis using commercial wall-
tracking software (Brachial Analyzer for Research v6.11.9, Medical Imaging 
Applications LLC, Coralville, IA, USA) to make vessel diameter measurements.  
Applanation tonometry measures changes in pressure using a pencil like pressure 
transducers (PCU-2000; Millar, Inc., Houston, Tx, USA) and can be applied over any 
artery of interest. Tracings were recorded using Windaq (Dataq, Inc.) and the foot of the 
pressure tracing was marked to determine the time difference between sites. Velocity was 
calculated as distance over time, where distance was measured between the carotid and 
femoral probes, or the sum of the brachial probe to the sternal notch, to anterior superior 
iliac spine, to ankle probe minus the distance between the brachial probe to sternal notch. 
Measures of dynamic arterial compliance and pulse wave velocity were assessed across 
multiple sites on the body to estimate stiffness of one or both conduit and peripheral 
segments of the arterial tree.  
Common carotid and femoral dynamic arterial compliance were measured using 
high-resolution Doppler ultrasound (Phillips iE33) with a 9 MHz linear array probe and 
concurrent applanation tonometry on the contralateral side of the body. Sampling was 
initiated through custom DUC2 software and sampled in 40-s simultaneous recording 
from both instruments. All ultrasound recordings were performed on the right side of the 
body. Changes in arterial diameter were assessed through ultrasound images, which were 
recorded at 46 Hz and saved to the ultrasound system before being transferred to a 
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computer with custom software (Brachial Analyzer) for analysis. Changes in pressure 
were measured using applanation tonometry and recorded via Windaq data acquisition 
(Dataq, Inc.) at 100 Hz and analyzed using the valley to peak pressure differential. The 
change in pressure was assessed relative to changes in diameter in order to calculate 
cross-sectional compliance and β-stiffness. 
 
Statistics. 
The statistical analysis for this research was performed using Prism software 
(GraphPad Prism 8, CA, USA). All subject characteristics are reported as mean ± SD and 
all additional data are reported as mean ± SEM. A Two-way ANOVA and Tukey post 
hoc test were used to compare groups and factor. There were repeated measurements over 
time with subject, condition, and sex analyzed. Significance was set at P < 0.05 for all 
analyses. 
  
RESULTS 
Subject Characteristics 
Sixteen (6 men, 10 women) healthy, non-smoking individuals participated in this 
study. Subject’s demographic and anthropometric characteristics obtained from their first 
study day include age, height, weight, body mass index, Baecke sport index, Physical 
activity index, and their 60% cycling power output, and are presented in Table 4.1 
separated by group. Demographic and anthropometric characteristics were obtained each 
study day and did not change throughout the course of the study with pre-study grouped 
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values (age 25 ± 4 yrs, height 171.8 ± 9.3 cm, weight 73.8 ± 11.8 kg, body mass index 25 
± 3.2 m
2
, mean ± SD). 
Exercise Responses. The amount of oxygen consumed at peak exercise (VO2Peak) 
throughout exercise training is shown in Figure 4.1. Pre-training VO2Peak was not 
different between control (2.63 ± 0.27 L min
-1
) and blockade (2.79 ± 0.23 L min
-1
) 
conditions. There was a main effect of time as both groups VO2Peak increased with 
training (P<0.001); however no difference was observed between groups (P=0.721) or 
interaction of condition (histamine receptor blockade) and time (training) (P=0.737). The 
control group increased VO2Peak above pre-training values at 2, 4, and 6 weeks (P<0.05), 
whereas the blockade group increased VO2Peak above pre-training values only at 4 and 6 
weeks (P<0.05) (Figure 4.1). 
The maximal amount of work (Watts) performed during peak exercise throughout 
exercise training is shown in Figure 4.2. Pre-training work was not different between 
control (227.5 ± 27.3 Watts) and blockade (227.5 ± 21.1 Watts) groups. There was a 
main effect of time (training) as maximal work performed increased in both groups 
(P<0.001); however no difference was observed between groups (P>0.999) nor was there 
an interaction of condition (histamine receptor blockade) and time (training) (P>0.999). 
Both groups increased work performed above pre-training values at 2, 4, and 6 weeks 
(P<0.05) (Figure 4.2). 
Resting Hemodynamics. Resting heart rate was not different between groups and did not 
change with exercise training (Figure 4.3). Pre-training resting heart rate was not 
different between control (61.7 ± 3.2 bpm) and histamine receptor blockade (65.1 ± 4.7 
bpm) conditions. 
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Table 4.1. Subject Characteristics  
 Control Blockade 
n 8 8 
Age (yrs) 25 ± 5 24 ± 4 
Height (cm) 175.2 ± 8.4 169.8 ± 9.4 
Weight (kg) 73.2 ± 13.6 74.2 ± 10.8 
Body Mass Index (kg m-2) 23.7 ± 3.0 26.0 ± 3.2 
Baecke sport index (arbitrary units) 2.5 ± 0.6 2.5 ± 0.8 
Physical activity index (MET hr-1 week-1) 22.2 ± 13.9 35.9 ± 10.5 
60% power output (W) 124 ± 37 123 ± 36 
Values are mean ± SD, MET, metabolic equivalents. 
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Figure 4.1. Absolute VO2Peak attained at each time point throughout the training study. 
White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre 
across both groups (main effect of time). There was no main effect of condition nor was 
there a condition x time interaction.  
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Figure 4.2. Maximal work attained at each time point throughout the training study. 
White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre 
across both groups (main effect of time). There was no main effect of condition nor was 
there a condition x time interaction. 
 
There was no main effect of time (training) for either group (P=0.546) or interaction of 
condition (histamine receptor blockade) and time (training) (P=0.296). Resting mean 
arterial pressure was not different between groups and did not change over time (Figure 
4.4). Pre-training resting mean arterial pressure was not different between control (86.3 ± 
4.8 mmHg) and histamine receptor blockade (86.6 ± 2.6 bpm) conditions. There was no 
main effect of time (training) for either group (P=0.783) or interaction of condition 
(histamine receptor blockade) and time (training) (P=0.605). 
Body Composition. Pre-training body composition measured as percent body fat was not 
different between control (23.3 ± 2.8 %) and histamine receptor blockade (24.3 ± 3.0 %) 
conditions (P=0.447). There was no main effect of time (training) for either experimental 
groups (P=178). Body composition following exercise training was not different between 
groups (P=0. 938). 
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Figure 4.3. Resting heart rate following 20 min of supine rest attained at each time point 
throughout the training study. White bars = Control; Gray bars = Blockade. Values are 
means ± SEM. There was no main effect of time, no main effect of condition, nor was 
there a condition x time interaction. 
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Figure 4.4. Resting mean arterial pressure following 20 min of supine rest attained at 
each time point throughout the training study. White bars = Control; Gray bars = 
Blockade. Values are means ± SEM. There was no main effect of time, no main effect of 
condition, nor was there a condition x time interaction. 
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Arterial Diameter. Resting carotid and femoral artery diameter, separated by 
experimental condition, and expressed in millimeters are shown in Figure 4.5. Pre-
training resting carotid artery lumen diameter was not different between control (5.95 ± 
0.19 mm) and histamine receptor blockade (6.21 ± 0.16 mm) conditions (P=0.238). There 
was a main effect of time (training) for both experimental groups (P<0.0001) as carotid 
artery lumen diameter was about 7% increased following exercise training. Resting 
carotid artery lumen diameter were increased from pre- (5.95 ± 0.19 mm) to post-exercise 
training (6.33 ± 0.24 mm) in the control group, and from pre- (6.21 ± 0.16 mm) to post-
exercise training (6.79 ± 0.13 mm) in the histamine blockade group (P<0.0001). The 
increase in carotid artery lumen diameter following exercise training was not different 
between groups (P=0.267) (Figure 4.5A). 
Pre-training resting femoral artery lumen diameter was not different between 
control (7.58 ± 0.44 mm) and histamine receptor blockade (8.67 ± 0.32 mm) conditions 
(P=0.086). There was a main effect of time (training) for both experimental groups 
(P<0.0001) as carotid artery lumen diameter was about 5% increased following exercise 
training. The control group femoral artery lumen diameter were increased from pre- (7.58 
± 0.44 mm) to post-exercise training (8.13 ± 0.45 mm) in the control group, and from 
pre- (8.67 ± 0.32 mm) to post-exercise training (9.06 ± 0.36 mm) in the histamine 
blockade group (P<0.0001). The increase in carotid artery lumen diameter following 
exercise training was not different between groups (P=0.462) (Figure 4.5B). 
Vascular Function. Dynamic arterial compliance of the carotid artery was not different 
between groups and did not change over time. Pre-training dynamic arterial compliance  
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Figure 4.5. Artery lumen diameter attained at each time point throughout the training 
study. White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 
vs Pre across both groups (main effect of time). There was no main effect of condition 
nor was there a condition x time interaction. 
 
was not different between control (0.213 ± 0.05 mm
2
 mmHg
-1
) and histamine receptor 
blockade (0.169 ± 0.04 mm
2
 mmHg
-1
) conditions. There was no main effect of time 
(training) for either group (P=0.392) or interaction of condition (histamine receptor 
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blockade) and time (training) (P=0.759). Dynamic arterial compliance of the femoral 
artery was not different between groups and did not change with training. Pre-training 
dynamic arterial compliance was not different between control (0.328 ± 0.41 mm
2
 
mmHg
-1
) and histamine receptor blockade (0.211 ± 0.06 mm
2
 mmHg
-1
) conditions. There 
was no main effect of time (training) for either group (P=0.399) or interaction of 
condition (histamine receptor blockade) and time (training) (P=0.644). 
Stiffness represented as β-stiffness index of the carotid artery was not different 
between groups and did not change with training. Pre-training β-stiffness index was not 
different between control (7.394 ± 0.84 ratio (no units)) and histamine receptor blockade 
(7.326 ± 0.77 ratio (no units)) conditions. There was no main effect of time (training) 
(P=0.697) for either groups (P=0.694) or interaction of condition (histamine receptor 
blockade) and time (training) (P=0.800). Stiffness represented as β-stiffness index of the 
femoral artery was not different between groups and did not change with training. Pre-
training β-stiffness index was not different between control (13.32 ± 4.29 ratio (no units)) 
and histamine receptor blockade (14.47 ± 3.76 ratio (no units)) conditions. There was no 
main effect of time (training) for ether group (P=0.316) or interaction of condition 
(histamine receptor blockade) and time (training) (P=0.757). 
Pulse wave velocity of the carotid to femoral artery was not different between 
groups and did not change with training. Pre-training carotid-femoral pulse wave velocity 
was not different between control (698.7 ± 32.8 cm s
-1
) and blockade (691.7 ± 32.6 cm s-
1
) conditions. There was no main effect of time (training) for either group (P=0.509) or 
interaction of condition (histamine receptor blockade) and time (training) (P=0.522). 
Pulse wave velocity of the brachial to pedal (ankle) artery was not different between 
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groups and did not change with training. Pre-training pulse wave velocity was not 
different between control (944.6 ± 50.8 cm s
-1
) and histamine receptor blockade (823.2 ± 
28.1 cm s
-1
) conditions. There was no main effect of time (training) for either group 
(P=0.280) or interaction of condition (histamine receptor blockade) and time (training) 
(P=0.649). 
 
DISCUSSION 
The purpose of this study was to determine the role of histamine receptor 
blockade on physiological adaptations induced by aerobic exercise training. We 
hypothesized that histamine receptor antagonists will blunt gains in aerobic capacity and 
measures of vascular health. The main finding of the present study was that combined 
blockade of histamine H1 and H2 receptors had no effect on the adaptations in exercise 
responses or vascular health induced by 6-weeks of endurance exercise training. These 
results suggest that chronically consuming antihistamines prior to exercise does not affect 
the adaptive ability to demonstrate improvements in measures of vascular health 
normally associated with exercise training. Additionally, consuming antihistamines prior 
to exercise does not affect the improvements in aerobic capacity that are observed 
following moderate intensity and duration exercise training.  
Exercise Capacity 
Exercise training resulted in increased aerobic capacity as evident by an increase 
in VO2Peak and work performed following 6-weeks of combined continuous and high 
intensity exercise training, with no differences in these adaptations caused by histamine 
receptor blockade. The ability to adapt to exercise training is highly variable across 
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individuals and that variability is not well understood (Green et al., 2012; Moreau & 
Ozemek, 2017; Peake et al., 2015). This issue was addressed by the combination of 
continuous moderate intensity exercise and high intensity interval exercise used during 
the 6-week exercise training protocol. The current subject population demonstrated some 
variability in aerobic capacity improvements, ranging from about 2-21% increase in 
VO2Peak, which is well within the expected variability for this exercise training duration 
and intensity combination (Bacon et al., 2013; Hautala, Kiviniemi, & Tulppo, 2009; 
David Montero & Díaz-Cañestro, 2015). On average there was about 11% improvement 
in VO2Peak following the 6-week exercise training protocol, which is in line with what 
other comparable exercise training studies have found (Bonne et al., 2014; Hautala et al., 
2009; D. H J Thijssen et al., 2007; Vollaard et al., 2009). The control group tended to 
demonstrate more improvement in VO2Peak than the blockade group (13% vs 9% 
respectively), however with the high variability of improved aerobic capacity normally 
observed, the difference in VO2Peak improvement is negligible and we conclude that the 
improvement in whole body oxygen consumption was not altered in a meaningful way 
between groups.  
Vascular Health 
Longitudinal studies have shown aerobic exercise training promote beneficial 
vascular health outcomes and reduce all-cause mortality, which is thought to occur in part 
through shear stress mediated improvements in endothelial nitric oxide availability 
(Green, 2009). While the current study did not directly measure bioavailable nitric oxide, 
histamine receptor antagonism has been shown to decrease expression of endothelial 
nitric oxide synthase following acute exercise (S A Romero et al., 2016). Histamine is an 
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established endothelial-dependent vasodilator that acutely modulates smooth muscle tone 
by activation of endothelial nitric oxide synthase and formation of nitric oxide. This led 
us to hypothesize that normal improvements in measures of vascular function would be 
blunted in the blockade group compared to the control following the exercise training 
protocol. Measuring flow mediated dilation, a gold standard measurement of vascular 
function, would have given insight into this question, however after making flow 
mediated dilation measurements in both the brachial and femoral arteries, technical 
problems with data acquisition prevented us from a possible answer. Thus, vascular 
health measures of arterial diameter, dynamic arterial compliance, and pulse wave 
velocity were also made and can give additional insight into histamine receptor blockade 
and vascular adaptations associated with exercise training. 
Arterial lumen diameter 
 Exercise training causes changes in blood flow throughout the body including 
increased blood flow to active skeletal muscle. These chronic changes in blood flow can 
cause changes in the lumen diameter of the arterial segments subjected to increased blood 
flow (Brownlee & Langille, 1991). This flow-induced adaptation is thought to occur in 
order to maintain normal shear stress since larger vessels will be able to accommodate 
higher blood flow with relatively lower shear stress (Dinenno et al., 2001). The current 
study saw increased artery lumen diameter in both the carotid and femoral arteries across 
both experimental groups. The carotid artery lumen increased by about 7% and the 
femoral artery lumen increased by about 5%, which are in line with what other 
comparable exercise training studies have reported (Dinenno et al., 2001; D. H J Thijssen 
et al., 2007). The lack of difference between experimental groups most likely indicates 
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that activation of histamine receptors and post-exercise vasodilation are not major 
contributors to conduit vessel remodeling with exercise training. It may also be 
explainable by the observation that histamine receptor blockade does not reduce blood 
flow during exercise (Ely et al., 2020), and therefore the elevated blood flow and shear 
pattern during exercise may have far greater influence than the post-exercise flow and 
shear pattern. 
Arterial stiffness 
Dynamic arterial compliance. Arterial compliance refers to the amount of arterial 
expansion and recoil that occurs with cardiac contraction and relaxation and is 
determined by both structural and functional properties of the artery (Tryggestad & Short, 
2014). Dynamic arterial compliance is decreased in sedentary individuals and multiple 
disease states, but will improve with continuous exercise training (Tanaka et al., 2000). 
Additionally, exercise training has been shown to increase total systemic arterial 
compliance in sedentary young subjects (Cameron & Dart, 1994). In the current study, 
measurements of arterial stiffness via dynamic arterial compliance did not change 
throughout the exercise training protocol. These results differ from those reported by 
previous studies in which arterial compliance was shown to decrease (improve) with 
acute cycle exercise (Kingwell et al., 1997) and after 4 weeks of exercise training at 
exercise intensities similar to those used in the present study (Cameron & Dart, 1994). 
The differences between the current results and those previously reported with similar 
exercise paradigms are likely due to methodological differences and measurements of 
total systemic vs single artery compliance. Additionally, previous measurements of total 
systemic compliance were made primarily from aortic waveform analysis via tonometry 
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and did not include diameter measurements. More recent observations, with similar 
methodology, have reported that arterial compliance improves with exercise training but 
in a different subject populations (>60 years old) who may have compromised 
compliance to start with, thus amplifying improvements with exercise training (D. H J 
Thijssen et al., 2007). Based on dynamic arterial compliance, the results of the present 
study suggest that in young healthy individuals who do not have compromised arterial 
compliance, this moderate exercise training protocol was not robust enough to illicit 
measurable changes.  
Pulse Wave Velocity. Arterial stiffness measured as pulse wave velocity describes 
the velocity at which the arterial pulse propagates through the arterial tree. Pulse wave 
velocity is the most robust and reproducible measurement of arterial stiffness (Laurent et 
al., 2006; Rourke et al., 2002). Carotid-femoral pulse wave velocity is a measurement of 
conduit artery stiffness and is predictive of cardiovascular outcomes in various disease 
conditions (Ben-Shlomo et al., 2014; Vlachopoulos et al., 2014). Brachial-ankle pulse 
wave velocity provides information about peripheral artery stiffness (Sugawara et al., 
2005) as well as some information about conduit artery stiffness. Pulse wave velocity is 
inversely related to compliance and is expected to decrease with exercise training, 
indicating less stiff arteries (Sugawara et al., 2005). Pulse wave velocity has been shown 
to decrease acutely with exercise (Kingwell et al., 1997) and with exercise training 
(Sugawara et al., 2005)(Sugawara et al., 2005)(Sugawara et al., 2005)(Sugawara et al., 
2005)(David Montero & Lundby, 2016; Sugawara et al., 2005). In both the carotid-
femoral and ankle-brachial pulse wave velocity measurements, we observed that velocity 
tended to decrease with exercise training; however, there was no statistical change with 
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training or with histamine receptor blockade. Based on pulse wave velocity, the results of 
the present study suggest that in young healthy individuals who do not have 
compromised arterial compliance, this moderate exercise training protocol was not robust 
enough to illicit measurable changes. 
Methodological considerations 
Measurements of vascular function through flow-mediated dilation would greatly 
contribute to a better understanding of the role of vascular health in adaptation to exercise 
training. Histamine is an established endothelial-dependent vasodilator through histamine 
H1 receptors, that, when bound, activates endothelial nitric oxide synthase, which 
produces nitric oxide causing vasodilation of the surrounding smooth muscle (Li et al., 
2003). In young healthy individuals, activation of endothelial H1 receptors through 
binding of histamine cause vasodilation and increased blood flow. Histamine receptor 
blockade has been shown to decrease expression of nitric oxide synthase following acute 
exercise (S A Romero et al., 2016). Additionally, histamine and nitric oxide have 
differing pro-and anti-inflammatory properties in cultured human cells (Li et al., 2003; 
Tanimoto et al., 2007) proving that histamine’s complex role in vascular health and 
disease is still being dissected. Due to the direct link between histamine and the 
endothelial-dependent release of nitric oxide, further research is needed to explore 
vascular function through flow mediated dilation and its role in how histamine mediated 
adaptation to aerobic exercise training.  
Conclusion 
Exercise training resulted in increased aerobic capacity evident by increased 
oxygen consumption and increased peak work following 6-weeks of combined 
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continuous and high intensity exercise training. Due to the lack of changes in pulse wave 
velocity or dynamic arterial compliance throughout exercise training, we conclude that in 
young healthy individuals who have nominal levels of arterial stiffness and do not have 
compromised arterial compliance, this moderate exercise training protocol was not robust 
enough to illicit measurable changes in clinical measures of arterial stiffness.   
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CHAPTER V 
Histamine and Cardiovascular Adaptation to Endurance Exercise – Oxygen 
Delivery 
 
This study was made possible through the contributions of Brendan W. Kaiser, Joshua E. 
Mangum, Emily A. Larson, Michael A. Francisco, Sydney Kobak, Christopher T. 
Minson, Hans C. Dreyer, Matthew Fogarty, Gary C. Sieck, and John R. Halliwill. 
Brendan, Josh, Emily, and Sydney provided much needed assistance with data collection 
throughout the study. Hans and Matthew helped collect and experiment with human 
skeletal muscle samples. John Halliwill and Chris Minson assisted in the intellectual 
development of the project. I was involved with all aspects of this project including the 
development of the protocol, funding through fellowship applications, completed all data 
collection, compiled the data, analysis of the data, and developed the manuscript.  
 
INTRODUCTION 
Aerobic exercise capacity increases with repeated exercise stress and can be 
quantified by measuring oxygen consumption during graded exercise tests (VO2Max). In 
young healthy sedentary individuals, VO2Max is thought to be limited by cardiac output, 
or the ability to deliver oxygen to working skeletal muscle in addition to basal metabolic 
demand while maintaining homeostasis (González-Alonso & Calbet, 2003; Lundby et al., 
2016; Saltin & Strange, 1992). Adaptations to exercise training that are oxygen delivery 
centric include blood volume expansion and angiogenesis (Bonne et al., 2014; Laughlin 
et al., 2012). Moderate intensity aerobic exercise training will result in improvements in 
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the ability to deliver oxygen during subsequent exercise and will continue to improve 
aerobic capacity through the duration of training (Bacon et al., 2013). Moderate intensity 
aerobic exercise causes increased histamine concentrations within the active skeletal 
muscle that is released from mast cell degranulation or through de novo formation 
through the enzyme histidine decarboxylase (Steven A. Romero et al., 2016). Blocking 
histamine H1 and H2 receptors during exercise modulates the normal change in skeletal 
muscle mRNA expression related to endothelial and vascular function, metabolism, 
angiogenesis, cell maintenance, and inflammation (S A Romero et al., 2016).  
Blocking the actions of histamine during exercise has potential to blunt 
enhancements in oxygen delivery, like increased red blood cell volume, normally 
associated with aerobic exercise training. The level of the enzyme histidine 
decarboxylase is very high in bone marrow compared to other tissue types, and histamine 
release in bone marrow initiates additional histamine induction through enzymatic 
activity (Hirata, 1975). Additionally, hematopoietic stem cells express histamine H2 
receptors that initiate changes in the cell cycle when activated; thus, antihistamines could 
inhibit hematopoiesis, specifically red blood cell formation, that would normally be 
associated with exercise training (Byron, 1877). These histamine-related mechanisms 
could mediate endurance exercise-induced adaptations in oxygen delivery, which could 
thus be blunted with chronic use of histamine receptor antagonists.  
Blocking the actions of histamine during exercise has potential to blunt 
enhancements in oxygen delivery through reduced signals for angiogenesis. Exercise 
promotes growth and remodeling of the capillary network, known as angiogenesis, within 
skeletal muscle. Angiogenesis is needed to support adaptation to exercise as it augments 
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blood flow to decrease transit time and increases surface area for increased diffusion of 
oxygen from red blood cells in skeletal muscle. Both sprouting and splitting angiogenesis 
have been shown to occur in response to increased blood flow which occurs during 
exercise (Egginton et al., 2001). Blood flow in the previously active skeletal muscle 
normally remains elevated following exercise and could be a continued stimulus for 
angiogenesis. However, blood flow in the previously active skeletal muscle following 
exercise is reduced with antihistamine consumption, which could limit the angiogenic 
stimulus (Barrett-O’Keefe et al., 2013; J.L. McCord & Halliwill, 2006). 
Acute aerobic exercise upregulates both pro- and anti-angiogenic growth factors 
within the previously active skeletal muscle such as vascular endothelial growth factor 
(VEGF), nitric oxide synthase, thrombospondin 1 and endostatin (Richardson et al., 
1999; S A Romero et al., 2016). Importantly, histamine receptor blockade modulates the 
balance of pro- and anti-angiogenic factors following acute exercise by blunting both 
nitric oxide synthase and thrombospondin 1 mRNA (S A Romero et al., 2016). The 
blunting of both a pro- and anti-angiogenic factor with histamine receptor blockade may 
influence vascular adaptations, like angiogenesis, with exercise training. Additionally, 
activation of histamine receptors during aerobic exercise upregulates the pro-angiogenic 
growth factor vascular endothelial growth factor (Ghosh et al., 2001), which is attenuated 
with histamine receptor blockade (S A Romero et al., 2016). The synergistic effect of 
histamine on vascular endothelial growth factor acts through H1 receptors as it is 
attenuated with histamine H1 receptor blockade (Lu et al., 2013). Additionally, histamine 
has been shown to directly stimulate angiogenesis through activation of histamine 
receptors and is independent from growth factors like vascular endothelial growth factor 
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(Qin et al., 2013). Taken together, histamine receptor activation and histamine itself 
could be a signal for angiogenesis associated with aerobic exercise training. Since 
antagonism of histamine receptors attenuates the upregulation of vascular endothelial 
growth factor, it could blunt the angiogenic potential normally associated with exercise 
training. 
It is unknown if chronically consuming antihistamines prior to exercise cause 
differences in the rate or scope to exercise-induced cardiovascular adaptations. The 
purpose of this study was to determine the role of histamine receptor activation in 
adaptations to aerobic exercise training. Specifically, following six weeks of aerobic 
cycling exercise training in young healthy inactive volunteers, we determined the effect 
of histamine receptor antagonists on improvements in aerobic capacity, blood volume, 
and angiogenesis. The hypothesis of this study is that in young healthy inactive 
volunteers, histamine receptor antagonists will blunt aerobic exercise-induced gains in 
VO2Peak and maximal work, as well as beneficial changes associated with increased 
oxygen delivery such as increased red blood cell volume and angiogenesis.  
 
METHODS 
Subjects 
This study was approved by the Institutional Review Board at the University of 
Oregon. Written informed consent was obtained from all subjects prior to participation 
and the study conformed to the principles of the Declaration of Helsinki. Seventeen (6 
men, 11 women) healthy, non-smoking individuals participated in this study and were 
considered recreationally active based on exercise habits over the previous 12 months 
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(Baecke, Burema, & Frijters, 1982). Subjects were deemed healthy following a standard 
health screening. Sixteen (10 women) subjects completed the study while one subject 
withdrew from the study after the second study day due to scheduling conflicts. The data 
from this subject was not included in any analysis. All subjects were required to abstain 
from supplements, caffeine, and alcohol for at least 12 h, and exercise for at least 24 h 
prior to all study days. None of the subjects were using any over the counter or 
prescription medications at the time of the study, with the exception of oral 
contraceptives. Women were studied irrespective of menstrual cycle phase and had a 
negative pregnancy test prior to all study days. Subjects reported to the laboratory 
following a 4 h fast and all study days took place in a thermoneutral lab environment. 
Data collection start-time varied across subjects due to scheduling conflicts; however, 
experimental start-time was held constant within a subject to minimize circadian 
influence on physiologic variables. With the exception of the first study day, all data 
collection occurred between 24-48 h after the most recent exercise session.  
 
Experimental Design 
The research protocol consisted of a double-blind placebo-controlled exercise 
training study. Subjects underwent a 6-week exercise training intervention (exercising 3-
4 times per week, totaling 21 sessions) with an experimental group receiving 
antihistamines (BLK) and a control group receiving a placebo (CTL) prior to each 
exercise session. There were 6 study days that included 2 separate study days for pre- and 
post-training measurements and 1 study day after every 7 exercise sessions, or 2 weeks, 
depending on subject schedules. Study days are referred to as “vascular testing days” or 
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“exercise testing days” based on the measurements that were made. Subjects started and 
ended the study with exercise testing days and both mid-point study days (following 2-
weeks of training) consisted of both vascular and exercise testing. All study days were 
conducted on the University of Oregon Campus in Esslinger Hall. Prior to starting the 
first study day, subjects were block-randomly assigned to the control or blockade group. 
Each exercise testing study day started with measurement of height and weight. 
The subject was then instrumented with a Polar chest-strap heart rate monitor and Hans-
Rudolph two-way non-rebreathing valve with headgear and nose clip. Subjects sat quietly 
on the bike for 2 min before warming up for 5 min and starting the incremental exercise 
test. Once peak oxygen consumption was reached, subjects cooled down for 3-4 min 
before completing a supra-maximal exercise effort to verify that VO2Peak had been 
attained. Each blood volume testing day started with measurements of body mass and 
height before the subject sat upright in a phlebotomy chair for 20 min before blood 
volume measurements were made. 
 
Histamine Receptor Blockade and Placebo.  
Common over-the-counter oral antihistamine drugs were used in the experimental 
arm of this study. Histamine H1 and H2 receptors were blocked using a dose of 540 mg 
fexofenadine and 300 mg ranitidine. Placebo pills were manufactured by a compounding 
pharmacy (Creative Compounds, Wilsonville, OR) and contained the inactive ingredients 
of the fexofenadine and ranitidine tablets. Subjects consumed the antihistamine 
medication, or placebo, with water 1 h prior to every exercise session, but not before data 
collection study days. 
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Exercise Testing and Training Protocol. 
Peak oxygen consumption. Subjects performed an incremental cycle exercise test 
(Lode Excalibur, Groningen, The Netherlands) to exhaustion, four times (study day 1, 16, 
30, 45) throughout the study. The exercise test consisted of 1-min workload increments 
until exhaustion to determine maximal oxygen uptake (VO2peak). Specifically, subjects 
expired breath was collected through a one-way valve connected to a pneumotach and 
mixing chamber and breathed normally during a 2-min resting period sitting quietly on 
the bike. After the rest period, subjects began pedaling at a self-selected cadence for a 4-
min warm-up period of low intensity cycling (40-130 W) determined as 1.5 times body 
weight (kg). Following the 4-min warm-up, subjects started the maximal exercised test 
and continued cycling while workloads increased at 20 or 30 W every min until volitional 
fatigue. Selection of the workload increment was subjective based on sex and training 
status, with the goal of producing exhaustion within 9-12 min. Whole body oxygen 
consumption (VO2) was measured with a mixing chamber (Parvomedics, Sandy, UT, 
USA). The peak test was stopped and a cool-down period (40-60 W) of 3-5 min was 
initiated once subject reached exhaustion. Criteria for ending the peak test include; 
respiratory exchange ratio of 1.10 or greater, age-predicted heart rate max (220 - age) was 
reached, pedaling cadence dropped below ~60 rpm, and perceived subjective exhaustion 
(rating of perceived exertion) on the Borg scale of 19-20 (Borg, 1970; Poole & Jones, 
2017). The peak test was ended once 3 of 4 criteria were met or the subject could not 
continue pedaling. Additionally, subjects completed a supramaximal exercise test (110% 
work rate, 90-120 s) to verify peak O2 consumption following the cool down (Poole & 
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Jones, 2017). Subjects continued to pedal and cool down for 3-5 min following the 
supramaximal exertion. 
Exercise Training Intervention. This study utilized a combination of exercise 
approaches including continuous exercise (CE) of moderate intensity aerobic cycling for 
1 h and high intensity interval training (HIIT) for 30 min. There were 21 exercise 
sessions (18 CE, 3 HIIT) through the 6-week exercise program with intensity prescription 
assessed every 7th exercise session. Continuous exercise has been shown to elicit a robust 
vasodilatory response during recovery from exercise that is reduced by ~80% via H1 and 
H2 histamine receptor blockade (Lockwood et al., 2005; Mccord & Halliwill, 2006; J.L. 
McCord et al., 2006). High intensity interval training was included to ensure increases in 
VO2peak with training as some individuals will not show, or have blunted, adaptation to 
continuous exercise alone (Bacon et al., 2013). 
Moderate Exercise Intensity. Continuous exercise consisted of a 5 min warm-up 
and cool-down at 30% VO2peak separated by a workload that produced 60% VO2peak for 
50 min. Steady state continuous exercise VO2 was confirmed to be 60% of peak within 
the first 2 exercise session after each assessment of VO2peak. The workload was adjusted, 
if needed, to achieve a workload that produced steady-state 60% VO2peak. This workload 
was used on each of the continuous exercise sessions until VO2peak was re-assessed.  
 High Intensity Interval Training Intensity. High intensity interval training 
consisted of 5-min warm-up and cool-down periods at 30% VO2peak separated by a 20-
min period of 3:1 interval training at 90% and 30% VO2peak for a total of five 3-min 
intervals at 90% VO2peak.  
 
83 
Blood Volume. 
Hemoglobin, hematocrit, and carbon monoxide bound to hemoglobin 
(carboxyhemoglobin (COHb)), were measured for the purpose of estimating blood 
volume and assessed with a carbon monoxide (CO) uptake method as previously 
described (Burge & Skinner, 1995). The CO uptake method was used for pre and post 
exercise training measurements (Day 2 and 46), while blood samples were collected to 
measure hematocrit and hemoglobin across all 4 data collection study days (2, 16, 30, and 
46). The CO uptake blood volume technique is based on the dilution of a tracer, inhaled 
CO, which binds to hemoglobin. Once CO is bound to hemoglobin (HbCO) its color 
changes (Burge & Skinner, 1995; David Montero et al., 2017; Siebenmann et al., 2017) 
and can be detected spectrophotometrically with the diode-array spectrophotometer 
OSM3 hexoximeter (OSM3 hexoximeter, Radiometer, Copenhagen, Denmark). 
Hematocrit was measured with the microcapillary (75 mm) centrifuge method (Autocrit 
Ultra 3, Becton Dickson, USA) and spun for 10 min at 11,700 rpm. Hemoglobin was 
measured with the OSM3 hexoximeter (day 2 and 46) and hemocue (day 2, 16, 30, 46) 
(Wilburn Medical, Kernersville, NC, USA). All blood samples were collected in 
heparinized syringes or vacutainers and transferred to capillary tubes or microcuvettes 
when necessary. Subjects sat in a phlebotomy chair for at least 20 min in the same body 
position before every blood draw for the volume measurements. 
Carbon Monoxide Uptake Method. The CO uptake method used a dosage of 1mL 
CO per kg body weight. This dosage is predicted to raise HbCO by ~6.5% to levels 
around 8% (Burge & Skinner, 1995). A closed rebreathing circuit was utilized for this 
measurement and consisted of a glass structure connected to 2 1 L non-diffusible 
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anesthesia bags and mouthpiece. The rebreathing circuit was pre-filled with 100% O2 and 
equipped with a soda-lime CO2 scrubber to prevent buildup of CO2 in the circuit. 
Subjects were instructed to exhale most of their breath to the environment before going 
onto the rebreathing circuit mouthpiece, that was still open to the environment, and 
exhaling to residual volume. Once the subject had expired to residual volume, a glass 
syringe filled with a calibrated volume of pure CO was connected to an open port. Within 
1 s of breathing down to residual volume, the subject inhaled maximally, and the CO was 
injected into the system. After reaching inspiratory capacity, the subject held their breath 
for 10 s before breathing normally for the remainder of the 2-min period, after which the 
subject breathed back down to residual volume and came off the mouthpiece. Blood 
samples were obtained before and 7 min after the CO was added to the rebreathing circuit 
in order to measure the change in HbCO% in accordance with previously described 
methods (Burge & Skinner, 1995).  
Venous Blood Sampling. During each study day, either a butterfly needle (day 16 
and 30) or venous catheter (day 2 and 46) was used to draw venous blood samples. A 
catheter was utilized for each CO uptake experiment to sample blood at specific times 
before and after CO administration. After disinfecting the antecubital region of the arm, 
an intravenous catheter was placed by inserting a 20- or 22-gauge needle into the vein. 
Once the catheter was in place, the needle was removed, and the catheter was connected 
to a saline locked extension set, held in place with a clear adhesive cover (Tagaderm, 3M, 
Maplewood, MN, USA). After each blood draw, the sampling line and catheter were 
cleared with non-lactated, non-dextrose saline solution (0.9%) and closed to both the 
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sampling line and the environment. Blood samples were obtained from the sampling line 
into a sterile heparinized syringe and immediately analyzed. 
 
Skeletal Muscle Biopsy.  
All skeletal muscle biopsies were performed on the University of Oregon campus 
in Pacific Hall by an expert muscle physiologist, Dr. Hans C. Dreyer. Prior to the 
procedure, subjects refrained from exercise for 24 h and arrived in lab fasted overnight. 
Biopsies were taken from the left vastus lateralis muscle under sterile technique. To start, 
the skin and underlying fascia were anesthetized using 1% lidocaine hydrochloride 
(Hospira Worldwide, Lake Forest, IL, USA) and subject perception of pain was verbally 
acquired to ensure the biopsy area was effectively anesthetized. Once verbal confirmation 
of local anesthetic was obtained, a small incision made in the skin and underlying fascia 
before introduction of a 5 mm Bergstrom biopsy needle to the vastus lateralis muscle. A 
20-cc syringe and tubing were attached to the aspiration port on the Bergstrom needle in 
order to apply negative pressure to assist the biopsy. After the vastus lateralis muscle 
sample was collected, a series of Steri-Strips (3M, Maplewood, MN, USA) were placed 
over the incision and covered with a sterile transparent dressing (Tagaderm). The tissue 
sample was blotted with gauze, and any visible adipose tissue was removed before the 
muscle sample was mounted on cork, covered in medium (Optimal Cutting Temperature 
Compound (OCT)), immediately fresh-frozen in melting isopentane cooled with liquid 
nitrogen and stored at -80
o
C until further analysis. The muscle sample mounted on cork 
and fresh frozen was used to access either the maximum velocity of the succinate 
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dehydrogenase reaction in single type-identified muscle fibers (SDHmax) or capillary 
density.  
Capillary Density: The assessment of capillary density was assessed using a 
Hematoxylin and Eosin staining procedure as previously described (“Guidelines for 
Hematoxylin & Eosin Staining,” 2001). Alternate 10 µm serial sections adjacent to those 
used for determination of SDHmax and fiber type, were placed on a cover slip and allowed 
to dry for 15 min to prevent lifting of the section. Samples were fixed in 10% buffered 
formalin solution for 20 s before being stained in hematoxylin (Gill’s III, Millipore 
Sigma GHD332-1L, St. Louis, MO, USA) for 2 min. Staining was stopped by detaining 
slides in 1% acid alcohol (1ml HCL/100ml 70% EtOH) for 10 s then rinsed in tap water 
for 5 min. A bluing reagent (0.3% ammonia water) was applied for 1 min before the 
slides were rinsed in distilled water to color the hematoxylin stain. The Eosin stain was 
applied by serial washes in 70% then 95% ethanol for 60 s each before staining slides in 
eosin-Y (Polysciences Cat309859, Warrington, PA, USA) for 60 s. The slides were then 
dehydrated by serial washes in duplicate of 95% and 100% ethanol for 60 s before the 
slides were cleared in xylene for 5 min. Slides were imaged using a Motic slide scanner 
(Motic, Richmond, British Columbia, Canada) with a 20x aperture according to 
manufacturer specifications. The number of capillary contacts was manually counted for 
each type identified muscle fiber that could be matched across SDHmax and fiber type 
serial sections. Manual capillary counting was achieved through increasing the digital 
zoom on the Tiff file (Figure 3.5) for individual type and SDHmax identified muscle cells.  
Muscle fiber types: Alternate 10 µm serial sections adjacent to those used for 
determination of SDHmax and H&E staining of capillaries, were placed on a cover slip 
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and allowed to dry for 15 min to prevent lifting of the section. A total of 5 sections were 
cut from each sample and mounted onto a single slide to assess all fiber types. Samples 
were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for 5 min prior to starting 
immunofluorescence staining protocols. Slides were washed thoroughly in 0.1 M 
phosphate buffer before being incubated overnight at 4
o
C with each section covered in a 
unique primary antibody.  
A total of 4 primary antibodies were used to determine immunoreactivity of 
myosin heavy chain (MyHC) isoforms expressed by different muscle fiber types: (1) A 
specific skeletal muscle MyHCSlow antibody (Novus, NBP2-50299 Mouse IgG, 
Centennial, CO, USA) was used at a 1:10 dilution to identify slow type I muscle fibers. 
(2) A specific fast skeletal muscle MyHC 2A antibody (SC-71 Developmental Studies 
Hybridoma Bank, Mouse IgG, Iowa City, IA, USA) was used at a 1:1 dilution to identify 
fast type IIa muscle fibers. (3) A specific skeletal muscle MyHC2X antibody (Novus, 
NBP1-22811 Mouse IgG, Centennial, CO, USA) was used at a 1:10 dilution to identify 
fast type IIx muscle fibers. (4) A non-specific skeletal muscle MyHCFast antibody (Vector 
VP-M665, Mouse IgG, Burlingame, CA, USA) was used at a 1:10 dilution to identify all 
fast type II muscle fibers and by exclusion any fibers expressing MyHC2B (type IIb 
muscle fibers for which there is no specific antibody). After the primary antibodies 
incubated overnight, the slides were washed thoroughly in 0.1 M phosphate buffer and 
then all sections were incubated for 2 h in secondary antibody at a 1:200 dilution (Cy3 
donkey anti-mouse IgG, ThermoFisher Scientific, Waltham, MA, USA) to assist in 
detection during imaging. Finally, the samples were washed in 0.1M phosphate buffer 
and allowed to dry before confocal microscopy. 
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Transverse vastus lateralis muscle sections were imaged using a 20x oil-
immersion objective (NA 1.0) on an Olympus FV2000 laser confocal microscope capable 
of simultaneous multilabel florescence imaging. Images were captured in a 1200 x 1200-
pixel array, with similar acquisition parameters across preparations. Type-identified 
fibers were paired with the sections used to determine SDHmax and capillary density.  
Peak Reactive Hyperemia. A measurement of vascular function termed, flow 
mediated dilation was collected 4 times throughout this study according to established 
methodology (Dick H.J. Thijssen et al., 2011) in order to examine well established 
increases in vascular function associated with aerobic exercise training and its role in 
oxygen delivery during exercise and improved exercise performance. However, technical 
issues associated with ultrasound video file size impacted the ability to observe peak 
dilation following arterial occlusion, which usually occurs about 30 s following release of 
the occlusion cuff. Due to these technical difficulties that would undermine validity of the 
measurement, our analysis of flow mediated dilation was excluded. However, we were 
able to consistently assess peak reactive hyperemia at the onset of occlusion cuff release. 
The measurement of peak reactive hyperemia can give some insight into microvascular 
adaptation with exercise training as increased reactive hyperemia can be indicative of 
more complex capillary networks allowing for increased bulk blood flow through the 
conduit artery. 
 
Statistics. 
The statistical analysis for this research was performed using Prism software 
(GraphPad Prism 8, CA, USA). All subject characteristics are reported as mean ± SD and 
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all additional data are reported as mean ± SEM. A Two-way ANOVA and Sidak post hoc 
test were used to compare groups and factor. There were repeated measurements over 
time with subject, condition, and sex analyzed. Significance was set at P < 0.05 for all 
analyses. 
  
RESULTS 
Subject Characteristics 
Sixteen (6 men, 10 women) healthy, non-smoking individuals participated in this 
study. Demographic and anthropometric characteristics were obtained each study day and 
did not change throughout the course of the study with pre-study grouped values (age 25 
± 4 yrs, height 171.8 ± 9.3 cm, weight 73.8 ± 11.8 kg, body mass index 25 ± 3.2 m
2
, 
mean ± SD). 
Exercise Responses. The amount of oxygen consumed at peak exercise (VO2Peak) 
throughout exercise training is shown in Figure 5.1. Pre-training VO2Peak was not 
different between control (2.63 ± 0.27 L min
-1
) and blockade (2.79 ± 0.23 L min
-1
) 
conditions. There was a main effect of time as in both groups VO2Peak increased with 
training (P<0.001); however no difference was observed between groups (P=0.721) or 
interaction of condition (histamine receptor blockade) and time (training) (P=0.737). The 
control group increased VO2Peak above pre-training values at 2, 4, and 6 weeks (P<0.05), 
whereas the blockade group increased VO2Peak above pre-training values only at 4 and 6 
weeks (P<0.05) (Figure 5.1). 
  The maximal amount of work (Watts) performed during peak exercise 
throughout exercise training is shown in Figure 5.2. Pre-training work was not different 
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between control (227.5 ± 27.3 Watts) and blockade (227.5 ± 21.1 Watts) groups. There 
was a main effect of time (training) as maximal work performed increased in both groups 
(P<0.001); however no difference was observed between groups (P>0.999) nor was there 
an interaction of condition (histamine receptor blockade) and time (training) (P>0.999). 
Both groups increased work performed above pre-training values at 2, 4, and 6 weeks 
(P<0.05) (Figure 5.2). 
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Figure 5.1. Absolute VO2Peak attained at each time point throughout the training study. 
White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre 
across both groups (main effect of time). There was no main effect of condition nor was 
there a condition x time interaction.  
 
Blood Volume. Of the 16 individuals who participated in this study, only a subset of 12 
completed all blood volume measurements. The demographic and anthropometric 
characteristics of these subjects are presented in Table 5.1. This information was obtained 
on the first study day and included age, height, weight, body mass index, Baecke sport 
index, Physical activity index, and their 60% cycling power output.  
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Figure 5.2. Maximal work attained at each time point throughout the training study. 
White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre 
across both groups (main effect of time). There was no main effect of condition nor was 
there a condition x time interaction. 
 
 
Table 5.1. Subject Characteristics  
 Control Blockade 
N 6 6 
Age (yrs) 24 ± 4 23 ± 3 
Height (cm) 172.8 ± 6.0 170.8 ± 9.9 
Weight (kg) 71.1 ± 12.5 77.1 ± 10.4 
Body Mass Index (kg m-2) 23.8 ± 3.4 26.5 ± 3.5 
Baecke sport index (arbitrary units) 2.8 ± 0.2 2.9 ± 0.4 
Physical activity index (MET hr-1 week-1) 23.8 ± 15.9 37.7 ± 12.3 
60% power output (W) 130 ± 29 126 ± 41 
Values are mean ± SD, MET, metabolic equivalents. 
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Blood volume was not different between groups and did not change with training. 
Pre-training blood volume was not different between control (5719 ± 529 mL) and 
histamine receptor blockade (6452 ± 431 mL) conditions. There was no main effect of 
time (training) in either group (P=0.434) or interaction of condition (histamine receptor 
blockade) and time (training) (P=0.329).  
Plasma volume was not different between groups and did not change with 
training. Pre-training plasma volume was not different between control (3746 ± 373 mL) 
and blockade (4212 ± 237 mL) conditions. There was no main effect of time (training) in 
either group (P=0.477) or interaction of condition (histamine receptor blockade) and time 
(training) (P=0.327).  
Red blood cell volume was not different between groups and did not change with 
training. Pre-training red blood cell volume was not different between control (1972 ± 
173 mL) and histamine receptor blockade (2239 ± 245 mL) conditions. There was no 
main effect of time (training) in either group (P=0.451) or interaction of condition 
(histamine receptor blockade) and time (training) (P=0.606). 
Packed cell volume or hematocrit throughout exercise training is shown in Figure 
5.3. Pre-training hematocrit was not different between control (39.64 ± 0.82 %) and 
histamine receptor blockade (39.35 ± 1.34 %) conditions. There was a main effect of time 
(training) with an increase in hematocrit (P=0.002), however no difference was observed 
between groups interaction of condition (histamine receptor blockade) and time (training) 
(P=0.886). In the control group, hematocrit increased above pre-training values at 2 
weeks (P=0.008) and 4 weeks (P=0.015), whereas in the histamine receptor blockade 
group, hematocrit tended to be higher at 2 weeks (P=0.079) and 4 weeks (P=0.056) after 
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exercise training. However, after 6 weeks of training, hematocrit levels in both groups 
were not different from pre-training values (P > 0.05) (Figure 5.3). 
Hemoglobin levels, represented as grams of hemoglobin per deciliter of blood, 
throughout exercise training are shown in Figure 5.4. Pre-training hemoglobin levels 
were not different between control (13.24 ± 0.21 g dL
-1
) and histamine receptor blockade 
(12.74 ± 0.45 g dL
-1
) conditions. 
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Figure 5.3. Hematocrit represented as a percentage at each time point throughout the 
training study. White bars = Control; Gray bars = Blockade. Values are means ± SEM. * 
P < 0.05 vs Pre across both groups (main effect of time). There was no effect of condition 
nor was there a condition x time interaction. 
 
There was a main effect of training as the control group, hemoglobin level increased 
(P=0.004); however no difference was observed between groups (P=0.970) or interaction 
of condition (histamine receptor blockade) and time (training) (P=0.280). In the control 
group, hemoglobin levels increased above pre-training values at 2 weeks (P=0.046), 
whereas in the blockade group, hemoglobin levels increased above pre-training values at 
6 weeks (P=0.043). Additionally, in the histamine blockade group, hemoglobin levels 
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tended to be higher compared to pre-training levels at 2 weeks (P=0.053) and 4 weeks 
(P=0.051) after training.  
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Figure 5.4. Hemoglobin represented as grams per deciliter of blood at each time point 
throughout the training study. White bars = Control; Gray bars = Blockade. Values are 
means ± SEM. * P < 0.05 vs Pre across both groups (main effect of time). There was no 
effect of condition nor was there a condition x time interaction. 
 
Muscle Responses. Of the 16 individuals who participated in this study, a subset of 10 
completed biopsy procedures. The demographic and anthropometric characteristics of 
these subjects are presented in Table 6.1 in the next chapter that focuses more on the 
biopsy results. Vastus lateralis muscle samples were assessed for changes in fiber cross 
sectional area, the number of capillary contacts per fiber, and the number of capillary 
contacts relative to fiber cross sectional area. All measures were compared to pre-training 
values, separated by group, and assessed by muscle fiber type.  
Muscle fiber cross sectional areas before and after exercise training are shown in 
Figure 5.5 through 5.7. Slow type I muscle fiber cross sectional area did not change from 
pre (3976 ± 521 µm
2
) to post-exercise training (3847 ± 579 µm
2
) in the control group 
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(P=0.929), nor from pre (3875 ± 610 µm
2
) to post-exercise training (4129 ± 308 µm
2
) in 
the histamine blockade group (P=0.828). Additionally, slow type I muscle fiber cross 
sectional area was not different between groups following training (P=0.905) (Figure 
5.5).  
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Figure 5.5. Slow type I muscle fiber cross section area represented as microns squared 
attained pre vs post throughout the training study. White bars = Control; Gray bars = 
Blockade. Values are means ± SEM. There was no main effect of time (training), no 
effect of condition, nor was there a condition x time interaction. 
 
Fast type IIa muscle fiber cross sectional area did not change from pre- (4628 ± 
473 µm
2
) to post-exercise training (4787 ± 435 µm
2
) in the control group (P=0.936), was 
not different from pre- (5035 ± 672 µm
2
) to post-exercise training (5731 ± 273 µm
2
) in 
the histamine blockade group (P=0.459). Additionally, fast type IIa muscle fiber cross 
sectional area was not different between groups following training (P=0.285) (Figure5.6). 
Fast type IIx muscle fiber cross sectional area did not change from pre- (6484 ± 502 µm
2
) 
to post-exercise training (6948 ± 609 µm
2
) in the control group (P=0.308) was not 
different from pre- (6725 ± 797 µm
2
) to post-exercise training (6761 ± 736 µm
2
) in the 
histamine blockade group (P=0.995). Additionally, fast type IIx muscle fiber cross 
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sectional area was not different between groups following exercise training (P=0.977) 
(Figure 5.7). 
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Figure 5.6. Fast type IIa muscle fiber cross section area represented as microns squared 
attained pre vs post throughout the training study. White bars = Control; Gray bars = 
Blockade. Values are means ± SEM. There was no main effect of time (training), no 
effect of condition, nor was there a condition x time interaction. 
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Figure 5.7. Fast type IIx muscle fiber cross section area represented as microns squared 
attained pre vs post throughout the training study. White bars = Control; Gray bars = 
Blockade. Values are means ± SEM. There was no main effect of time (training), no 
effect of condition, nor was there a condition x time interaction. 
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Capillary contacts per muscle fiber expressed in absolute number of capillaries 
before and after exercise training are shown in Figure 5.8 through 5.10. Slow type I 
muscle fiber capillary contacts were significantly increased from pre- (5.2 ± 0.2 capillary 
contacts) to post-exercise training (7.9 ± 0.2 capillary contacts) in the control group 
(P=0.0002), and from pre- (5.3 ± 0.5 capillary contacts) to post-exercise training (8.3 ± 
0.2 capillary contacts) in the histamine blockade group (P=0.0005). The increase in the 
number of capillaries following exercise training was not different between groups in 
slow type I muscle fibers (P=0.477) (Figure 5.8).  
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Figure 5.8. Capillary contacts per slow type I muscle fibers expressed in absolute 
number of capillaries before and after exercise training throughout the training study. 
White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre 
(main effect of time). There was no effect of condition nor was there a condition x time 
interaction. 
 
Fast type IIa muscle fiber capillary contacts were significantly increased from 
pre- (4.5 ± 0.2 capillary contacts) to post-exercise training (8.1 ± 0.6 capillary contacts) 
in the control group (P=0.0039), and from pre- (5.1 ± 0.5 capillary contacts) to post-
exercise training (8.6 ± 0.5 capillary contacts) in the histamine blockade group 
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(P=0.0142). The post-training control group was not different from the histamine 
blockade group following exercise training in fast type IIa muscle fibers (P=0.667) 
(Figure 5.9). Fast type IIx muscle fiber capillary contacts were not significantly increased 
from pre- (4.2 ± 0.5 capillary contacts) to post-exercise training (4.9 ± 0.4 capillary 
contacts) in the control group (P=0.178), or from pre- (4.0 ± 0.2 capillary contacts) to 
post-exercise training (4.9 ± 0.2 capillary contacts) in the histamine blockade group 
(P=0.144). Following exercise training capillary contacts were not different between 
groups in fast type IIx muscle fibers (P=0.121) (Figure 5.10). 
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Figure 5.9. Capillary contacts per fast type IIa muscle fibers expressed in absolute 
number of capillaries before and after exercise training throughout the training study. 
White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre 
(main effect of time). There was no effect of condition nor was there a condition x time 
interaction. 
 
Capillary contacts per muscle fiber cross sectional area expressed in centimeters 
squared before and after exercise training is shown in Figure 5.11 through 5.13. Slow 
type I muscle fiber capillaries per fiber cross sectional area significantly increased from 
pre- (14.5 ± 1.5 cm
2
) to post-exercise training (21.9 ± 3.1 cm
2
) in the control group 
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(P=0.0175), but did not change from pre- (11.6 ± 2.6 cm
2
) to post-exercise training (17.1 
± 2.9 cm
2
) in the histamine blockade group (P=0.1395). The post-training control group 
was not different from the histamine blockade group following exercise training in slow 
type I muscle fibers (P=0.281) (Figure 5.11). 
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Figure 5.10. Capillary contacts per fast type IIa muscle fibers expressed in absolute 
number of capillaries before and after exercise training throughout the training study. 
White bars = Control; Gray bars = Blockade. Values are means ± SEM. There was no 
effect of time, condition, nor was there a condition x time interaction. 
 
Fast type IIa muscle fiber capillaries per fiber cross sectional area were significantly 
different from pre- (10.0 ± 0.8 cm
2
) to post-exercise training (16.1 ± 1.5 cm
2
) in the 
control group (P=0.001), and from pre- (9.4 ± 1.2 cm
2
) to post-exercise training (14.4 ± 
1.8 cm
2
) in the histamine blockade group (P=0.012). The post-training control group was 
not different from the histamine blockade group in fast type IIa muscle fibers (P=0.519) 
Figure 5.12). Fast type IIx muscle fiber capillaries per fiber cross sectional area were 
significantly different from pre- (7.0 ± 0.8 cm
2
) to post-exercise training (9.1 ± 1.0 cm
2
) 
in the control group (P=0.018), but not from pre (6.3 ± 0.8 cm
2
) to post-exercise training 
100 
(7.2 ± 1.1 cm
2
) in the histamine blockade group (P>0.459). The post training control 
group was not different from the histamine blockade group in fast type IIx muscle fibers 
(P=0.329) (Figure 5.13). 
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Figure 5.11. The number of capillaries per slow type I muscle fiber cross sectional area 
expressed in capillaries per centimeters squared before and after exercise training 
throughout the training study. White bars = Control; Gray bars = Blockade. Values are 
means ± SEM. * P < 0.05 vs Pre (main effect of time). There was no effect of condition 
nor was there a condition x time interaction. 
 
Femoral blood flow, shown in Figure 5.14, was measured following a 5 min 
vascular occlusion separated by experimental condition and expressed in millimeters min
-
1
 over time. Pre-training peak femoral blood flow was not different between control 
(723± 73 mL min
-1
) and histamine receptor blockade (902 ± 110 mL min
-1
) conditions 
(P=0.407). There was a main effect of time (training) for both experimental groups 
(P<0.0001) as peak femoral blood flow was increased 24% following exercise training. 
The control group peak femoral blood flow were increased from pre- (723± 73 mL min
-1
) 
to post-exercise training (1027 ± 97 mL min
-1
) in the control group, and from pre- (902 ± 
101 
110 mL min
-1
) to post-exercise training (1099 ± 119 mL min
-1
) in the histamine blockade 
group (P<0.0001). As discussed in an earlier chapter, carotid artery lumen diameter 
increased following exercise training, but this increase was not different between groups 
(P=0.426) (Figure 4.5B). 
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Figure 5.12. The number of capillaries per fast type IIa muscle fiber cross sectional area 
expressed in capillaries per centimeters squared before and after exercise training 
throughout the training study. White bars = Control; Gray bars = Blockade. Values are 
means ± SEM. * P < 0.05 vs Pre (main effect of time). There was no effect of condition 
nor was there a condition x time interaction. 
 
DISCUSSION 
The purpose of this study was to determine the role of histamine receptor 
blockade on physiological adaptations induced by aerobic exercise training. We 
hypothesized that histamine receptor antagonists will blunt gains in aerobic capacity, by 
effecting the physiology behind adaptations to oxygen delivery. We focused on two of 
the early adaptations which support enhanced oxygen delivery during aerobic exercise: 
changes in blood volume and changes in capillarization of skeletal muscle. We did not 
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choose to explore changes in cardiac function, as the generally take longer to develop 
than the timeframe of our training protocol. The main finding of the present study was 
that combined blockade of histamine H1 and H2 receptors had no effect on the adaptations 
in oxygen delivery induced by 6-weeks of endurance exercise training as evidenced by 
changes in blood volume (not an evident adaptation during the time course of our 
protocol) and changes in capillarization of skeletal muscle (which did increase in 
response to training). These results suggest that chronically consuming antihistamines 
prior to exercise does not affect the adaptation that promotes a greater ability to deliver 
additional oxygen to working skeletal muscle and a greater aerobic capacity with 
training.  
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Figure 5.13. The number of capillaries per fast type IIa muscle fiber cross sectional area 
expressed in capillaries per centimeters squared before and after exercise training 
throughout the training study. White bars = Control; Gray bars = Blockade. Values are 
means ± SEM. * P < 0.05 vs Pre (main effect of time). There was no effect of condition 
nor was there a condition x time interaction. 
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Figure 5.14. Peak femoral blood flow attained at each time point throughout the training 
study. White bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 
vs Pre (main effect of time). There was no main effect of condition nor was there a 
condition x time interaction. 
 
Exercise Capacity 
Exercise training resulted in increased aerobic capacity as evident by an increase 
in VO2Peak and work performed following 6-weeks of combined continuous and high 
intensity exercise training, with no differences in these adaptations caused by histamine 
receptor blockade. On average there was about 11% improvement in VO2Peak following 
the 6-week exercise training protocol, which is in line with what other comparable 
exercise training studies have found (Bonne et al., 2014; Hautala et al., 2009; D. H J 
Thijssen et al., 2007; Vollaard et al., 2009). The control group tended to demonstrate 
more improvement in VO2Peak than the blockade group (13% vs 9% respectively), 
however with the high variability of improved aerobic capacity normally observed, the 
difference in VO2Peak improvement is negligible and we conclude that the improvement in 
whole body oxygen consumption was not altered in a meaningful way between groups. 
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Adaptations to exercise that are oxygen delivery centric include blood volume expansion 
and angiogenesis. The current study demonstrated that changes in the ability to deliver 
oxygen through increased blood volume did not contribute to the increased aerobic 
capacity, however angiogenesis was increased following exercise training and likely 
played a critical role in the observed improvements in exercise capacity.  
 
Blood Volume 
Expansion of red blood cell and plasma volume with exercise training is a 
fundamental adaptation and primary driver of the enhanced ability to consume oxygen 
via increased oxygen delivery through increased cardiac preload and maximal cardiac 
output (David Montero et al., 2015). Improvements in oxygen consumption following 
exercise training are not solely due to passive increases in blood volume, and rely on the 
combined adaptations of vascular oxygen delivery mechanisms and blood volume 
expansion (Warburton et al., 2004). 
Blood volume, plasma volume, and red blood cell volume did not change 
throughout exercise training in the present study. However, hematocrit was found to 
increase in the control group and hemoglobin levels were found to increase across both 
groups but at different time points. These results are not consistent with previous reports 
in the literature as increased red blood cell volume is thought to be a main determinant of 
cardiorespiratory fitness and is expected to increase with aerobic exercise training 
(Lundby et al., 2016). Evidence that blood volume should increase with exercise training 
comes from studies that show exercise training-derived increases in blood volume cause 
increased VO2Max that is reversed when red blood cell volume is experimentally 
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manipulated to pre-exercise training levels through phlebotomy (Bonne et al., 2014). 
Additionally, sedentary individuals, who have no history of exercise training but higher 
than average VO2Max, have enhanced red blood cell volume, demonstrating the 
importance of red blood cell volume and oxygen delivery in determining maximal 
oxygen consumption during exercise (Martino et al., 2002). Analysis of blood volume 
expansion with exercise training shows that when results are pooled across studies, red 
blood cell volume does not always increase with exercise training (D. Montero & 
Lundby, 2017; Michael N. Sawka et al., 2000). However, when data are stratified by age, 
young healthy individuals show a moderate, yet consistent increase in red blood cell 
volume in response to exercise training. Additionally, a positive correlation was found 
between the duration and intensity of training and the increase in red blood cell volume 
(D. Montero & Lundby, 2017). Based on this meta-analysis it is possible that the exercise 
training regimen used in the present study was not long or intense enough to observe 
increases in red cell volume that are normally associated with exercise training in similar 
populations.  
The principle factor regulating red cell volume expansion is the hormone 
erythropoietin, which is stimulated by factors like hypoxia and reduced central venous 
pressure that occur during exercise (M.N. Sawka, 1999). Plasma erythropoietin levels 
increase approximately 30% following 60-min period of cycle exercise at 50-70% 
VO2Max in untrained individuals. However, acute plasma erythropoietin responses to 
exercise decrease with continued exercise training (David Montero et al., 2017). These 
findings suggest sedentary individuals will have a robust erythropoietin response to 
exercise that will decrease with further exercise exposure at the same intensity and could 
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shine light on why there was no observed increase in red blood cell volume throughout 
the present study, with the majority of exercise sessions held at 60% of aerobic capacity. 
Hematocrit is the ratio of the volume of red blood cells to the total volume of 
blood and usually slightly decreases with exercise training due to expansion of both red 
blood cells and larger increase in plasma volume (Michael N. Sawka et al., 2000). The 
present study found an increase in hematocrit after two and four weeks of exercise 
training. These data are difficult to interpret as there was considerable variability within 
and across subjects that could have led to the current results. Hematocrit returned to pre-
training values by week 6 of training and there was no difference between groups.  
Hemoglobin is the iron-containing oxygen-transport metalloprotein found in red 
blood cells and its levels are tightly correlated with changes in red blood cell volume. 
Hemoglobin increased in the control group following two weeks of exercise training but 
returned to pre-training values for the remainder of the study. The histamine receptor 
blockade group showed no change in hemoglobin levels for the first 4 weeks of training, 
but hemoglobin increased at week 6 of training. With no change in red cell volume it is 
difficult to justify increased hemoglobin at different time points throughout the study. 
When hemoglobin values from the carbon monoxide rebreathing technique are used, 
there is no main effect of time, condition, or interaction between the variables. If 
hemoglobin levels did increase slightly, it was not a large enough increase to justify the 
larger increase in oxygen consumption that was observed throughout the study.  
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Angiogenesis  
Both sprouting and splitting angiogenesis have been shown to occur in response 
to increased blood flow which occurs during exercise (Egginton et al., 2001). Blood flow 
in the previously active skeletal muscle normally remains elevated following exercise and 
could be a continued stimulus for angiogenesis. However, blood flow in the previously 
active skeletal muscle following exercise is reduced with antihistamine consumption, 
which could limit the angiogenic stimulus (Barrett-O’Keefe et al., 2013; J.L. McCord & 
Halliwill, 2006). Additionally, acute aerobic exercise upregulates both pro- and anti-
angiogenic growth factors within the previously active skeletal muscle such as vascular 
endothelial growth factor (VEGF), nitric oxide synthase, thrombospondin 1 and 
endostatin (Richardson et al., 1999; S A Romero et al., 2016). Importantly, histamine 
receptor blockade modulates the balance of pro- and anti-angiogenic factors following 
acute exercise by blunting both nitric oxide synthase and thrombospondin 1 messenger 
ribonucleic acid (S A Romero et al., 2016). The blunting of both a pro- and anti-
angiogenic factor with histamine receptor blockade may influence vascular adaptations, 
like angiogenesis, with exercise training. 
 Angiogenesis occurred in response to 6-weeks of combined continuous and high 
intensity exercise training and was evident by an increase in the number of capillary 
contacts per fiber and the capillary density relative to fiber cross sectional area. All fiber 
types expressed increased numbers of capillaries per muscle fiber following training. 
Both slow type I and fast type IIa muscle fibers displayed an increase in angiogenesis, 
while fast type IIx fibers did not when the number of capillaries was normalized relative 
to fiber cross sectional area. Slow type I muscle fibers showed the greatest increase in 
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angiogenesis, which is appropriate for the intensity of exercise predominantly used 
throughout the training study. Exercise on a cycle ergometer at 60% VO2Max for 50 min is 
accomplished through recruitment of slow type I and fatigue resistant fast type IIa muscle 
fibers; however fast type IIx fibers are not be recruited at this moderate intensity exercise 
(Egan & Zierath, 2013). Therefore, these angiogenesis results fall in line with what is 
expected as increased blood flow is the primary signal that drives angiogenesis and it is 
likely that only slow type I and fast type IIa muscle fibers were primarily recruited 
throughout exercise training.  
Peak Femoral Hyperemia. Blood flow to any tissue is determined by the pressure 
gradient between the arterial and venous vasculature and the resistance to flow (Hautala 
et al., 2009). Vascular resistance, or conductance, is determined by the number and 
diameter of vessels within the tissue of interest. The femoral artery is a conduit vessel 
transporting blood to skeletal muscle along with every other tissue in the leg region. Peak 
femoral hyperemia increased, compared to pre-training measures, in both groups at all 
time points through the training study. This increase in peak femoral hyperemia is 
additional indirect evidence that there was microvascular adaptation in the skeletal 
muscle associated with exercise training and helps corroborate the increase in capillary 
density also found. 
 
Methodological considerations 
 The use of haematoxylin and eosin for capillary density measurements needs 
some consideration in the current study due to the higher than normal capillary contacts 
per fiber reported. Haematoxylin and eosin is used commonly for histology and will non-
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specifically stain nuclei and extracellular proteins. Therefore, it is possible that the high 
number of capillaries reported were inflated by the nonspecific staining of nuclei. This 
method has been verified in the past with additional immunohistochemical analysis of 
capillaries and found complete convergence of results (Proctor et al., 1995). Additional 
analysis by immunohistochemical analysis would help verify the high capillary counts in 
the current study. 
 
Conclusion 
Exercise training resulted in increased aerobic capacity evident by consuming 
more oxygen and preforming more work following 6-weeks of combined continuous and 
high intensity exercise training. Blood volume did not change throughout exercise 
training in this study; thus, it was not a necessary contributor to the observed aerobic 
capacity enhancements. However, angiogenesis increased with exercise training as 
evident in both histological measures of capillarization and functional tests of peak 
vasodilatory capacity. Thus, this well-known primary contributor to increased oxygen 
delivery to the working skeletal muscle and to enhanced aerobic capacity increased in our 
study but was not affected by histamine receptor blockade. 
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CHAPTER VI 
Histamine and Cardiovascular Adaptation to Endurance Exercise – Oxygen 
Utilization 
 
This study was made possible through the contributions of Brendan W. Kaiser, Joshua E. 
Mangum, Emily A. Larson, Michael A. Francisco, Sydney Kobak, Hans C. Dreyer, 
Matthew Fogarty, Gary C. Sieck, and John R. Halliwill. Brendan, Josh, Emily, and 
Sydney provided much needed assistance with data collection throughout the study. Hans 
and Matthew helped collect and experiment with human skeletal muscle samples. Gary 
gave me the opportunity to elevate the science around analyzing the muscle samples. 
John R. Halliwill assisted in the intellectual development of the project. I was involved 
with all aspects of this project including the development of the protocol, funding through 
fellowship applications, completed all data collection, compiled the data, analysis of the 
data, and developed the manuscript.  
 
INTRODUCTION 
Aerobic exercise capacity increases with repeated exercise stress and can be 
quantified by measuring oxygen consumption during graded exercise tests (VO2Max). In 
young healthy sedentary individuals, VO2Max is thought to be limited by cardiac output, 
or the ability to deliver oxygen to working skeletal muscle in addition to basal metabolic 
demand while maintaining homeostasis (González-Alonso & Calbet, 2003; Lundby et al., 
2016; Saltin & Strange, 1992). However, the ability to utilize oxygen in skeletal muscle 
through oxidative metabolism can also be a limiting factor in some populations and must 
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be explored to understand the full picture of adaptation to exercise training (Joyner & 
Coyle, 2008; David Montero & Díaz-Cañestro, 2015). Adaptations to exercise training 
that are oxygen utilization centric are located within the working skeletal muscle and 
include increased mitochondrial volume density and oxidative function. Moderate 
intensity aerobic exercise training will demonstrate improvements in the ability to utilize 
oxygen during subsequent exercise and will continue to improve aerobic capacity with 
the duration of training (Egginton, 2009; Przyklenk et al., 2017). 
Moderate intensity aerobic exercise causes increased histamine concentrations 
within the active skeletal muscle that is released from mast cell degranulation or through 
de novo formation through the enzyme histidine decarboxylase (Steven A. Romero et al., 
2016). Histamine activates H1 and H2 receptors on vascular endothelial cells and vascular 
smooth muscle cells to acutely cause vasodilation and promote increased blood flow. 
Previously active skeletal muscle vasculature will remain dilated for hours following 
exercise and result in reduced arterial pressure during that time. The increased blood flow 
and reduced arterial pressure following exercise is attenuated by blocking histamine H1 
and H2 receptors (Mccord & Halliwill, 2006; J.L. McCord et al., 2006; Steven A. Romero 
et al., 2016). Additionally, blocking histamine H1 and H2 receptors during exercise 
modulates the normal change in skeletal muscle mRNA expression related to endothelial 
and vascular function, metabolism, angiogenesis, cell maintenance, and inflammation (S 
A Romero et al., 2016).  
It is unknown if chronically consuming antihistamines prior to exercise causes 
differences in the rate or scope to exercise-induced cardiovascular adaptation. The 
purpose of this study was to determine the role of histamine receptor activation in the 
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adaptations to aerobic exercise training. Specifically, following six weeks of aerobic 
cycling exercise training in young healthy inactive volunteers, we determined the effect 
of histamine receptor antagonists on improvements in aerobic capacity and skeletal 
muscle succinate dehydrogenase activity (SDH activity). The hypothesis of this study is 
that histamine receptor antagonists will blunt positive physiologic adaptation, or gains in 
aerobic capacity, by effecting the ability to utilize oxygen during subsequent exercise. 
Specifically, following six weeks of aerobic cycling exercise training in young healthy 
inactive volunteers, we hypothesized that histamine receptor antagonists will blunt 
exercise induced gains in aerobic capacity measured as VO2Peak and maximal work, and 
blunt increases in skeletal muscle succinate dehydrogenase activity.  
 
METHODS 
Subjects 
This study was approved by the Institutional Review Board at the University of 
Oregon. Written informed consent was obtained from all subjects prior to participation 
and the study conformed to the principles of the Declaration of Helsinki. Ten (4 men, 6 
women) healthy, non-smoking individuals participated in this study and were considered 
recreationally active based on exercise habits over the previous 12 months (Baecke, 
Burema, & Frijters, 1982). Subjects were deemed healthy following a standard health 
screening. Sixteen (10 women) subjects completed the study while one subject withdrew 
from after the second study day due to scheduling conflicts. The data from this subject 
were not included in any analysis. All subjects were required to abstain from 
supplements, caffeine, and alcohol for at least 12 h, and exercise for at least 24 h prior to 
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all study days. No subjects were using any over the counter or prescription medications at 
the time of the study, with the exception of oral contraceptives. Women were studied 
irrespective of menstrual cycle phase and had a negative pregnancy test prior to all study 
days. All muscle biopsy samples were obtained between 7-8 am following an overnight 
fast. With the exception of the first study day, all data collection occurred between 24-48 
h after the most recent exercise session.  
 
Experimental Design 
The research protocol consisted of a double-blind placebo-controlled exercise 
training study. Subjects underwent a 6-week exercise training intervention (exercising 3-
4 times per week, totaling 21 sessions) with an experimental group receiving 
antihistamines (BLK) and a control group receiving a placebo (CTL) prior to each 
exercise session. There were 4 study days that included 2 study days for pre- and post-
training measurements (muscle biopsy and VO2Peak) and 1 study day after every 7 
exercise sessions, or 2 weeks, depending on subject schedules (VO2Peak). All experiments 
were conducted on the University of Oregon Campus with muscle biopsy procedures 
completed in Pacific Hall and exercise testing completed in Esslinger Hall. Prior to 
starting the first study day, subjects were block-randomly assigned to a control or 
blockade group. 
Each exercise testing study day started with measurements of height and weight. 
The subject was then instrumented with a Polar chest-strap heart rate monitor and Hans-
Rudolph two-way non-rebreathing valve with headgear and nose clip. Subjects sat quietly 
on the bike for 2 min before warming up for 5 min and starting the incremental exercise 
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test. Once peak oxygen consumption was reached, subjects cooled down for 3-4 min 
before completing a supra-maximal exercise effort to verify VO2Peak had be attained.  
 
Histamine Receptor Blockade and Placebo.  
Common over-the-counter oral antihistamine drugs were used in the experimental 
arm of this study. Histamine H1 and H2 receptors were blocked using a dose of 540 mg 
fexofenadine and 300 mg ranitidine. Placebo pills were manufactured by a compounding 
pharmacy (Creative Compounds, Wilsonville, OR) and contained the inactive ingredients 
of the fexofenadine and ranitidine tablets. Subjects consumed the antihistamine 
medication, or placebo, with water 1 h prior to every exercise session, but not before data 
collection study days. 
 
Exercise Testing and Training Protocol. 
Peak oxygen consumption. Subjects performed an incremental cycle exercise test 
(Lode Excalibur, Groningen, The Netherlands) to exhaustion, four times (study day 1, 16, 
30, 45) throughout the study. The exercise test consisted of 1-min workload increments 
until exhaustion to determine maximal oxygen uptake (VO2peak). Specifically, subjects 
expired breath was collected through a one-way valve connected to a pneumotach and 
mixing chamber and breathed normally during a 2-min resting period sitting quietly on 
the bike. After the rest period, subjects began pedaling at a self-selected cadence for a 4-
min warm-up period of low intensity cycling (40-130 W) determined as 1.5 times body 
weight (kg). Following the 4-min warm-up, subjects started the maximal exercised test 
and continued cycling while workloads increased at 20 or 30 W every min until volitional 
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fatigue. Selection of the workload increment was subjective based on sex and training 
status, with the goal of producing exhaustion within 9-12 min. Whole body oxygen 
consumption (VO2) was measured with a mixing chamber (Parvomedics, Sandy, UT, 
USA). The peak test was stopped and a cool-down period (40-60 W) of 3-5 min was 
initiated once subject reached exhaustion. Criteria for ending the peak test include; 
respiratory exchange ratio of 1.10 or greater, age-predicted heart rate max (220-age) was 
reached, pedaling cadence dropped below ~60 rpm, and perceived subjective exhaustion 
(rating of perceived exertion) on the Borg scale of 19-20 (Borg, 1970; Poole & Jones, 
2017). The peak test was ended once 3 of 4 criteria were met or the subject could not 
continue pedaling. Additionally, subjects completed a supramaximal exercise test (110% 
work rate, 90-120 s) to verify peak O2 consumption following the cool down (Poole & 
Jones, 2017). Subjects continued to pedal and cool down for 3-5 min following the 
supramaximal exertion. 
Exercise Training Intervention. This study utilized a combination of exercise 
approaches including continuous exercise of moderate intensity aerobic cycling for 1 h 
and high intensity interval training for 30 min. There were 21 exercise sessions (18 
continuous exercise and 3 high intensity exercise training) through the 6-week exercise 
program with intensity prescription assessed every 7 exercise sessions. Continuous 
exercise has been shown to elicit a robust vasodilatory response during recovery from 
exercise that is reduced by ~80% via H1 and H2 histamine receptor blockade (Lockwood 
et al., 2005; Mccord & Halliwill, 2006; J.L. McCord et al., 2006). High intensity interval 
training was included to ensure increases in VO2peak with training as some individuals 
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will not show, or have blunted, adaptation to continuous exercise alone (Bacon et al., 
2013). 
Moderate Exercise Intensity. Continuous exercise consisted of 5-min warm-up 
and cool-down periods at 30% VO2peak separated by a workload that produced 60% 
VO2peak for 50 min. Steady state continuous exercise VO2 was confirmed to be 60% of 
peak within the first 2 exercise sessions after each assessment of VO2peak. The workload 
was adjusted, if needed, to achieve a workload that produced steady-state 60% VO2peak. 
This workload was used on each of the continuous exercise sessions until VO2peak was re-
assessed.  
 High Intensity Interval Training Intensity. High intensity interval training 
consisted of 5-min warm-up and cool-down periods at 30% VO2peak separated by a 20-
min period of 3:1 interval training at 90% and 30% VO2peak for a total of five 3-min 
intervals at 90% VO2peak.  
 
Skeletal Muscle Biopsy.  
All skeletal muscle biopsies were performed on the University of Oregon campus 
in Pacific Hall by an expert muscle physiologist, Dr. Hans C. Dreyer. Prior to the 
procedure, subjects refrained from exercise for 24 h and arrived in lab fasted overnight. 
Biopsies were taken from the left vastus lateralis muscle under sterile technique. To start, 
the skin and underlying fascia were anesthetized using 1% lidocaine hydrochloride 
(Hospira Worldwide, Lake Forest, IL, USA) and subject perception of pain was verbally 
acquired to ensure the biopsy area was effectively anesthetized. Once verbal confirmation 
of local anesthetic was obtained, a small incision made in the skin and underlying fascia 
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before introduction of a 5 mm Bergstrom biopsy needle to the vastus lateralis muscle. A 
20-cc syringe and tubing were attached to the aspiration port on the Bergstrom needle in 
order to apply negative pressure to assist the biopsy. After the vastus lateralis muscle 
sample was collected, a series of Steri-Strips (3M, Maplewood, MN, USA) were placed 
over the incision and covered with a sterile transparent dressing (Tagaderm). The tissue 
sample was blotted with gauze, and any visible adipose tissue was removed before the 
muscle sample was mounted on cork, covered in medium (Optimal Cutting Temperature 
Compound (OCT)), immediately fresh-frozen in melting isopentane cooled with liquid 
nitrogen and stored at -80
o
C until further analysis. The muscle sample mounted on cork 
and fresh frozen was used to access either the maximum velocity of the succinate 
dehydrogenase reaction in single type-identified muscle fibers (SDHmax) or capillary 
density.  
Succinate dehydrogenase activity: Vastus lateralis muscle biopsy samples were 
cut in transverse serial sections at 6 µm thickness using a cryostat (Reichert Jung 
Frigocut 2800 Cryostat, Reichert Microscope Services, Depew, NY, USA), maintained at 
a temperature of -30
o
C. Sections were used for a quantitative assessment of the maximum 
velocity of succinate dehydrogenase reaction using a previously described quantitative 
histochemical procedure (Blanco et al., 1988; Enad et al., 1989; Fogarty et al., 2020; 
Proctor et al., 1995). Sections were cut and placed on a cover slip where they were 
immediately visualized to determine cross-section orientation of cells, maintained at 5
o
C 
with a control solution covering the section on the slide. Once the orientation of the 
section was confirmed, serial sections were cut from the sample at 6 m for SDHmax 
measurements and at 10 µm thickness to identify capillaries (haematoxylin and eosin, 
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H&E stain) and fiber type (immunoreactivity to myosin heavy chain, MyHC, antibodies), 
as described below in detail. 
For SDHmax determinations, a baseline image was acquired (Olympus IX71, 
Olympus America, Melville, NY) with a camera and image capture system running 
software (Elements C-ER, Nikon, Tokyo, Japan) for image processing. Images were 
acquired using a 20x objective (1.0 NA) and captured in a 1200 x 1200-pixel array, with 
similar acquisition parameters across samples. An interference filter (570 nm) was used 
to limit the spectral range of the light source to the optimal absorbance wavelength for 
nitroblue tetrazolium diformazan (the SDH reaction indicator). Once the baseline image 
was acquired, the control solution was removed via suction and a solution containing 80 
M succinate (to maximize substrate availability for the SDH reaction) was added. 
Thereafter, images were acquired every 15 s for a 10-min period with no changes to the 
environmental conditions or image processing system throughout the experiment. 
Both control (no succinate) and succinate (80 nM) solutions contained 1.5 mM nitro blue 
tetrazolium (NTB – reaction indicator), 5 mM EDTA, 0.2 mM PMS, and 0.1 mM azide in 
0.1 M phosphate buffer (pH = 7.6). The maximum concentration of succinate for the 
succinate dehydrogenase activity reaction was previously determined (Blanco et al., 
1988; Enad et al., 1989) and validated for human muscle fibers (Proctor et al., 1995). In 
the quantitative histochemical procedure, the progressive precipitation of diformazan 
from the reduction of nitro blue tetrazolium is used as the reaction indicator (Blanco et 
al., 1988; Proctor et al., 1995). The linearity of the accumulation of NBT diformazan in 
individual vastus lateralis muscle fibers was confirmed across a 20-min period. Based on 
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the linearity of the SDH reaction, a final end-point time of 10 min was selected to avoid 
any saturation of the imaging system. 
Muscle fiber types: Alternate 10 µm serial sections adjacent to those used for 
determination of SDHmax and H&E staining of capillaries, were placed on a cover slip 
and allowed to dry for 15 min to prevent lifting of the section. A total of 5 sections were 
cut from each sample and mounted onto a single slide to assess all fiber types. Samples 
were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for 5 min prior to starting 
immunofluorescence staining protocols. Slides were washed thoroughly in 0.1 M 
phosphate buffer before being incubated overnight at 4
o
C with each section covered in a 
unique primary antibody.  
A total of 4 primary antibodies were used to determine immunoreactivity of 
myosin heavy chain (MyHC) isoforms expressed by different muscle fiber types: (1) A 
specific skeletal muscle MyHCSlow antibody (Novus, NBP2-50299 Mouse IgG, 
Centennial, CO, USA) was used at a 1:10 dilution to identify slow type I muscle fibers. 
(2) A specific fast skeletal muscle MyHC 2A antibody (SC-71 Developmental Studies 
Hybridoma Bank, Mouse IgG, Iowa City, IA, USA) was used at a 1:1 dilution to identify 
fast type IIa muscle fibers. (3) A specific skeletal muscle MyHC2X antibody (Novus, 
NBP1-22811 Mouse IgG, Centennial, CO, USA) was used at a 1:10 dilution to identify 
fast type IIx muscle fibers. (4) A non-specific skeletal muscle MyHCFast antibody (Vector 
VP-M665, Mouse IgG, Burlingame, CA, USA) was used at a 1:10 dilution to identify all 
fast type II muscle fibers and by exclusion any fibers expressing MyHC2B (type IIb 
muscle fibers for which there is no specific antibody). After the primary antibodies 
incubated overnight, the slides were washed thoroughly in 0.1 M phosphate buffer and 
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then all sections were incubated for 2 h in secondary antibody at a 1:200 dilution (Cy3 
donkey anti-mouse IgG, ThermoFisher Scientific, Waltham, MA, USA) to assist in 
detection during imaging. Finally, the samples were washed in 0.1M phosphate buffer 
and allowed to dry before confocal microscopy. 
Transverse vastus lateralis muscle sections were imaged using a 20x oil-
immersion objective (NA 1.0) on an Olympus FV2000 laser confocal microscope capable 
of simultaneous multilabel florescence imaging. Images were captured in a 1200 x 1200-
pixel array, with similar acquisition parameters across preparations. Type-identified 
fibers were paired with the sections used to determine SDHmax and capillary density.  
 
Statistics. 
The statistical analysis for this research was performed using Prism software 
(GraphPad Prism 8, CA, USA). All subject characteristics are reported as mean ± SD and 
all additional data are reported as mean ± SEM. A Two-way ANOVA and Sidak post hoc 
test were used to compare groups and factor. There were repeated measurements over 
time with subject, drug, and training effect analyzed. Significance was set at P<0.05 for 
all analyses. 
  
RESULTS 
Subject Characteristics 
Ten (4 men, 6 women) healthy, non-smoking individuals participated in this 
study. The demographic and anthropometric characteristics of subjects obtained on their 
first study day included: age, height, weight, body mass index, Baecke sport index, 
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Physical activity index, and their 60% cycling power output (Table 6.1). Similar 
demographic and anthropometric information was obtained each study day and did not 
change throughout the course of the study with pre-study grouped values (age 24 ± 5 yrs, 
height 171.8 ± 9.6 cm, weight 74.3 ± 11.3 kg, body mass index 25 ± 3.5 m
2
, mean ± SD). 
Exercise Responses. The amount of oxygen consumed at peak exercise (VO2Peak) 
throughout exercise training is shown in Figure 6.1. Pre-training VO2Peak was not 
different between control (2.36 ± 0.32 L min
-1
) and blockade (2.60 ± 0.18 L min
-1
) 
conditions. There was a main effect of time (training) as VO2Peak in both groups increased 
with training (P=0.001); however no difference was observed between groups (P=0.732) 
nor was there an interaction of condition (histamine receptor blockade) and time 
(training) (P=0.807). The control and blockade group increased VO2Peak above pre-
training values (P=0.01; P=0.019, respectively) (Figure 6.1). 
Table 6.1. Subject Characteristics 
Values are mean ± SD, MET, metabolic equivalents.    
 Control Blockade 
n 6 4 
Age (yrs) 24 ± 6 24 ± 4 
Height (cm) 173.9 ± 9.5 168.8 ± 10.2 
Weight (kg) 71.6 ± 12.1 78.4 ± 9.9 
Body Mass Index (kg m-2) 23.6 ± 2.0 27.7 ± 4.0 
Baecke sport index (arbitrary units) 2.2 ± 0.5 2.8 ± 0.6 
Physical activity index (MET hr-1 week-1) 19.4 ± 9.3 29.7 ± 7.0 
60% power output (W) 120 ± 33 128 ± 27 
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The maximal amount of work (Watts) performed during peak exercise throughout 
exercise training is shown in Figure 6.2. Pre-training work was not different between 
control (208.0 ± 24.7 Watts) and blockade (232.5 ± 17.9 Watts) groups. There was a 
main effect of time (training) as maximal work performed increased in both groups 
(P<0.001), however no difference was observed between groups (P>0.523) nor was there 
an interaction of condition (histamine receptor blockade) and time (training) (P>0.696). 
Both control and blockade groups performed increased work during exercise after 6 
weeks of training as compared to pre-training values (P=0.0002; P=0.0018, respectively). 
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Figure 6.1. Absolute VO2Peak attained pre vs post throughout the training study. White 
bars = Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre across 
both groups (main effect of time). There was no main effect of condition nor was there a 
condition x time interaction.  
 
Muscle Responses. Vastus lateralis muscle samples were assessed for changes the 
maximum velocity of the succinate dehydrogenase reaction (SDHmax). All measures were 
compared to pre-training values, separated by group, and assessed by muscle fiber type.  
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Figure 6.2. Maximal work attained pre vs post throughout the training study. White bars 
= Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre (main 
effect of time). There was no effect of condition or condition x time interaction. 
 
Changes in SDH activity for slow type I muscle fibers, as reflected by the 
maximal velocity of the succinate dehydrogenase reaction, are shown throughout exercise 
training in Figure 6.3. Slow type I muscle fiber maximal velocity of the succinate 
dehydrogenase reaction was significantly different from pre- (1.4 ± 0.1 mmol fumerate L
-
1
 min
-1
) to post-exercise training (3.4 ± 0.4 mmol fumerate L
-1
 min
-1
) in the control group 
(P=0.0002), and from pre- (2.0 ± 0.5 mmol fumerate L
-1
 min
-1
) to post-exercise training 
(2.5 ± 0.6 mmol fumerate L
-1
 min
-1
) in the histamine blockade group (P=0.039). The 
post-training control group was not different from the histamine blockade group 
(P=0.707).  
Changes in SDH activity for fast type IIa muscle fiber maximal velocity of the 
succinate dehydrogenase reaction was significantly different from pre- (1.2 ± 0.2 mmol 
fumerate L
-1
 min
-1
) to post-exercise training (2.7 ± 0.3 mmol fumerate L
-1
 min
-1
) in the 
control group (P<0.0001), and from pre- (1.6 ± 0.3 mmol fumerate L
-1
 min
-1
) to post-
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exercise training (2.6 ± 0.4 mmol fumerate L
-1
 min
-1
) in the histamine blockade group 
(P=0.008). The post-training control group was not different than the histamine blockade 
group in fast type IIa muscle fibers (P=0.718) (Figure 6.4).  
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Figure 6.3. Slow type 1 SDH activity represented as maximal succinate dehydrogenase 
activity before and after exercise training throughout the training study. White bars = 
Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre (main effect 
of time). There was no effect of condition nor was there a condition x time interaction. 
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Figure 6.4. Fast type IIa SDH activity represented as maximal succinate dehydrogenase 
activity before and after exercise training throughout the training study. White bars = 
Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre (main effect 
of time). There was no effect of condition nor was there a condition x time interaction. 
 
125 
Fast type IIx muscle fiber maximal velocity of the succinate dehydrogenase 
reaction was significantly different from pre- (0.8 ± 0.2 mmol fumerate L
-1
 min
-1
) to post-
exercise training (1.7 ± 0.3 mmol fumerate L
-1
 min
-1
) in the control group (P=0.004), but 
not different from pre- (1.0 ± 0.2 mmol fumerate L
-1
 min
-1
) to post-exercise training (1.4 
± 0.3 mmol fumerate L
-1
 min
-1
) in the histamine blockade group (P=0.252). Additionally, 
the post-training control group was not different than the histamine blockade group in 
fast type IIx muscle fibers (P=0.956) (Figure 6.5). 
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Figure 6.5. Fast type IIx SDH activity represented as maximal succinate dehydrogenase 
activity before and after exercise training throughout the training study. White bars = 
Control; Gray bars = Blockade. Values are means ± SEM. * P < 0.05 vs Pre (main effect 
of time). There was no effect of condition nor was there a condition x time interaction. 
 
DISCUSSION 
 The purpose of this study was to determine the role of histamine receptor 
blockade on physiological adaptations induced by aerobic exercise training. We 
hypothesized that histamine receptor antagonists will blunt gains in aerobic capacity, by 
effecting the ability to utilize oxygen. The main finding of the present study was that 
combined blockade of histamine H1 and H2 receptors did not blunt adaptations in oxygen 
126 
utilization induced by 6-weeks of endurance exercise training as determined by either 
whole body VO2Peak or direct measures of the capacity of a representative oxidative 
enzyme. These results suggest that chronically consuming antihistamines prior to 
exercise does not affect the adaptive ability to utilize additional oxygen within working 
skeletal muscle, an adaptation that promotes greater aerobic function during subsequent 
exercise bouts.  
 
Exercise Capacity 
Exercise training resulted in increased aerobic capacity as evident by an increase 
in VO2Peak and work performed following 6-weeks of combined continuous and high 
intensity exercise training, with no differences in these adaptations caused by histamine 
receptor blockade. For the subjects who underwent biopsy measures, on average there 
was about 14% improvement in VO2Peak following the 6-week exercise training protocol, 
which is in line with what other comparable exercise training studies have found (Bonne 
et al., 2014; Hautala et al., 2009; D. H J Thijssen et al., 2007; Vollaard et al., 2009). The 
control group demonstrated slightly more improvement in VO2Peak than the blockade 
group (15% vs 14% respectively), however with the high variability of improved aerobic 
capacity normally observed, the difference in VO2Peak improvement is negligible and we 
conclude that the improvement in whole body oxygen consumption was not altered in a 
meaningful way between groups. We note that the changes in this set of subjects is 
comparable to what was reported in the preceding chapters which were based on a larger 
set of subjects. Changes in the ability to utilize oxygen through increased maximum 
velocity of the succinate dehydrogenase reaction are consistent with the increased aerobic 
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capacity observed and likely a direct contributor. That said, our hypothesis that histamine 
receptor blockade would blunt the increase in oxygen utilization is not supported by these 
results.  
 
SDH Activity 
Mitochondrial content will increase up to 100% and remain at that elevated steady 
state following 6-weeks of exercise training depending on intensity and duration of 
exercise (Hoppeler, 1986). Moderate improvements in VO2Max (around 5-20%) with 6-
weeks of endurance exercise training can be explained by the large increases (50-100%) 
in mitochondrial content and ability to utilize oxygen. Interestingly, moderate 
improvements in VO2Max fail to explain the large increases in exercise performance 
within the same time frame (Levine, 2008; Vollaard et al., 2009). The stimulus for 
mitochondrial biogenesis is muscle contraction; thus, mitochondrial biogenesis is fiber 
type specific (Hood, 2001). Muscle fibers that are not recruited during exercise training 
will display limited or no mitochondrial adaptations. With moderate intensity endurance 
training, mitochondrial biogenesis will be greatest in slow type I muscle fibers due to 
recruitment patterns during exercise. Moderate intensity endurance training will also 
drive modest changes in fast type IIa fibers, but limited changes in mitochondrial 
biogenesis of fast type IIx skeletal muscle fibers (Howald, 1985).  
Mitochondrial density is not heterogeneous throughout skeletal muscle and is 
different across muscle fiber types, which are separated into slow (type I) and fast (type 
IIa and IIx). Muscle fiber type is dependent on contractile protein (myosin heavy chain 
isoform) expression, which determine the mechanical and energetic properties of muscle 
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fibers (Widrick, Romatowski, Karhanek, & Fitts, 1997). Requirements for motor unit 
recruitment for force production determine the activation patterns of different muscle 
fiber types. Slow motor units comprising type I muscle fibers are recruited first, followed 
by fast fatigue resistant motor units comprising type IIa fibers and finally more fatigable 
fast motor units comprising type IIx fibers (Bawa, 2002; Mantilla, Seven, Zhan, & Sieck, 
2011; Seven, Mantilla, & Sieck, 2014). Slow type I and fast type IIa muscle fibers have 
the highest mitochondrial volume densities and oxidative capacity followed while fast 
type IIx muscle fibers have the lowest mitochondrial volume densities and oxidative 
capacities. Due to the high oxidative capacity of slow type I and fast type IIa muscle 
fibers, they also require the greatest amount of oxygen delivery and thus have the greatest 
number of surrounding capillaries (Anderson, 1975; Mantilla, Seven, & Sieck, 2014). 
Slow type I and fast type IIa muscle fibers are the first to be recruited during exercise and 
are the most fatigue resistant due to their relative size and high mitochondrial volume 
density; however they produce the least force per cross-sectional area among the different 
fiber types (Widrick et al., 1997).  
During exercise, motor units are recruited depending on intensity and duration of 
work required. Therefore, metabolic pathways will also differ through different 
modalities, intensities, and durations of exercise. For example, exercise on a cycle 
ergometer at 60% VO2Max for 50 min will recruit all slow type I and most fast type IIa 
muscle fibers, however fast type IIx fibers will not be recruited (Egan & Zierath, 2013). 
Due to the high proportion of slow type I and fast type IIa muscle fiber types involved 
with this intensity and duration of exercise; ATP will be produced primarily through 
oxidative metabolism. During high intensity exercise at 90% VO2Max for 3 min, it is likely 
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that recruitment of all muscle fiber types will be required to achieve the desired force 
production. Due to all muscle fiber types being recruited and the short duration of high 
intensity exercise, energy production will be a mix of aerobic and anaerobic metabolism 
to achieve adequate ATP production for force generation (Egan & Zierath, 2013). 
Additionally, cycling exercise is predominantly completed by knee extensor muscles, 
specifically the vastus medialis and vastus lateralis, with approximately 80% of total 
muscle activation, measured by electromyogram, coming from the two muscles equally 
(Duggan, Donne, & Fleming, 2017). Therefore, increases in whole-body oxygen 
consumption during cycling exercise will primarily come from oxidative phosphorylation 
of the slow type I and fast type IIa muscle fibers found within the vastus medialis and 
vastus lateralis muscles. 
 SDH activity increased in response to 6-weeks of combined continuous and high 
intensity exercise training and was quantified by an increase in the maximum velocity of 
the succinate dehydrogenase reaction. SDH activity increased across all three muscle 
fiber types and showed the largest increases in slow type I fibers with less substantial 
increases in fast type IIa muscle fibers and the smallest increase in fast type IIx muscle 
fibers. The maximum velocity of the succinate dehydrogenase reaction increased by 
about 35% in slow type I muscle fibers, which is similar in scale to what others have 
reported with similar duration exercise training (Hoppeler, Howald, & Weibel, 1985). 
These results agree with what was expected as slow type I and fast type IIa muscle fibers 
were likely to be recruited most frequently throughout exercise training. Histamine 
receptor blockade did not blunt the gains in SDH activity. 
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Methodological Considerations 
Increases in mitochondrial biogenesis can be assessed using multiple methods 
including direct assessment of organelle volume in relation to total cellular volume 
(mitochondrial volume density), total count of mitochondrial DNA copy number, or 
expression of inducible coactivators like peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha that regulate the expression of mitochondrial proteins (Hood, 
2001). Additionally, mitochondrial content can be assessed by the maximal velocity of 
reactions of marker enzymes like citrate synthase or succinate dehydrogenase under 
supraphysiological substrate concentration conditions in vitro (Henriksson & Reitman, 
1977; Proctor et al., 1995). Changes in mitochondrial volumes estimated 
morphometrically are highly correlated with changes in enzyme maximum velocity 
values, which allows functional measurements of potential oxygen utilization 
(Reichmann et al., 1985). 
It is well established that the mitochondrial enzyme citrate synthase increases 
with aerobic exercise training (Tonkonogi, Harris, & Sahlin, 1997). Citrate synthase is 
the initial enzyme of the citric acid cycle and a marker of mitochondrial matrix 1. Citrate 
synthase is qualitatively assessed through colorimetric assay in which the intensity of 
light absorbance is proportional to increased citrate synthase activity levels. The enzyme 
succinate dehydrogenase is unique in that it is the only enzyme that participates in both 
the citric acid cycle and the electron transport chain. In the citric acid cycle, succinate 
dehydrogenase catalyzes the oxidation of succinate to fumarate, a necessary step as the 
cycle will not continue without the presence of fumarate. Additionally, following 
succinate oxidation, the enzyme transfers electrons directly to the quinone pool, which 
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makes up complex II of the electron transport chain and serves as a vital connection 
between the two aerobic energy systems (Cecchini, 2003). The critical role of succinate 
dehydrogenase in both the citric acid cycle and electron transport chain makes the 
maximum velocity of the succinate dehydrogenase reaction a great marker of oxidative 
capacity (Fogarty et al., 2020). Additionally, the maximum velocity of the succinate 
dehydrogenase reaction has been validated in skeletal muscle and gives a quantitative 
assessment of mitochondrial function (Blanco et al., 1988). A limitation of the maximum 
velocity of the succinate dehydrogenase reaction is that it does not indicate if existing 
mitochondria have improved function or additional mitochondrial biogenesis has 
occurred, which would also exhibit increased SDH activity. These issues can be answered 
by quantifying mitochondrial DNA copy number, which was completed in muscle 
samples obtained for this study. However, this data was not included as fiber type 
proportion could not be quantified, which is necessary to determine if mitochondrial 
volume, mitochondrial function, or both contributed to changes in mitochondrial DNA 
copy number. Therefore, we know the maximum velocity of the succinate dehydrogenase 
reaction was increased with exercise training, but don’t know if that increase came from 
increased function of previously existing mitochondria, or newly formed mitochondria.  
 
Conclusion 
Exercise training resulted in increased aerobic capacity evident by consuming 
more oxygen and preforming more work following 6-weeks of combined continuous and 
high intensity exercise training. SDH activity increased with exercise training and is 
known to be a primary contributor to the observed aerobic capacity enhancements when 
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inactive individuals first begin exercise training. Histamine receptor blockade did not 
blunt improvements in SDH activity associated with aerobic exercise training nor did the 
negatively impact on whole body measures of aerobic capacity. 
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CHAPTER VII 
CONCLUSIONS AND FUTURE DIRECTIONS 
Main Findings 
It has been well established by the previous work done in this lab that histamine 
receptor activation is intricately involved with the response to exercise. We know that 
histamine concentrations increase within skeletal muscle during moderate intensity 
aerobic exercise. Histamine is released locally from working skeletal muscle by mast cell 
degranulation and de novo formation via the enzyme histidine decarboxylase. Local 
skeletal muscle histamine receptor activation plays a large role in the sustained post-
exercise vasodilation as well as systemic responses following exercise such as post-
exercise hypotension. Histamine receptor activation appears to either drive or modulate 
the differential regulation of hundreds of protein coding genes in skeletal muscle that are 
linked to endothelial and vascular function, metabolism, angiogenesis, cell maintenance, 
and inflammation. Due to the large effect that histamine receptor activation has on post-
exercise responses to acute exercise, it presented a unique opportunity to explore how 
histamine receptor activation could have the potential to modulate physiological 
adaptions to repeated exercise stress. 
The overall purpose of this dissertation was to determine the role of histamine 
receptor activation in adaptations to aerobic exercise training. We hypothesized that 
histamine receptor antagonists will blunt positive physiologic adaptation, such as gains in 
aerobic capacity, affecting the ability to deliver and utilize oxygen during subsequent 
exercise. Exercise training resulted in increased aerobic capacity evident by both a 
greater ability to consume oxygen and to preform work at a higher rate following 6-
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weeks of combined continuous and high intensity exercise training, as highlighted in 
Chapter IV. Chapter IV also presented the response to exercise training for measurements 
of vascular health that are commonly improved with habitual exercise. Vascular health 
measurements such as arterial compliance, pulse wave velocity, and resting 
hemodynamics were unchanged following exercise training. The lack of effectiveness of 
exercise to change these measures of vascular health could indicate the subject population 
was not starting from a deficit, or not sedentary enough, to be able to observe changes in 
these variables. Subjects were only included if they were deemed healthy, and they were 
generally young, which leaves little room for improvement in these vascular health 
measures. Another factor that likely played a role in in unchanged measures of vascular 
health and resting hemodynamics was the moderate intensity continuous exercise 
modality used in this study and the relatively short duration of the intervention. 
Adaptations to exercise training are largely duration and intensity dependent, so increased 
exercise intensity would have been more likely to demonstrate changes in these 
measurements. Further, it is well-known that some of the adaptations to aerobic exercise, 
such as cardiac restructuring, take longer to develop than the time frame of our exercise 
intervention. In contrast, femoral arterial lumen diameter increased with exercise training, 
indicating that some conduit vascular adaptation had occurred in response to the level of 
stimuli provided by this exercise program. Thus, while improved aerobic capacity 
following exercise training was not accompanied by changes in vascular health 
measurements, it was associated with more directly related vascular adaptations that 
promote greater blood flow to active muscle. However, these adaptations did not appear 
to be dependent on activation of histamine receptors during exercise, as blockade of these 
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receptors did not influence pattern of vascular and functional changes to exercise 
training. 
Chapter V investigated mechanisms of oxygen delivery and how they played a 
role in the increased aerobic capacity observed following exercise training. Blood volume 
and red blood cell volume did not change throughout exercise training. Blood volume 
expansion has been reported as a primary driver involved with increases in aerobic 
capacity associated with exercise training, and blood volume expansion involves both an 
increase in plasma volume and an increase in red blood cell mass through erythropoiesis. 
With these expectations in place, it was unexpected that we did not observe a change in 
blood volume, although there were some transient and inconsistent changes in 
hemoglobin and hematocrit observed at intermediate timepoints during the project. It is 
possible that a longer duration exercise training program or one involving higher intensity 
exercise would be more likely to demonstrate changes in blood volume. It is unfortunate 
that the stimuli for a change in blood volume was insufficient, as histamine receptor 
activation has direct links to red blood cell production and an effect in response to 
exercise training could have become apparent under conditions in which blood volume 
expansion had occurred. In contrast to the lackluster blood volume response, 
angiogenesis as measured by the number of capillary contacts per muscle fiber and 
capillary density (the number of capillaries relative to fiber cross sectional area) increased 
with exercise training in slow type I and fast type IIa muscle fiber types. This adaptation 
to exercise training was also evident in the peak vasodilatory capacity as assessed by 
reactive hyperemia in the femoral artery. However, despite previous work in this lab 
which has shown that histamine receptor activation increases pro-angiogenic factors 
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following acute exercise, histamine receptor blockade did not blunt the angiogenic gains 
associated with exercise training. The result of the current study demonstrate that 
histamine receptor blockade does not blunt pro-angiogenic factors enough to cause 
differences in physiologic adaptation, or that other redundant signals are available which 
can drive angiogenesis in the absence of a histaminergic signal. These combined results 
give evidence that the physiological adaptations that support greater oxygen delivery 
after exercise training are not dependent on histamine receptor activation during or 
immediately after exercise to be fully expressed. Either the activation of histamine 
receptors does not contribute to these adaptations, or the systems for adaptation are 
resilient and other mechanisms are equally capable of driving adaptations such as 
angiogenesis.  
Chapter VI investigated mechanisms of oxygen utilization and how they play a 
role in the increased aerobic capacity observed following exercise training. Muscle fiber 
aerobic capacity as measured by the maximum velocity of the succinate dehydrogenase 
reaction increased with exercise training in all fiber types. The changes in SDH activity 
were type dependent with greater adaptation occurring in slow type I and fast type IIa 
muscle fibers, which were recruited at greater proportions during most of the exercise 
completed. When interpreted in conjunction with the improvements in whole-body peak 
oxygen consumption, they support the dogma that early adaptations to exercise training 
that improve aerobic fitness are largely peripheral adaptation within the active skeletal 
muscle that support higher energy production via oxidative energy systems. Despite prior 
evidence from our lab that histamine receptor activation modulates adaptation in these 
energy systems following a single bout of exercise, results from this project were not able 
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to show any evidence that these adaptations within skeletal muscle are affected by 
histamine receptor blockade. Thus, the many measures in this dissertation project suggest 
that histamine receptor activation is not necessary to drive an increase in oxidative 
capacity. Either the activation of histamine receptors does not contribute to these 
adaptations, or the systems for adaptation are resilient and other mechanisms are equally 
capable of driving adaptations such as mitogenesis.  
To summarize, the results of my thesis indicate that the ability to deliver oxygen 
through increased blood volume via hematopoiesis did not contribute to increased aerobic 
capacity and was not affected by histamine receptor blockade. However, the ability to 
deliver oxygen through increased angiogenesis (assessed via capillary density and 
corroborated by peak vasodilatory capacity) and utilize oxygen through increased 
SDHMax and corroborated by VO2peak contribute to increased exercise capacity but that 
these adaptations occur either independent of the effects of histamine receptor activation 
or that adaptation is generated by redundant mechanisms in a highly resilient manner. 
 
Significance 
Activation of the histamine H1 and H2 receptor pathway appears responsible for 
much of the robust post-exercise hemodynamic response and either drives or modulates 
many changes in gene expression that occur following acute aerobic exercise. However, 
many of these acute effects linked to histamine do not appear to translate into the longer-
term adaptations to chronic exercise. The research objectives outlined in this dissertation 
represent an advance in the basic scientific and mechanistic literature of adaptation to 
aerobic exercise training. The results of this thesis research reject the hypothesis that 
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activation of the histamine H1 and H2 receptor pathway is necessary for the full 
expression of the adaptations to aerobic exercise in young sedentary individuals. The 
mechanisms by which repeated exercise stress are translated into beneficial physiological 
adaptation are yet to be fully explained, although molecular transducers are being 
cataloged by many research teams. Activation of the histamine H1 and H2 receptor 
pathway during exercise is intricately involved with acute exercise responses, however 
the robust mechanisms responsible for physiological adaptation to exercise training are 
not clearly affected due to redundant systems in place to achieve hormesis. Thus, a 
fundamental question remains: why and to what affect is histamine released from skeletal 
muscle in response to exercise? 
 
Future Directions 
The Halliwill Lab is known for studying cardiovascular regulation in response to 
exercise and how histamine receptor activation plays a vital role in driving these 
physiological consequences of aerobic exercise stress. Histamine is produced and 
released from skeletal muscle during exercise and plays a vital role in multiple 
physiological pathways associated with acute aerobic exercise responses. The current 
study provides new information about the interaction between histamine receptor 
activation and exercise training, but raises more questions than it answers, and results in 
what can be considered a “histamine paradox”. Why do acute exercise studies show such 
clear evidence for a role of histamine in adaptation to exercise when a chronic exercise 
training study shows no evidence of a role. How does histamine blockade paradoxically 
leave a broad footprint on the exercise transcriptome, yet no imprint on training adaptions 
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that are inherently dependent on transcriptional changes for key outcomes such as the 
ability to deliver and utilize oxygen through increases in angiogenesis and SDH activity?  
 Based on previous research from the Halliwill Lab and the current results, this 
line of research would benefit from an exercise training program of greater intensity and 
duration. Increasing the intensity and duration of exercise training would widen any 
potential differences that could be observed in capillary density and/or SDH activity. The 
current study utilized exercise intensity and duration that had been used in previous 
research in the Halliwill Lab. This intensity and duration of exercise was designed, in 
part, to be achievable by young healthy sedentary individuals, which it was successful in 
doing as exercise adherence was close to 100%. Using that knowledge to move forward, 
exercise intensity should be increased by 15-20% of VO2Peak with additional exercise 
days included each week. One possibility would be to move the high intensity interval 
training sessions between the continuous exercise training sessions with fewer recovery 
days resulting in increased exercise stress. Additionally, the subject population of young 
healthy sedentary individuals would be improved by utilizing a clinical population that is 
starting at more of an aerobic deficit. Subject populations such as aged individuals, 
peripheral artery disease, or spinal cord injury (with different exercise modalities) would 
be more likely to demonstrate differences between groups due to their aerobic deficit and 
increased ability to improve or may have fewer or less robust redundancies to drive 
adaptation to chronic exercise. 
 Additional research is also needed to discern whether observed increases in SDH 
activity are due to improvements of existing mitochondrial oxidative capacity or due to 
mitochondrial biogenesis. This could be accomplished with the same skeletal muscle 
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biopsy technique and the addition of mitochondrial DNA copy number measurements 
extrapolated by fiber type proportions in the biopsy samples. Skeletal muscle fiber type 
shifts associated with exercise training would also illuminate the issue of mitochondrial 
volume vs function. 
Future exercise training research should focus on the interaction between 
improvements in capillary density and SDH activity and if they adapt at the same rate or 
if one variable drives the other. This question would be difficult to answer in human 
research model and would benefit from animal or tissue work where the stimulus for 
either variable could be isolated. For example, an animal model could be used to induce 
muscle contraction (a stimulus for mitochondrial biogenesis) while clamping blood flow 
(a stimulus of angiogenesis) through the muscle.  
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APPENDIX A 
INFORMED CONSENT DOCUMENT 
INFORMED CONSENT FORM 
TITLE: Histamine and Cardiovascular Adaptation to Endurance Exercise 
INVESTIGATOR: Dr. J. R. Halliwill and Colleagues 
This is an important form. Please read it carefully. It tells you what you need to 
know about this study. If you agree to take part in this research study, you need to 
sign the form. Your signature means that you have been told about the study and 
what the risks are. Your signature on this form also means that you want to take 
part in this study. 
Why is this research study being done? When humans exercise, histamine is 
released by exercising muscle and has the potential to either trigger or modulate the 
recovery response to exercise. The long-term goal of this research protocol is to better 
understand the link between chronic aerobic exercise, histamine, and adaptation in the 
context of exercise training and physical recovery from exercise. This topic is both 
clinically and scientifically important. You have been asked to participate in this study 
because you are a healthy individual who does not participate in routine aerobic or 
cardiovascular exercise training. 
What will happen in the study? 
This schematic summarizes the research measurements that are made throughout this 
experiment. This experiment will span 46 consecutive days, which will include all 
experimental testing and exercise sessions. To participate in this research, you will need 
to be able to travel to the research area, located on the University of Oregon campus, 
multiple days of the week, including weekends. The exercise training is designed to be 
difficult and will be challenging to complete. You are expected to consistently participate 
and communicate with the researchers throughout the experimental period. 
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Initial Visit 
Prescreen. You will arrive at Dr. Halliwill’s laboratory in Esslinger Hall at the University of 
Oregon for an initial visit. This initial visit will take approximately 1 hour. You will meet 
with one of the investigators of the study to discuss the project, to see the laboratory, 
and to read this form. Your height and weight and resting blood pressure will be 
measured, and you will be asked questions about your health history. You will be given a 
physical activity questionnaire, which will allow investigators to determine your activity 
level. 
Exercise Training Sessions (~21 hours over 6 weeks) 
Aerobic exercise. The exercise training protocol will span 6 weeks. You will conduct 21 
exercise sessions on a stationary bicycle with a rest day between every exercise 
session. All exercise will be completed in the Exercise and Environmental Physiology 
Lab in Esslinger Hall at the University of Oregon. You are advised to wear a t-shirt with 
shorts and tennis shoes for all exercise sessions. One hour prior to arrival, you will 
consume medication we have previously provided.  
A member of the research team will be present during all exercise sessions. Upon 
arrival, a research assistant will instrument you with a heart rate monitor that straps 
around your chest. Subjects will not be provided with food or beverages (other than 
water) during the exercise sessions. Upon completion of each exercise session, subjects 
will be given a snack (Granola bar) and fluids (18oz Gatorade) to eat and drink. 
There will be two different types (moderate/hard) of stationary bicycle exercise 
completed during this study. The majority of exercise (16 out of 21 sessions) will consist 
of moderate intensity exercise, which will be difficult, but at a level where you could keep 
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up a conversation while exercising. You will also complete hard intensity exercise, (5 out 
of 21 sessions) which will be very difficult and at a level where you could not keep up a 
conversation while exercising. Hard intensity exercise will have a short amount of easy 
exercise before and after, and the hard exercise will last 3 minutes at a time. 
If you are a woman who can still become pregnant, you will be asked to undergo a 
pregnancy test during each exercise session. You will be asked to provide a sample of 
urine in the women’s restroom near the physiology lab. If the test is “positive,” indicating 
that you are pregnant, you will not be allowed to participate and will be advised to see 
your physician or the University of Oregon Health Center. 
Antihistamines. A custom pillbox organizer containing 2 weeks of either an antihistamine 
or placebo will be provided. You will consume the pills provided one hour before each 
exercise session. Once you have consumed the pills you will contact (text/e-mail) 
research personnel with a picture of the labeled pillbox organizer. Your exercise session 
should start one hour after this information has been sent. The antihistamines are 
Allegra and Zantac, common over-the-counter medications. The placebo tablets contain 
the inactive found in Allegra and Zantac, but none of the active ingredients. You will not 
know which pills you are taking throughout the study.  
Pre and post-exercise testing.  
Measurements made before (Pre-) and after (Post-) the exercise training program will 
take two consecutive days to complete. You will report to the Exercise and 
Environmental Physiology Lab in Esslinger Hall at the University of Oregon. Day 1 will 
include a skeletal muscle biopsy, a maximal exercise test (VO2peak) and measures of 
cardiac output. Day 2 will include resting hemodynamic testing, blood profiling and 
volume measurements, vascular function tests, and body composition analysis. All 
measurements included are detailed below. 
Pre and post-exercise training study day 1 (~3 hours). 
1. Muscle biopsies. You will arrive at Dr. Dreyer’s laboratory in the Center for 
Medical Education and Research at the University of Oregon to participate in the 
experimental protocol. The testing will take approximately 1-2 hours. A total of 2 
biopsies will be taken from your right leg throughout the whole experiment (one 
before and one after all your training sessions are completed). This biopsy will be 
performed through a single incision and involves taking a small piece of muscle 
from your leg. First, a small patch of hair is removed (if needed) from your thigh 
and the skin is cleaned and sterilized. Next, the skin and tissue below where the 
biopsy will be obtained will be numbed with a local anesthetic (lidocaine). After 
your leg is numb we will make a small incision about the size of this dash “____” 
at approximately mid-thigh. Through this incision a needle about the size of the 
letter “O” will be advanced into the muscle. A single piece of thigh muscle will 
then be removed with the needle, the skin closed with a single stitch and light 
dressing will be applied. This will be done once in one leg before exercise 
training, and once in the same leg after you have completed the exercise 
training. 
2. Peak exercise testing. You will cycle on a stationary cycle ergometer while 
wearing a mouth piece, nose clip, and electrocardiogram electrodes (heart 
rhythm monitor). After 5 minutes of spinning at a comfortable speed, a constant 
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speed will then be used, while the resistance of the ergometer is increased until 
you reach exhaustion. This is to measure your overall aerobic fitness level. It 
normally takes 10 to 15 minutes for people to reach their maximum effort. This 
test will establish your maximal exercise tolerance and will be used to select an 
appropriate workload for exercise during the study visits.  
3. Cardiac Output. Cardiac output will be estimated before and during the peak 
exercise test using an open-circuit acetylene uptake method. You will breathe a 
gas mixture containing 0.6% acetylene, 9.0% helium, 20.9% oxygen, and 
balance nitrogen for 8 - 10 breaths. The acetylene and helium are physiologically 
inert and used for routine pulmonary function testing. 
Pre and post-exercise training day2 (~7 hours). 
1. Resting Heart rate and blood pressure. We will connect you to a 3-lead 
electrocardiogram that involves placing pads on your skin on both of your chest 
and stomach. Blood pressure will be measured using an inflation cuff on the right 
upper arm.  
2. Blood volume assessment. We will estimate your total blood volume using a 
technique where you breathe in a small amount of the gas, carbon monoxide 
(CO), and measure how much CO makes it into your blood. In the CO uptake 
test, first, we will place a small flexible needle (these are called “intravenous 
catheters”, and are smaller than the lead of a pencil) into a vein near your elbow. 
The skin will be cleaned thoroughly before this procedure with alcohol swabs. 
The catheter placement will be performed by a member of the lab highly-trained 
in this technique. After the intravenous catheter has been placed, we will ask you 
to sit quietly for 30 minutes before the procedure begins. Throughout the test, we 
will take two small blood samples of ~5mL each (about 1 teaspoon), for a total of 
~10mL on each day (~20mL total for the entire study), to measure the amount of 
the gas, CO, in your blood. The vials in which we collect the blood will be coded 
such that the investigators can determine all samples came from the same 
subject and the time the sample was taken. No one will be able to determine your 
identity from the sample.  
During the blood volume assessment, you will breathe on a closed rebreathing 
system for several minutes. This means you will inhale and exhale into a bag. 
Your nose will be closed with a nose clip. The air in this rebreathing system is 
pre-filled with 100% oxygen. We will inject a dose of the gas CO into the 
breathing system and you will inhale deeply to make sure you inhale as much 
CO as possible. CO is a gas that quickly moves from the air in your lungs to your 
blood. To further help this you will hold your breath for ~10 seconds after you 
deeply inhale. You will then continue to rebreathe on the system for an additional 
minute and 50 seconds (2 minutes total). At the end of the rebreathing period, 
you will exhale all of the air out that you possibly can into the bag. When you 
cannot get any more air out, you will come off of the rebreathing system and 
breathe normal room air. We will measure the amount of CO present in your 
lungs by breathing into a small tube connected to a device that can measure CO, 
and take a small blood sample to measure the amount of CO in your blood 
before and after you breathe on the rebreathing system. After the last blood 
sample, we will remove the catheter from your arm and place a sterile bandage 
over the site.  
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It is important for you to realize that you may stop when you wish because of 
feelings of nausea, light- headedness or discomfort. 
3. Blood sampling for lipid, glucose, and lactate profiling. We will collect a venous 
blood sample of less than 10 ml for subsequent testing for lipid, glucose, and 
lactate profiling. This blood sample will be collected before mearurments of blood 
volume are conducted. 
4. Arterial compliance. A small probe (ultrasound Doppler probe) will be held over 
an area of skin over multiple areas of your body including your groin, neck, and 
arm. We will use this probe over your groin-hip intersection to image your femoral 
artery. We will use this probe over your neck to image your carotid artery. We will 
use this probe over your arm to image your brachial artery. The ultrasound 
Doppler probe uses ultrasound waves to measure blood flow in these arteries. A 
pencil-type probe that measures changes in pressure will be used over the same 
areas. All measurements will take approximately 2 min per site, and you will be 
asked to be calm and quiet during these measurements. This is a non-invasive 
procedure and should not be uncomfortable, other than some minor pressure at 
the measurement sites. 
5. Flow mediated dilation. A small probe (ultrasound Doppler probe) will be held 
over an area of skin over multiple areas of your body including your groin and 
arm. We will use this probe over your groin-hip intersection to image your femoral 
artery and over your arm to image your brachial artery. We will use the 
ultrasound probe to make a 2 minute measurement at baseline and a 3 minute 
measurements following a 5 minute occlusion caused by the inflation of a cuff 
around your lower arm or leg. 
6. Body composition alaysis. Measurements will be made using calipers to measure 
skinfold thickness at various sites on the body. The sum of the skinfold thickness 
can be used with height and weight measurements to calculate percent body fat. 
We will measure skinfold thickness at 7 sites around your body including your 
chest, arm, stomach, back, and leg.  
Mid-Training Assessments (~6 hours). 
The two mid-training assessment days will be identical and a number of measurements 
that have already been detailed above will be repeated. These tests include measuring 
resting heart rate and blood pressure, blood volume, peak exercise test, arterial 
compliance, and flow mediated dilation. All measurements will be the same as outlined 
above except for the blood volume measurement, which will switch methodology to use 
a small blood draw to estimate blood volume and takes much less time. 
Food intake log and other restrictions. Subjects will be asked to refrain from consuming 
caffeine or medications for 12 hours and abstain from exercise or alcohol for 24 hours 
prior to all data collection visits. Subjects will be asked to refrain from food consumption 
for 2 hours before each exercise visit. Subjects will be asked to complete a Food Intake 
Log of their food consumption 24 hours prior and during experiment data collection 
visits. Subjects will be given a copy of their food logs and will be asked to match their 
food intake to the best of their ability, as indicated in the log, on the subsequent data 
collection visits. 
Post-biopsy care 
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After the biopsy procedures, you will go over things that you must do to help minimize 
the risk of infection. We will also provide a hardcopy of these instructions for you to take 
home. The handout is titled “Things to Remember After Muscle Biopsy,” and must be 
taken seriously. We will also periodically contact you to see how the biopsy site is doing.  
We ask that the day after each biopsy, if you are not scheduled for a Follow-Up Visit, 
you email a close-up picture of each biopsy site and send it to us for us to ensure 
everything looks healthy. If anything appears to need further inspection, you will be 
asked to come in to the lab for a closer look. We ask that you return to the lab 7 days 
after the experiment to have your sutures removed and the biopsy site inspected. This 
will take about 20 minutes.  
If you are unable to return for the 7-day post biopsy visit, you must have a qualified 
medical professional familiar with suture removal take out the two sutures. You will be 
asked to send the researchers images of each site before and after the sutures are 
removed, so that the researchers can confirm the sites are healthy and healing as 
expected. If after viewing the images, the researchers decide that they require further 
inspection and/or medical treatment, you will be advised to see your doctor as soon as 
possible or visit urgent care or the emergency room. You will be asked to follow up with 
us and let us know the outcome of the doctor’s visit.  
Should you opt for the alternative path, any costs incurred by the medical professional 
are the responsibility of the subject as well as any costs incurred as a result of further 
needed medical attention for the site. If after viewing the images, if the researchers 
decide that they require further inspection and/or medical treatment, the subject will be 
advised to see their doctor as soon as possible or visit urgent care or the emergency 
room. You will be asked to follow up with the researchers and let us know the outcome 
of the doctor’s visit. 
If you would prefer to have a qualified medical professional outside of the research team 
perform the suture removal, please initial here: _______________ date:_________ 
How long will I be in the study?  
You will be in the study for a total of 46 days consisting of 6 data collection days and 21 
exercise sessions. Your total involvement would be about 36 hours.  
What are the risks of the study?  
Muscle biopsies. The muscle biopsy carries the potential risk of pain, bleeding, bruising, 
infection, and scar formation at the site of the biopsy. Careful sterile technique should 
reduce the likelihood of any of these complications. The risk of bleeding is about 0.2%; 
the risk of bruising or a blue-and-black mark is 1.4%; and infection is so small that the 
precise number is unknown. After the study, you have a 50% chance of experiencing 
soreness at the site of biopsy for 24 to 48 hours. Additionally, you may experience 
numbness around the area of the biopsy site (2x2 inches), which will likely go away with 
time (sensation returns) but in very rare instances may never return. The risk that you 
experience numbness is less than 0.5% and the risk that the numbness never goes 
away is much less. The scar will be approximately as long as the dash “____”. 
Lidocaine. The risk associated with lidocaine is similar in character to those observed 
with other local anesthetics. Some of the more common adverse reactions include 
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nervousness, dizziness, blurred vision, tremor, drowsiness, tinnitus, numbness, 
disorientation, hypotension, nausea and vomiting. 
Exercise testing. There is some minor discomfort associated with exercise testing and 
training, including temporary fatigue, shortness of breath, and muscle soreness. These 
sensations resolve within minutes after the testing or training sessions are 
completed. There is a high possibility of residual muscle soreness in the few days 
following the exercise test and the higher intensity training sessions. This muscle 
soreness will be greater at the beginning of the experimental period because you will 
have completed exercise that you are unaccustomed to performing. Muscle soreness 
will usually begin around 1 day after you finish an exercise bout, and last for 1-2 days. 
Heart rate and blood pressure will be constantly monitored during exercise. The exercise 
session will be terminated if you feel light-headed, nauseated, or experience any other 
adverse signs or symptoms. There is also the risk of a heart attack or death during an 
exercise test. The risk of a complication requiring hospitalization is about 1 incident in 
1000. The risk of a heart attack during or immediately after an exercise test is less than 
1 incident in 2500. The risk of death during or immediately after an exercise test is less 
than 1 incident in 10,000. In the unlikely case of a life-threatening heart rhythm, the 
laboratory is equipped with an Automatic Electronic Defibrillator that is in the same room 
where the study is taking place. In the event of an emergency, 911 will be called and we 
will direct an ambulance to the correct location. 
Blood Volume Assessment. Healthy nonsmoking city dwellers typically have CO level of 
1.5-2.0% (the percentage of hemoglobin in the blood that is bound by CO).. This test will 
increase this level by roughly 6%. Although you do not want to increase your level of 
CO, the levels used for this test are low and present minimal risks. The side effects 
associated with excessive CO typically occur at levels above 8% and may include 
headache, fatigue, shortness of breath, nausea, cherry-red colored lips, dizziness, and 
death, the last of which rarely occurs below 15% CO in normal individuals. This method 
has been in use in research for measuring blood volume for over 100 years without 
notable complications. Over time the CO bound to hemoglobin in your blood will be 
removed. This process will occur naturally over the several hours following the test. For 
every 5 to 6 hours that passes after the test, half of the CO will leave your blood. Thus, 
after 15-18 hours you would have less than 1% CO in your blood.  
If, for any reason, your post-administration CO rises above 10% or you develop side-
effects associated with excess CO, we will initiate O2 therapy to accelerate CO 
clearance from your system. O2 will be given using a nasal administration similar to what 
someone may wear while in the hospital. Administering O2 reduces the half-life of CO 
(speeds up the process of getting rid of it) from ~5 hours to ~80 minutes. We will 
measure CO throughout the O2 administration and periodically afterwards. We will stop 
treatment if CO is < 8% or the symptoms go away. If symptoms progress or do not 
improve, 911 will be called and we will direct an ambulance to the correct location. In the 
unlikely case of an adverse cardiovascular event, the laboratory is equipped with an 
Automatic Electronic Defibrillator. 
Venous Blood sampling. In total, about 80 ml of blood will be withdrawn over the course 
of the study, which is less than that associated with standard blood donation programs, 
where 450-500ml of blood (half a quart) is routinely withdrawn. You should not donate 
blood or volunteer for another research study where blood will be drawn for 8 weeks 
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following completion of the study. The 8-week period is recommended to allow your 
body to reproduce the blood that was taken during the study days.  
Oral fexofenadine and ranitidine. There are minimal risks associated with the oral 
administration of fexofenadine (brand name Allegra) or ranitidine (brand name Zantac), 
which include nausea, diarrhea, and headache. You will be asked to consume 540 mg of 
fexofenadine and 300 mg of ranitidine, these amounts are within the upper limits of 
single dosage recommended by the manufactures. Fexofenadine in one time dosages 
up to 800 mg and 28 days of 690 mg every 12 hours have been given without adverse 
effects. Similarly, ranitidine has been given in dosages of 400 mg for 28 days without 
any major side effects. The 540 mg dose of fexofenadine hydrochloride is greater than 
the 180 mg over-the-counter recommended. This amount of fexofenadine is still safe for 
humans as single doses up to 1980 mg and 690 mg two times per day for a month 
showed no ill outcomes. The 300 mg dose of ranitidine hydrochloride is in-line with the 
manufacturers recommended dose. These medications are some of the most widely 
used over the counter (OTC) medications and are effective for treatment of seasonal 
allergies and excessive stomach acid secretion. There are no know risks associated with 
the placebo tablets, which were manufactured by a compounding pharmacy (Creative 
Compounds, Wilsonville, OR) and contain the inert ingredients found in the Allegra and 
Zantac antihistamine tablets without the active ingredients. You will not know which pills 
you are taking throughout the study.  
Occlusion by blood pressure cuff. The inflation of the blood pressure cuff to stop blood 
flow may cause a slight tingling sensation and may cause slight bruising.  The 
sensations with prolonged blood flow occlusion greater than 10 minutes are similar to 
those when a limb has “fallen asleep.”  During certain surgical procedures, blood flow is 
often stopped for 2 hours without any significant risk to the patient.  If, at any time, you 
experience any discomfort you may request that the blood pressure cuff be either 
loosened or removed. 
Tracking of Taxable Income. Please note, compensation from participation in Human 
Subjects Research studies is taxable income. If your compensation totals $600 or more 
in a calendar year, the University is required to report the income to the IRS. The 
University requires its departments to track participant compensation and may contact 
you to complete a Form W-9 for tax reporting purposes. Because of the federal and 
University tracking requirements, your name will be associated with participation in 
research. Department and University administrators will have access to this information, 
but will not have access to research data. 
The study may include risks that are unknown at this time. 
Are there benefits to taking part in this study?  
This study will not make your health better. Measurements are not being conducted for 
diagnostic purposes. The results will not be reviewed by a physician. The purpose of this 
study is to provide more information on how humans respond to exercise. Our hope is 
that by better understanding the physiology of how the human body responds to 
exercise, we will be better able to use exercise in the prevention and treatment of 
diseases such as hypertension (high blood pressure) and other forms of cardiovascular 
disease. 
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What other choices do I have if I don’t take part in this study?  
This study is only being done to gather information. You may choose not to take part in 
this study.  
What are the costs of tests and procedures?  
You will not pay for any tests or procedures that are done just for this research study. 
You will get up to $200 for participating in this study, including $170 for completing all 
the research testing and $30 for completing at least 90% of the aerobic exercise training 
sessions. This money is for the inconvenience and time you spent in this study. If you 
start the study but stop before the study has ended, the amount of money you receive 
will be pro-rated at a rate of $10 per research testing hour that you complete.  
Who is funding this research study? 
This study is being funded by The Eugene & Clarissa Evonuk Memorial Graduate 
Fellowship in Environmental or Stress Physiology 
Who can answer my questions? 
You may talk to Dr. John Halliwill at any time about any question you have on this study. 
You may contact Dr. Halliwill by calling the Department of Human Physiology at (541) 
600-4337. 
What are my rights if I take part in this study? 
Taking part in this research study is your decision. You do not have to take part in this 
study, but if you do, you can stop at any time. Your decision whether or not to participate 
will not affect your relationship with the University of Oregon. 
You do not waive any liability rights for personal injury by signing this form. Biomedical 
research involves some risk of injury. In spite of all precautions, you might develop 
medical complications from participating in this study. 
The investigators may stop you from taking part in this study at any time if it is in your 
best interest, if you do not follow the study rules, or if the study is stopped. For example, 
if the investigators determine the study is overly stressful for you (as indicated by body 
language and an elevated heart rate and/or blood pressure) they may stop you from 
participating in the study. Or if you express pain or discomfort beyond what is normally 
expected, the investigators stop you from participating in the study.  
If you are physically injured because of the project, you and your insurance company will 
have to pay your doctor bills. If you are a UO student or employee and are covered by a 
UO medical plan, that plan might have terms that apply to your injury.  
If you experience harm because of the project, you can ask the State of Oregon to pay 
you. If you have been harmed, there are two University representatives you need to 
contact. Here are their addresses and phone numbers: 
General Counsel      Research Compliance Services 
Office of the President    5237 University of Oregon 
1226 University of Oregon    Eugene, OR 97403-5237 
150 
Eugene, OR 97403-1226    (541) 346-2510 
(541) 346-3082 
A law called the Oregon Tort Claims Act may limit the amount of money you can receive 
from the State of Oregon if you are harmed. 
What about confidentiality? 
Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential and will be disclosed only with your permission. Subject 
identities will be kept confidential by assigning you a “subject identification number”. The 
names associated with each subject identification number will be kept in a locked file 
cabinet in Dr. Halliwill’s office area.  
Research Compliance Services and/or authorized representatives of the Food and Drug 
Administration (FDA) or National Institute of Health (NIH) may need to review records of 
individual subjects. As a result, they may see your name, but they are bound by rules of 
confidentiality not to reveal your identity to others. 
The list of names will be destroyed when study results are published or 24 months after 
your participation, whichever comes first. All blood and muscle samples will be 
destroyed when study results are published or 5 years after your participation, whichever 
comes first. Other information may be stored by the researchers indefinitely. 
You will be asked to complete a Medical History Form on the study day which will list 
personal identifying information so that in the unlikely event of a medical emergency in 
which we would activate the emergency medical system, we would be able to provide 
this information to emergency healthcare providers. This document will be retained in a 
locked file cabinet in the Exercise and Environmental Physiology Lab until you complete 
the study, after which it will be placed in a locked confidential documents disposal bin 
which is emptied by a secure shredding service. 
I have had an opportunity to have my questions answered. I have been given a 
copy of this form. I agree to take part in this study.  
If you have questions regarding your rights as a research subject, contact Research 
Compliance Services, 5219 University of Oregon, Eugene, OR 97403, 541/346-2510. 
Your signature indicates that you have read and understand the information provided 
above, that you willingly agree to participate, that you may withdraw your consent at any 
time and discontinue participation without penalty, that you will receive a copy of this 
form, and that you are not waiving any legal claims, rights or remedies. 
______________________________________________ 
(Signature of Participant)     (Date) 
______________________________________________ 
(Signature of Individual Obtaining Consent)   (Date) 
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